Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,37249,405,3.29 [1.83-5.90],6.434114072282676e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AAMDC,Mth938 domain-containing protein,36223,386,0.82 [0.68-1.00],0.0462762489599208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,42503,452,1.04 [0.90-1.22],0.5780505829332391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,35986,394,1.22 [0.92-1.61],0.1642557350396184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABHD14B,Protein ABHD14B,42230,453,0.95 [0.82-1.11],0.5343806619547875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,42503,452,1.03 [0.91-1.17],0.6027355507889491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABO,Histo-blood group ABO system transferase,37239,408,0.98 [0.91-1.05],0.493207546713914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,35986,394,1.02 [0.87-1.18],0.8410479318094353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41668,448,1.38 [1.25-1.52],4.019026722797775e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36507,400,1.05 [0.92-1.20],0.4811953282312404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37203,406,1.00 [0.90-1.11],0.989712992550243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,42291,455,1.22 [0.90-1.66],0.1924031920657014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE,Angiotensin-converting enzyme,37239,408,2.51 [1.76-3.58],3.193095376345696e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,41880,443,1.70 [1.48-1.95],3.2474960362303085e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACHE,Acetylcholinesterase,36382,391,1.41 [1.07-1.86],0.0156967439718841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,37041,407,1.08 [0.99-1.18],0.074860197804509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42691,456,1.14 [0.96-1.34],0.1253854060525187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,36116,394,0.62 [0.48-0.79],0.0001126859531522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,42866,459,1.96 [1.55-2.48],1.7153745740329875e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,43000,464,1.16 [1.01-1.33],0.0345676306101355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRBP,Acrosin-binding protein,37037,409,1.03 [0.79-1.33],0.8485301136147667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACRV1,Acrosomal protein SP-10,36116,394,0.85 [0.75-0.96],0.0099504873326046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,35986,394,1.17 [0.89-1.54],0.2599546183131006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",41880,443,1.39 [1.18-1.63],6.65229788260347e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,35986,394,1.07 [0.91-1.25],0.4046442068395819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN4,Alpha-actinin-4,41875,450,0.87 [0.64-1.17],0.3559262958551809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,42294,453,2.61 [1.95-3.50],1.5177610030738183e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,42691,456,1.31 [1.16-1.49],2.09612028658542e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,35986,394,1.40 [1.19-1.65],5.487311774929657e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACYP1,Acylphosphatase-1,36248,391,0.99 [0.85-1.16],0.9305589497209008
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,43147,461,1.41 [1.13-1.75],0.0021857234051259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,42423,454,1.89 [1.57-2.26],8.21555771009886e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36116,394,1.91 [1.61-2.27],1.7572954018179705e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41880,443,1.77 [1.34-2.33],5.695483453831583e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42367,453,0.52 [0.41-0.66],6.111212147039264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,43147,461,0.73 [0.58-0.91],0.0053670200748018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,43004,460,1.69 [1.28-2.22],0.0001750554156715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37041,407,2.45 [1.86-3.23],1.9136137713211011e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36116,394,1.64 [1.25-2.14],0.0003105428580191
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,43204,461,0.45 [0.31-0.63],5.002061051766659e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42503,452,1.60 [1.30-1.97],9.45985146299771e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41880,443,1.24 [0.97-1.58],0.0889749440713822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36116,394,1.36 [1.04-1.77],0.0236378149777997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42814,456,0.82 [0.68-0.99],0.03869170943643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,37205,407,3.38 [2.68-4.27],8.776820052987807e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,36223,386,1.47 [0.97-2.22],0.0682825861351635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,37203,406,1.05 [0.82-1.34],0.6833749351329743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41668,448,0.82 [0.61-1.10],0.1898635613593461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADD1,Alpha-adducin,36382,391,0.88 [0.76-1.02],0.0963245562282596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,42294,453,1.04 [0.80-1.34],0.7761440833799707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,36382,391,2.18 [1.76-2.71],9.53464501717999e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,37041,407,1.33 [1.12-1.58],0.0012409233689765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,42864,461,1.20 [0.90-1.61],0.2195938893899769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,42992,460,1.11 [0.85-1.45],0.4534663901980518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,37203,406,1.25 [0.89-1.77],0.2007587647491178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,42503,452,1.38 [1.26-1.52],1.3759602402506339e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,42691,456,0.90 [0.66-1.22],0.5075386162324521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,35984,403,1.09 [0.96-1.25],0.1995125516836045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,36382,391,1.02 [0.89-1.16],0.8003137901539089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41880,443,1.02 [0.92-1.13],0.7335707243991502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,37249,405,1.49 [1.29-1.72],5.1277985007795e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,43059,464,4.45 [3.25-6.08],9.346265011560964e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,35986,394,1.07 [0.93-1.22],0.3707353876832528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFAP1,Actin filament-associated protein 1,36382,391,0.84 [0.74-0.95],0.007461762088051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFM,Afamin,37249,405,0.82 [0.50-1.33],0.4223921019049411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AFP,Alpha-fetoprotein,42223,451,1.08 [0.95-1.23],0.238139465089352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,35984,403,0.94 [0.84-1.05],0.2547844795934728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,42592,456,0.85 [0.69-1.04],0.1145393747051113
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,41370,434,1.20 [1.10-1.31],3.241936544298002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,41598,446,1.03 [0.89-1.20],0.6530197576946083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,42864,461,1.81 [1.46-2.23],5.4358511044429634e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,43147,461,0.94 [0.80-1.10],0.4161477607230437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGT,Angiotensinogen,37239,408,1.18 [0.79-1.77],0.4147433044977704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,42691,456,1.24 [1.12-1.38],4.171534528550116e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHCY,Adenosylhomocysteinase,42691,456,1.07 [0.94-1.21],0.2953186867526374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,36223,386,1.04 [0.76-1.40],0.8197639547481606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK2,Protein AHNAK2,36223,386,1.54 [1.16-2.06],0.0032199612987085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37037,409,1.02 [0.88-1.18],0.7950692381500973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,37239,408,1.21 [0.84-1.74],0.3132257385691956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,42620,456,1.05 [0.95-1.17],0.3052045016163773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",36175,396,1.05 [0.92-1.18],0.4732280910646002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1,Allograft inflammatory factor 1,41668,448,1.23 [1.04-1.45],0.0147890980852531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,36223,386,0.91 [0.74-1.10],0.3266255802394919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42433,452,1.17 [1.08-1.26],0.0001184747642717
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK1,Adenylate kinase isoenzyme 1,42691,456,1.08 [0.94-1.23],0.2876506889014004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",37122,409,1.06 [0.96-1.16],0.2382336945202221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKAP12,A-kinase anchor protein 12,36382,391,1.08 [0.68-1.72],0.751188428068941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,41668,448,1.03 [0.92-1.16],0.6076707658183613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,36175,396,1.28 [1.11-1.48],0.0006577659074264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,41880,443,1.11 [0.95-1.29],0.1768383861321725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,36116,394,1.15 [1.01-1.33],0.0419968559436444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,41707,446,1.06 [0.92-1.21],0.4295882916859633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,37147,408,0.97 [0.90-1.04],0.3918690827862596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,41467,448,0.89 [0.76-1.04],0.1338212328210347
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALCAM,CD166 antigen,43204,461,2.27 [1.52-3.37],5.341875424940488e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,42688,457,1.26 [1.08-1.45],0.0023889902130645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",37037,409,1.14 [0.95-1.36],0.1747845350960392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42550,453,1.37 [1.24-1.51],4.3406732111982526e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37147,408,1.51 [1.25-1.82],1.3570345555020904e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALMS1,Alstrom syndrome protein 1,36507,400,0.95 [0.75-1.21],0.6758334245564568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,36116,394,1.03 [0.94-1.12],0.5471917734342395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",42503,452,1.28 [1.20-1.36],4.93355774011628e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,41875,450,0.79 [0.55-1.12],0.1766739098825195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,42997,461,1.90 [1.26-2.87],0.0021128727946308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37205,407,1.03 [0.70-1.51],0.8898683669122747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,41707,446,1.09 [0.96-1.25],0.1751899817094852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO1,Amphoterin-induced protein 1,36175,396,1.05 [0.87-1.27],0.6363510130240835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMIGO2,Amphoterin-induced protein 2,42503,452,1.52 [1.05-2.19],0.0253378333034292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,41875,450,0.93 [0.77-1.11],0.4027330703434573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,36382,391,1.08 [0.84-1.38],0.5441964659758527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOTL2,Angiomotin-like protein 2,36900,408,0.97 [0.78-1.22],0.810196285835725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMPD3,AMP deaminase 3,37122,409,1.01 [0.88-1.16],0.9136584822958036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,34897,380,0.89 [0.73-1.10],0.2779894649756921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,41019,440,0.76 [0.64-0.91],0.0032059780732588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,39767,426,0.72 [0.60-0.86],0.0004051621200672
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,42565,455,1.53 [1.20-1.94],0.0005231114007627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,42534,457,0.99 [0.90-1.10],0.8465968691734213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,43059,464,2.70 [2.23-3.27],1.990982469002913e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,42075,443,2.35 [1.76-3.14],7.659200955570108e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,42729,460,1.40 [1.14-1.72],0.0014455112638808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,42706,456,1.59 [1.25-2.02],0.0001482669244004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,42795,460,1.86 [1.55-2.23],2.6969950786579856e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,43059,464,1.51 [1.22-1.87],0.0001218018020817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANK2,Ankyrin-2,35986,394,1.05 [0.92-1.20],0.4802740866116285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36116,394,0.95 [0.83-1.08],0.407162088299386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,35893,396,1.03 [0.86-1.24],0.7336188144987709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,41668,448,1.16 [1.01-1.33],0.0313818927376805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36223,386,0.81 [0.60-1.09],0.158617249006804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,42777,457,1.85 [1.38-2.47],3.5078273614665625e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA1,Annexin A1,36177,389,1.05 [0.86-1.30],0.6178195552130996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,41707,446,1.40 [1.28-1.54],8.17361969720657e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA11,Annexin A11,42557,452,1.02 [0.89-1.16],0.777002476059149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,35669,382,1.24 [1.09-1.41],0.0008337812044371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA3,Annexin A3,43004,460,1.06 [0.94-1.20],0.3202239185958933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA4,Annexin A4,42487,452,0.99 [0.88-1.12],0.9079986474046948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,41577,440,1.40 [1.05-1.87],0.0225207897705629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],41875,450,1.02 [0.88-1.19],0.7692610207418493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,42847,457,2.38 [1.80-3.15],1.4832594762864362e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,37037,409,1.05 [0.93-1.18],0.432876079665201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP2B1,AP-2 complex subunit beta,36175,396,1.07 [0.88-1.31],0.497183242313638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3B1,AP-3 complex subunit beta-1,37041,407,1.05 [0.92-1.19],0.459285372387342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,37122,409,1.00 [0.82-1.23],0.9738063890065276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42503,452,1.20 [1.01-1.42],0.0421241673906865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,36916,400,0.87 [0.65-1.16],0.3541427029211429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42928,464,1.18 [1.03-1.36],0.0201041019299285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,42691,456,0.67 [0.57-0.80],4.879264130976361e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA1,Apolipoprotein A-I,37249,405,1.18 [0.84-1.64],0.3399136691838783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,37239,408,1.38 [1.14-1.68],0.0011549895744333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA4,Apolipoprotein A-IV,37249,405,0.95 [0.72-1.25],0.7177921640175815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOB,Apolipoprotein B-100,37239,408,1.06 [0.68-1.65],0.7954712480909403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOBR,Apolipoprotein B receptor,36223,386,1.09 [0.86-1.39],0.4626459006660417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOC1,Apolipoprotein C-I,37174,404,0.96 [0.74-1.23],0.719774481376324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOD,Apolipoprotein D,35560,386,0.98 [0.77-1.26],0.8871220152529843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOE,Apolipoprotein E,37249,405,1.04 [0.91-1.18],0.6070673409884597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,37239,408,0.80 [0.58-1.12],0.1919498823359426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOH,Beta-2-glycoprotein 1,42688,457,1.21 [0.96-1.52],0.1092582672243912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOL1,Apolipoprotein L1,37239,408,0.91 [0.76-1.08],0.2636119839861807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOM,Apolipoprotein M,42779,457,1.01 [0.75-1.35],0.955816557129948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,42628,457,1.04 [0.92-1.18],0.551094257613527
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APPL2,DCC-interacting protein 13-beta,36382,391,0.96 [0.88-1.05],0.3483419709302179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APRT,Adenine phosphoribosyltransferase,42302,453,1.04 [0.87-1.25],0.6650102163458209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,36507,400,0.96 [0.82-1.12],0.5790480746319973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,42503,452,2.35 [2.02-2.72],2.3617632154847866e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARF6,ADP-ribosylation factor 6,37041,407,0.96 [0.88-1.05],0.3653675961797761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARFIP1,Arfaptin-1,37147,408,1.03 [0.90-1.19],0.6435133046500989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG1,Arginase-1,42441,455,0.92 [0.78-1.08],0.3086501518231996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARG2,"Arginase-2, mitochondrial",37037,409,0.96 [0.75-1.21],0.7073735104446479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,41668,448,0.96 [0.80-1.16],0.6876448054469361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,41668,448,0.97 [0.84-1.11],0.6405324903515395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,36507,400,1.00 [0.76-1.31],0.9743151294070908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,36382,391,0.96 [0.84-1.08],0.4707171029771622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,35893,396,1.04 [0.92-1.19],0.5235810412351215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,37122,409,1.05 [0.94-1.17],0.4151436579352726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,37147,408,1.04 [0.94-1.15],0.4685943994717726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,42620,454,0.95 [0.88-1.04],0.2796321335773816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,35984,403,1.16 [1.02-1.32],0.0207490163238998
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,35984,403,0.94 [0.72-1.22],0.6407545410153545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,41707,446,1.01 [0.82-1.25],0.8990218154547817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,35986,394,1.18 [1.03-1.35],0.0174774798119957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,35986,394,0.95 [0.74-1.22],0.674432222988514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,35984,403,1.05 [0.89-1.23],0.5887714723226207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,41875,450,0.96 [0.74-1.24],0.7398603271669439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,35986,394,0.96 [0.79-1.17],0.6705519226368659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,42688,457,1.23 [1.02-1.47],0.0295979055431852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,42503,452,1.17 [1.01-1.36],0.0379267304983111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,42847,457,0.76 [0.60-0.96],0.0234120376536803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,35984,403,0.92 [0.78-1.10],0.3774261553189831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,41875,450,1.21 [1.03-1.42],0.0187302472212944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,36852,406,1.47 [1.22-1.77],4.18695960081172e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH2,Neutral ceramidase,42367,453,0.88 [0.76-1.02],0.085274357194064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,42367,453,2.64 [2.06-3.40],2.8760328559322614e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,37239,408,2.29 [1.63-3.24],2.264667582442196e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPN,Asporin,37203,406,1.68 [1.26-2.25],0.0003994075562708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,37147,408,0.97 [0.84-1.12],0.6460735499678824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,36223,386,0.96 [0.86-1.06],0.3789905113059288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASS1,Argininosuccinate synthase,35986,394,0.91 [0.80-1.03],0.151285194221296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,41707,446,1.00 [0.88-1.13],0.975105691387642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,35893,396,0.99 [0.74-1.34],0.9586314581235283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG16L1,Autophagy-related protein 16-1,37041,407,1.01 [0.90-1.13],0.8364544235241922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATG4A,Cysteine protease ATG4A,41668,448,1.07 [0.93-1.24],0.3526293148421509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,42814,456,1.17 [1.04-1.33],0.0115749377003534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,35986,394,1.05 [0.86-1.28],0.6354677305133041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,35986,394,1.13 [0.82-1.56],0.4651916068446826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,35986,394,1.06 [0.82-1.37],0.6556685181688041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP1B4,Protein ATP1B4,35893,396,1.18 [0.94-1.48],0.1524042970235506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,35986,394,1.02 [0.86-1.21],0.8493530054834622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",35986,394,0.96 [0.79-1.17],0.7193127497733577
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",42864,461,1.03 [0.95-1.11],0.4637116052362404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",41707,446,0.98 [0.79-1.22],0.8835308937053136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,41668,448,1.06 [0.86-1.31],0.5679172662699057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,42503,452,0.90 [0.65-1.25],0.5390286608271897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,41633,446,1.06 [0.93-1.20],0.4070361386313252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,36223,386,0.97 [0.85-1.12],0.6986766376256467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,35986,394,0.96 [0.85-1.07],0.4519905738456898
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,37041,407,1.60 [1.28-2.00],3.769414445637999e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRN,"Attractin, Isoform 2",37249,405,0.87 [0.48-1.59],0.6556145971846197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN10,Ataxin-10,41707,446,0.92 [0.81-1.04],0.172146129265137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2,Ataxin-2,35984,403,0.97 [0.88-1.06],0.475036403570466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN2L,Ataxin-2-like protein,37147,408,0.95 [0.77-1.18],0.6424635391018707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATXN3,Ataxin-3,37122,409,1.02 [0.87-1.20],0.7873142703290965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,42620,454,0.97 [0.88-1.06],0.4530508651583408
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,42847,457,1.00 [0.73-1.35],0.9849469331660864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZI2,5-azacytidine-induced protein 2,37147,408,1.02 [0.86-1.22],0.8081905426994721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,41371,442,1.13 [1.02-1.25],0.0167801145364243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,37249,405,1.71 [1.41-2.07],4.744855464422904e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,35986,394,1.54 [0.96-2.49],0.0758177486848068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36223,386,1.90 [1.44-2.50],4.993033866165211e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",42864,461,2.30 [1.72-3.07],1.896549233764943e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",42688,457,0.89 [0.63-1.26],0.5125456292662187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,36116,394,1.13 [0.80-1.59],0.4800611973407783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,42620,454,1.07 [0.95-1.20],0.2607167682102285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,42294,453,0.82 [0.66-1.01],0.061645377290688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,36116,394,0.98 [0.80-1.20],0.8399543770611838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG6,Large proline-rich protein BAG6,41880,443,1.05 [0.83-1.33],0.6875078951636635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41668,448,1.35 [1.19-1.53],2.112229447506632e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,41668,448,1.54 [1.17-2.02],0.0020132730732005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,42620,454,0.95 [0.88-1.04],0.260945764471248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAP18,Chromatin complexes subunit BAP18,37122,409,1.18 [1.04-1.34],0.009457465690286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,36175,396,1.12 [1.01-1.26],0.0363949069168727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,41639,442,1.10 [1.00-1.21],0.0630200051693478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAM,Basal cell adhesion molecule,42688,457,2.07 [1.50-2.85],9.392374891719774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,42367,453,0.34 [0.26-0.43],9.85506953320492e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37203,406,1.59 [1.21-2.09],0.0008285661654678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",35984,403,0.94 [0.77-1.13],0.4917085412260964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCHE,Cholinesterase,36554,398,0.61 [0.44-0.83],0.0020428662850199
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,37041,407,1.03 [0.86-1.24],0.7387298193071969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L1,Bcl-2-like protein 1,37122,409,1.02 [0.92-1.13],0.6973426505403237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42620,454,1.38 [1.11-1.70],0.0035210026843395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L15,Bcl-2-like protein 15,36116,394,1.16 [1.00-1.36],0.0522789032762274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,35893,396,1.08 [0.93-1.24],0.3005632200799757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,37037,409,0.99 [0.79-1.25],0.9387977784259808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,42620,454,0.98 [0.89-1.08],0.6835709219405023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,37205,407,0.97 [0.87-1.09],0.6577524696963801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,36223,386,0.97 [0.82-1.15],0.7424267706512973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BEX3,Protein BEX3,35893,396,0.91 [0.71-1.15],0.4277896605347766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,37205,407,1.10 [0.99-1.23],0.0794598327023235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGN,Biglycan,41598,445,0.96 [0.89-1.04],0.2961993947199313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,35984,403,1.02 [0.88-1.17],0.8200868075840674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,35986,394,1.41 [0.94-2.12],0.1011427128814857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BID,BH3-interacting domain death agonist,42620,454,1.04 [0.92-1.18],0.5542794273907945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIN2,Bridging integrator 2,42688,457,1.01 [0.92-1.11],0.8116438198274345
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,41668,448,0.95 [0.82-1.09],0.4433302767115982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLMH,Bleomycin hydrolase,43204,461,1.03 [0.80-1.34],0.8154025284785258
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLNK,B-cell linker protein,36116,394,0.92 [0.72-1.19],0.5446680499526444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,35984,403,0.96 [0.84-1.11],0.6032906858970624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37122,409,1.00 [0.78-1.27],0.9728185198984378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BLVRB,Flavin reductase,42688,457,1.10 [0.96-1.24],0.1605877706359273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP10,Bone morphogenetic protein 10,36382,391,1.71 [1.20-2.45],0.0033161903353039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP4,Bone morphogenetic protein 4,42294,453,1.08 [0.91-1.29],0.3735843624115746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMP6,Bone morphogenetic protein 6,41810,442,1.29 [1.04-1.59],0.0198024286924607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,36382,391,2.71 [1.89-3.90],6.595988000902482e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37203,406,1.17 [0.88-1.56],0.2763843241408421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36116,394,1.40 [1.13-1.73],0.0017266405723978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOC,Brother of CDO,41880,443,1.54 [1.07-2.22],0.0206013167359239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,35984,403,1.09 [0.92-1.29],0.3084549839241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,36223,386,0.93 [0.77-1.12],0.4500705857412366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,34946,375,0.99 [0.90-1.08],0.8029212045561392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,42584,455,1.56 [1.36-1.79],9.247675460327723e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB2,BPI fold-containing family B member 2,37131,406,1.09 [0.94-1.27],0.2600748133861517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRAP,BRCA1-associated protein,36700,403,0.95 [0.87-1.04],0.304366126556801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD1,Bromodomain-containing protein 1,36507,400,1.18 [0.86-1.61],0.3073641702126621
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD2,Bromodomain-containing protein 2,35984,403,1.00 [0.73-1.37],0.9983733636752692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRD3,Bromodomain-containing protein 3,35986,394,0.75 [0.59-0.96],0.0229057740445202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRDT,Bromodomain testis-specific protein,35986,394,1.13 [0.86-1.48],0.3828591014268412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,41707,446,1.24 [1.02-1.50],0.027247534705463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,35984,403,0.80 [0.61-1.06],0.1169865793874402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,37147,408,1.28 [0.99-1.63],0.0552836503473071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,43075,460,4.74 [3.27-6.86],1.643184735062719e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSND,Barttin,35893,396,1.20 [0.91-1.57],0.1935185933651184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,43074,461,1.05 [0.87-1.26],0.6211173574162416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,43074,461,1.70 [1.51-1.92],6.634885324859748e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTC,Probetacellulin,41668,448,1.04 [0.92-1.17],0.5129152553246051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTD,Biotinidase,37249,405,0.62 [0.39-0.98],0.0414236880623195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,35893,396,1.02 [0.91-1.15],0.7498113225194493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,36964,409,0.79 [0.59-1.05],0.0998294134853993
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,42864,461,2.08 [1.55-2.79],1.1320942772513615e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,42620,454,1.64 [1.34-2.01],1.6621913569846916e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTNL10,Butyrophilin-like protein 10,35893,396,0.92 [0.71-1.20],0.5503359962500931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,41707,446,1.13 [1.00-1.27],0.0445320076949325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,35986,394,1.14 [0.86-1.51],0.3552517127783366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QA,Complement C1q subcomponent subunit A,42933,458,2.11 [1.48-2.99],3.272915793621661e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37147,408,1.02 [0.88-1.17],0.8288054463492946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,36116,394,1.08 [0.86-1.34],0.5230326398348935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42847,457,1.76 [1.48-2.11],3.81162525058917e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36382,391,1.24 [0.94-1.63],0.1253669637874553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37147,408,1.36 [1.05-1.77],0.0205134439870396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36314,390,0.89 [0.73-1.09],0.2713910730467966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1R,Complement C1r subcomponent,37249,405,1.58 [1.02-2.43],0.038773111575206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1RL,Complement C1r subcomponent-like protein,37188,404,1.39 [0.84-2.30],0.1974043711267651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1S,Complement C1s subcomponent,37249,405,1.94 [1.24-3.02],0.0036973902334086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2,Complement C2,42779,457,1.83 [1.22-2.74],0.0035051411040866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,41633,446,1.30 [1.08-1.57],0.0058629630188983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C2orf69,UPF0565 protein C2orf69,36175,396,1.05 [0.89-1.24],0.5727145107355336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C3,Complement C3,35368,380,1.31 [1.09-1.58],0.0046678305598189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C4BPB,C4b-binding protein beta chain,42814,456,0.91 [0.74-1.13],0.3939125133591351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,37249,405,2.25 [1.27-4.01],0.0057885151702502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,36351,397,4.35 [3.33-5.68],3.332080228572638e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7orf50,Uncharacterized protein C7orf50,37122,409,1.30 [0.90-1.88],0.1670729833261728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C8B,Complement component C8 beta chain,37249,405,1.16 [0.84-1.60],0.3771593703914477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9,Complement component C9,37239,408,1.29 [1.08-1.54],0.0047791285611899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C9orf40,Uncharacterized protein C9orf40,37041,407,1.03 [0.91-1.16],0.6411995590163097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA1,Carbonic anhydrase 1,41736,447,1.05 [0.91-1.22],0.4736222878500105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA11,Carbonic anhydrase-related protein 11,41668,448,1.23 [0.96-1.57],0.1096214783688446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA12,Carbonic anhydrase 12,42503,452,1.76 [1.40-2.22],1.3828182228038416e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA13,Carbonic anhydrase 13,42223,447,0.98 [0.90-1.06],0.5490750955191197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,43059,464,0.46 [0.37-0.58],9.359662453324372e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA2,Carbonic anhydrase 2,42551,456,1.11 [0.98-1.25],0.1049518791259757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA3,Carbonic anhydrase 3,43133,461,1.04 [0.91-1.19],0.5803740849757959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,43204,461,2.50 [1.79-3.49],6.822199164731725e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",41880,443,1.19 [1.09-1.30],7.61359313703922e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,42557,457,0.73 [0.64-0.83],3.2537247477249386e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA7,Carbonic anhydrase 7,36507,400,0.96 [0.72-1.29],0.7897859327118774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA8,Carbonic anhydrase-related protein,36116,394,0.80 [0.52-1.23],0.3049386517975982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,43059,464,1.69 [1.45-1.98],2.985172542661815e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CABP2,Calcium-binding protein 2,36175,396,0.95 [0.81-1.12],0.5594020912658404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,35984,403,1.00 [0.73-1.36],0.9773731218197452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,35986,394,0.91 [0.74-1.11],0.3426081278820472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,35984,403,0.99 [0.83-1.18],0.9068189047018776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37147,408,1.08 [0.96-1.21],0.2089774499197509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CACYBP,Calcyclin-binding protein,36317,391,0.98 [0.89-1.08],0.7253617027382273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CADPS,Calcium-dependent secretion activator 1,36175,396,1.36 [1.12-1.66],0.0020460558951831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB1,Calbindin,42503,452,0.90 [0.75-1.09],0.2993289783060642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALB2,Calretinin,41707,446,1.36 [1.07-1.74],0.0123578219559047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,42293,453,1.38 [1.23-1.55],2.1060855520333583e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,37122,409,1.33 [1.07-1.66],0.0100938058790005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42932,462,0.96 [0.89-1.05],0.3927955011263114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36223,386,1.01 [0.89-1.16],0.8576866728178855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,35986,394,1.23 [0.96-1.57],0.1096629068625691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41668,448,1.03 [0.84-1.25],0.8030232276237468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36175,396,1.10 [0.93-1.31],0.2738455935475413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37147,408,1.03 [0.94-1.13],0.5393377843804246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,42574,455,1.53 [1.01-2.31],0.0425353745235676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,42361,454,1.34 [1.17-1.53],2.084913410207904e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPN3,Calpain-3,37037,409,1.34 [1.07-1.66],0.009640632280569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,37122,409,1.12 [1.03-1.22],0.0096583092354957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,41707,446,1.02 [0.86-1.21],0.8048622827439483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,36175,396,1.11 [0.88-1.39],0.3934255688118471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,41707,446,1.11 [0.99-1.24],0.0870205447456251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,41707,446,1.07 [0.95-1.21],0.2859959523815156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,42620,454,0.97 [0.85-1.10],0.5969837758537757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP3,Caspase-3,43204,461,0.98 [0.89-1.09],0.7560642683173031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP4,Caspase-4,36507,400,1.00 [0.94-1.06],0.9928593952134293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP7,Caspase-7,37122,409,1.01 [0.89-1.13],0.9216745862283564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP8,Caspase-8,42938,461,0.92 [0.80-1.05],0.2227738202067826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP9,Caspase-9,36116,394,0.96 [0.81-1.13],0.5952071478586056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASQ2,Calsequestrin-2,35986,394,0.94 [0.76-1.17],0.5990712938424136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAT,Catalase,36690,403,1.00 [0.83-1.20],0.9701592985720028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,42627,456,1.19 [1.06-1.33],0.0040517195931816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN1,Cerebellin-1,35984,403,1.07 [0.98-1.18],0.1463398580987236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,43059,464,0.51 [0.40-0.66],3.618663891988109e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,36223,386,1.37 [1.15-1.64],0.0003736233488406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBX2,Chromobox protein homolog 2,35986,394,0.97 [0.74-1.27],0.8334210307677767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42367,453,1.00 [0.89-1.13],0.9497539967111868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,37122,409,1.10 [0.93-1.30],0.2836498842920775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,37037,409,1.10 [0.90-1.34],0.3569507904161845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,36175,396,0.83 [0.60-1.16],0.2768457017584758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,37147,408,1.08 [0.95-1.22],0.24328012734583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,42691,456,2.10 [1.70-2.60],7.634614193537944e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36223,386,0.98 [0.84-1.15],0.8321667960712578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,43147,461,1.55 [1.24-1.93],0.0001018193297139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL13,C-C motif chemokine 13,43074,461,0.95 [0.84-1.07],0.3922178946878456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,42565,455,1.27 [1.04-1.54],0.0174105001726639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,43204,461,1.56 [1.31-1.85],4.778563653454193e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,43204,461,1.58 [1.33-1.86],1.009499940425985e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,42585,458,1.17 [1.07-1.28],0.0005168081092054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,42083,454,1.02 [0.90-1.14],0.7930839287570292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,43074,461,1.08 [1.01-1.15],0.015346915202375
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL2,C-C motif chemokine 2,42294,453,1.07 [0.91-1.25],0.4341098805726885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,43147,461,1.39 [1.29-1.50],6.502602491489922e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,42864,461,2.03 [1.76-2.34],8.198024583447748e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,42248,452,1.63 [1.41-1.88],4.103354435543587e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,42864,461,1.22 [1.00-1.48],0.0515440599374751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL24,C-C motif chemokine 24,42795,460,1.03 [0.93-1.14],0.5728574788137104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,43147,461,1.32 [1.12-1.57],0.0010511863153324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,42620,454,1.10 [1.01-1.20],0.0286711973030888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,42691,456,1.20 [1.04-1.37],0.0103524335744783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,42490,451,1.42 [1.25-1.62],8.852877302142217e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,42620,454,1.15 [1.03-1.29],0.0145979875484045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,42723,460,1.05 [0.94-1.19],0.38446807903565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,42847,457,1.04 [0.96-1.13],0.3438946179006834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,42620,454,1.35 [1.20-1.54],2.091270861736672e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL8,C-C motif chemokine 8,42997,461,1.00 [0.87-1.15],0.9664722798565326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,42432,449,1.15 [1.03-1.29],0.0151040077964051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,42655,458,1.09 [0.94-1.26],0.253642950444327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,43133,458,1.84 [1.48-2.29],3.8760237505832966e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,43059,464,1.39 [1.13-1.70],0.0015749737896756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN5,CCN family member 5,42688,457,0.93 [0.75-1.16],0.5292474213262992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCND2,G1/S-specific cyclin-D2,36507,400,1.13 [0.87-1.48],0.3564102267050505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCNE1,G1/S-specific cyclin-E1,36116,394,0.93 [0.81-1.06],0.2885203503049075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCS,Copper chaperone for superoxide dismutase,42367,453,0.95 [0.79-1.14],0.5532751730441297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,41668,448,0.97 [0.80-1.17],0.7292639450218263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,37041,407,1.44 [1.15-1.81],0.0017797761149636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD109,CD109 antigen,42688,457,1.23 [0.95-1.59],0.1142690915745608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,41809,448,2.25 [1.87-2.71],1.1895300225666484e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD160,CD160 antigen,43147,461,1.00 [0.84-1.18],0.975734049984642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,42847,457,1.84 [1.54-2.21],3.248161703275856e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164,Sialomucin core protein 24,42688,457,1.06 [0.77-1.47],0.7036370495162896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,36175,396,1.09 [0.83-1.43],0.5368293326469826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD177,CD177 antigen,42618,454,1.04 [0.97-1.11],0.2924938834983208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,42814,456,0.99 [0.70-1.39],0.935315532959334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2,T-cell surface antigen CD2,35986,394,1.02 [0.80-1.31],0.8511279060340733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200,OX-2 membrane glycoprotein,42620,454,1.22 [0.90-1.67],0.2006873980635087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,42478,453,1.04 [0.82-1.33],0.7334069157438602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,41777,444,1.54 [1.24-1.92],9.719450558798652e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,42792,455,0.85 [0.68-1.06],0.1476125019419081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD22,B-cell receptor CD22,43147,461,0.90 [0.74-1.11],0.3251003318252605
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD226,CD226 antigen,36116,394,0.74 [0.58-0.94],0.0124370318176246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD244,Natural killer cell receptor 2B4,43147,461,0.94 [0.69-1.28],0.7044739965214445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,37205,407,0.74 [0.59-0.94],0.0144291829789348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,42814,456,1.95 [1.63-2.33],3.6324172807947524e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,42367,453,1.90 [1.53-2.36],4.4027595769012205e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,42656,457,2.13 [1.68-2.70],4.1270150745800707e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,41668,448,1.41 [1.15-1.73],0.0011534822414216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,42691,456,1.05 [0.92-1.20],0.4578671168720363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,36382,391,1.83 [1.33-2.51],0.0001852942744767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,43074,461,2.01 [1.61-2.52],9.685194715337711e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,42925,464,2.09 [1.74-2.50],2.7314920318086788e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,43059,464,1.50 [1.30-1.75],7.569101182614265e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LG,CMRF35-like molecule 9,42688,457,1.39 [1.11-1.74],0.0042668309377966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,42503,452,2.65 [2.10-3.34],2.470987130896848e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD33,Myeloid cell surface antigen CD33,42814,456,1.15 [1.03-1.29],0.0135413896637598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,42929,461,0.58 [0.41-0.83],0.0025664402400981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD36,Platelet glycoprotein 4,36116,394,1.16 [0.94-1.43],0.1591703142080228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42503,452,0.67 [0.51-0.87],0.003260716574816
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,35984,403,1.06 [0.79-1.41],0.6949989489758576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,36507,400,0.91 [0.66-1.24],0.5341970606182427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,36116,394,1.03 [0.92-1.15],0.6223050199571228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,42560,452,1.73 [1.38-2.15],1.170861362238132e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,42654,459,1.38 [1.17-1.61],8.198594898581903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40LG,CD40 ligand,43147,461,1.07 [0.96-1.19],0.2161678536368442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,42424,453,1.46 [1.10-1.94],0.0088356097081949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD48,CD48 antigen,42795,460,2.27 [1.74-2.96],1.2271651996604878e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,42997,461,1.34 [1.07-1.68],0.0115554398287793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,41181,432,1.59 [1.17-2.15],0.0028329117428245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD58,Lymphocyte function-associated antigen 3,42583,456,1.72 [1.06-2.79],0.0290557128038849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,41146,445,1.81 [1.31-2.50],0.0003524955810169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5L,CD5 antigen-like,37041,402,1.56 [1.27-1.91],1.6193919930193056e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,43075,460,1.03 [0.88-1.21],0.6889107549827436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD63,CD63 antigen,42294,453,1.13 [0.95-1.34],0.1537506609384222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD69,Early activation antigen CD69,42482,455,1.04 [0.94-1.15],0.4211430263750045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,36046,393,1.46 [1.18-1.81],0.0004856717527292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,42620,454,1.63 [1.34-1.97],7.935813610215251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD72,B-cell differentiation antigen CD72,36382,391,1.14 [0.91-1.44],0.250677577629733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,43074,461,2.06 [1.65-2.57],1.213631670537528e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,43147,461,1.43 [1.20-1.69],5.052785507675428e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,37203,406,2.63 [2.06-3.36],7.0466584959923376e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD82,CD82 antigen,36507,400,1.10 [0.86-1.40],0.4607640744494742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,42620,454,2.45 [1.98-3.02],1.6183089695877863e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD84,SLAM family member 5,42620,454,0.97 [0.75-1.27],0.837723129576005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,37041,407,1.56 [1.13-2.16],0.0064611041193762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,43074,461,1.07 [0.90-1.26],0.4434421013310393
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,41082,440,1.57 [1.20-2.06],0.0010777243252521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99,CD99 antigen,42688,457,1.21 [0.79-1.85],0.3927896922077227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,42688,457,2.06 [1.47-2.88],2.7642090711286885e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDA,Cytidine deaminase,37133,406,0.85 [0.69-1.05],0.1336747242454379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDAN1,Codanin-1,37122,409,0.65 [0.40-1.06],0.0840013422950813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC123,Cell division cycle protein 123 homolog,35893,396,0.96 [0.81-1.13],0.6138866851181269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC25A,M-phase inducer phosphatase 1,35893,396,0.98 [0.76-1.26],0.8782273869804743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,36967,406,1.02 [0.88-1.17],0.80721355688057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,41668,448,1.00 [0.87-1.16],0.985566883300966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,42814,456,1.01 [0.92-1.12],0.7952402160384691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,37041,407,1.00 [0.91-1.10],0.9514990871185832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,42367,453,1.77 [1.54-2.02],1.8193698344521879e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,41251,440,1.21 [0.99-1.47],0.0583943838512569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH15,Cadherin-15,43000,461,0.81 [0.70-0.94],0.0062596748941475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH17,Cadherin-17,42691,456,1.11 [0.98-1.25],0.1039990863074711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,42691,456,1.92 [1.53-2.41],2.1333847429678733e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH22,Cadherin-22,36507,400,1.00 [0.71-1.42],0.9854928931163348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,37122,409,1.02 [0.69-1.49],0.9384848240175409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH3,Cadherin-3,43074,461,1.06 [0.84-1.33],0.6253996465881939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH4,Cadherin-4,35984,403,1.11 [0.90-1.35],0.3253630498589601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,43204,461,0.92 [0.70-1.22],0.5762252949573694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH6,Cadherin-6,42691,456,1.14 [0.92-1.41],0.2343345422984849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,41707,446,0.99 [0.80-1.23],0.931392045526406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,42503,452,1.33 [1.18-1.51],5.811418603397532e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,42691,456,0.57 [0.46-0.70],5.1263459249690494e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK1,Cyclin-dependent kinase 1,35893,396,1.00 [0.76-1.32],0.9749187416607166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37147,408,0.97 [0.81-1.15],0.6901226529751611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,35984,403,1.04 [0.87-1.25],0.6396513624235912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,42503,452,0.94 [0.86-1.02],0.1143413596187468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42503,452,0.97 [0.89-1.07],0.5747786082038011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,42503,452,0.89 [0.69-1.16],0.3959692918985675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42726,459,1.62 [1.18-2.23],0.0029643303525461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDSN,Corneodesmosin,43018,459,1.18 [0.98-1.43],0.0881330249028461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42747,453,5.09 [3.57-7.26],2.7437897383526055e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37041,407,0.55 [0.49-0.61],5.420257284578519e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36507,400,0.95 [0.83-1.10],0.516756584442523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37041,407,1.58 [1.24-2.00],0.0001844019835466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36507,400,1.26 [1.05-1.52],0.0123324471763619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42620,454,1.14 [1.03-1.25],0.0086141781168362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41668,448,1.16 [0.98-1.39],0.0904738234598602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41140,439,1.57 [1.41-1.76],1.368204272662642e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37205,407,1.88 [1.59-2.22],6.75930089788519e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41880,443,1.48 [1.27-1.73],6.184294553188444e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,36116,394,0.94 [0.69-1.27],0.6758769587847624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,41880,443,1.20 [0.97-1.49],0.1000202233771541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,37205,407,0.83 [0.72-0.97],0.0147668176634452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,43129,460,0.82 [0.71-0.94],0.0050418844012763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36382,391,0.89 [0.63-1.26],0.511629956819726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEMIP2,Cell surface hyaluronidase,36116,394,1.39 [1.08-1.78],0.0109044412148147
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,35984,403,1.14 [0.97-1.33],0.1096576906645407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPF,Centromere protein F,36507,400,1.02 [0.85-1.22],0.8190949695198648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CENPJ,Centromere protein J,36507,400,1.05 [0.91-1.20],0.520059155456466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP112,Centrosomal protein of 112 kDa,35986,394,1.09 [0.89-1.34],0.4208341258450688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP152,Centrosomal protein of 152 kDa,35893,396,0.97 [0.76-1.23],0.7953304740587002
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP164,Centrosomal protein of 164 kDa,41875,450,1.07 [0.94-1.22],0.2882378556482216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP170,Centrosomal protein of 170 kDa,36223,386,1.05 [0.92-1.20],0.4407561942943814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP20,Centrosomal protein 20,41668,448,1.08 [0.96-1.21],0.212971875154688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP290,Centrosomal protein of 290 kDa,36507,400,0.94 [0.77-1.14],0.5215095656710982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP350,Centrosome-associated protein 350,35893,396,0.89 [0.67-1.17],0.401541593330641
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,41542,435,1.00 [0.88-1.14],0.9989213821146636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,41668,448,0.96 [0.84-1.11],0.5834849720075272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CERT,Ceramide transfer protein,41707,446,1.06 [0.92-1.22],0.4147173987883117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,42781,456,1.17 [1.06-1.28],0.0017828362401412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,42503,452,1.22 [1.06-1.41],0.0067394048470602
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES3,Carboxylesterase 3,42503,452,0.95 [0.84-1.08],0.423970241600986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,41707,446,0.97 [0.85-1.11],0.6780405372365418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN3,Centrin-3,37041,407,1.01 [0.90-1.15],0.8262136286597612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,36577,395,1.85 [1.37-2.50],6.204116477424596e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFC1,Cryptic protein,41668,448,1.05 [0.87-1.26],0.6050772201459111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,37249,405,1.63 [1.07-2.46],0.0214410722914332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,35093,382,2.43 [1.58-3.74],5.2033098401505736e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR2,Complement factor H-related protein 2,36966,398,1.08 [0.90-1.29],0.4156688720610355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR4,Complement factor H-related protein 4,37183,405,1.08 [0.95-1.24],0.2415317356445691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,36760,401,1.33 [1.05-1.69],0.0164734757770867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,37249,405,1.81 [1.11-2.96],0.0167505597835622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFP,Properdin,37249,405,0.59 [0.37-0.93],0.0243809647558793
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,42688,457,1.33 [1.19-1.50],1.2986185631370576e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37239,408,1.11 [0.90-1.38],0.3347861955606842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGN,Cingulin,36175,396,1.44 [1.17-1.78],0.0006995415011383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,42691,456,1.68 [1.39-2.03],6.227972306095958e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41668,448,1.09 [0.94-1.25],0.2593706548616242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,36382,391,0.86 [0.71-1.05],0.1356957818115504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37122,409,1.93 [1.59-2.33],1.445986787108688e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,37037,409,2.14 [1.66-2.75],3.160436624222563e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,41880,443,0.91 [0.69-1.19],0.492716227429478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,37205,407,1.49 [1.37-1.63],2.2176793867905706e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGB,Secretogranin-1,42928,461,0.98 [0.79-1.20],0.8228399767492776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,41728,444,1.58 [1.45-1.72],1.384559974742716e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHIT1,Chitotriosidase-1,42852,460,1.06 [1.00-1.13],0.0555856987806803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,42788,454,1.46 [1.12-1.90],0.0055552523113756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,36175,396,0.96 [0.81-1.14],0.6412592964019467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,42367,453,0.93 [0.83-1.04],0.1983965647407439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHMP6,Charged multivesicular body protein 6,37203,406,0.92 [0.77-1.09],0.3346033942665857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHP1,Calcineurin B homologous protein 1,35984,403,0.91 [0.79-1.06],0.2167392142708077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,42795,460,2.43 [1.90-3.12],2.671567909445032e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL2,Chordin-like protein 2,42691,456,1.12 [0.96-1.32],0.1561444491347324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,36175,396,1.07 [0.82-1.41],0.6233744000527498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIAPIN1,Anamorsin,42814,456,1.02 [0.89-1.18],0.7367055116289448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,37205,407,1.61 [1.34-1.94],3.586420021511065e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,36507,400,0.98 [0.77-1.24],0.8713163592497557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,37041,407,1.01 [0.91-1.12],0.8338024416314016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CIT,Citron Rho-interacting kinase,36175,396,1.34 [1.10-1.63],0.0035900495528785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,42935,459,2.35 [1.83-3.02],2.1765729029793565e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,37205,407,1.78 [1.52-2.09],1.0012887992561905e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42511,456,1.27 [1.11-1.45],0.0004657048545496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLASP1,CLIP-associating protein 1,35893,396,0.93 [0.80-1.09],0.3599259767265937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLC,Galectin-10,42632,455,1.16 [1.03-1.30],0.0157391608863731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,42367,453,1.50 [1.19-1.90],0.0007531251438447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,42614,457,1.28 [1.07-1.53],0.0064399324868918
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,36116,394,1.45 [0.89-2.37],0.1324167803964729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,42688,457,2.06 [1.60-2.66],2.4392270165445282e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,41880,443,1.59 [1.24-2.04],0.0002617412308004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,43074,461,1.02 [0.93-1.11],0.6850486685926457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,36175,396,0.95 [0.76-1.18],0.6258951516093116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,36388,394,0.24 [0.15-0.37],7.901859921411296e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,42620,454,0.73 [0.58-0.92],0.0081922077724114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,42620,454,1.11 [0.93-1.33],0.2309598534170452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,42620,454,1.51 [1.33-1.71],1.6467772044347055e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,42620,454,0.80 [0.62-1.04],0.0912697917350481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,37138,407,0.88 [0.73-1.07],0.2074956695439092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,42550,455,2.61 [2.03-3.36],9.921806655079856e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,41668,448,1.94 [1.64-2.29],3.492007604743133e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,43147,461,1.21 [1.03-1.42],0.0189414572386412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,36175,396,1.76 [1.47-2.10],7.686550216797568e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,36175,396,1.40 [1.09-1.81],0.0080963980469149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLINT1,Clathrin interactor 1,35893,396,0.95 [0.76-1.17],0.6238586852551531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,42620,454,0.96 [0.89-1.04],0.3197950069030653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,43059,464,2.47 [1.71-3.56],1.2125468178741807e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLNS1A,Methylosome subunit pICln,36175,396,0.87 [0.64-1.18],0.3608626254880653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42293,453,1.11 [1.01-1.21],0.0244330085624276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,42620,456,0.77 [0.69-0.87],1.178366578111736e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSPN,Claspin,41633,446,0.88 [0.67-1.16],0.3787663610581454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN1,Calsyntenin-1,41707,446,1.06 [0.90-1.25],0.5030852794466599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,43147,461,1.69 [1.41-2.02],1.4491627151947833e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN3,Calsyntenin-3,37122,409,1.91 [1.43-2.56],1.2926440704594055e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLTA,Clathrin light chain A,41880,443,1.05 [0.88-1.26],0.5775772110173925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLU,Clusterin,37249,405,0.97 [0.70-1.34],0.8324851414419853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,42616,456,0.98 [0.82-1.18],0.8387967020322497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,37203,406,1.03 [0.93-1.15],0.5381715961194269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CMIP,C-Maf-inducing protein,37037,409,0.92 [0.82-1.04],0.1807015743573208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,42847,457,0.57 [0.49-0.66],1.0313996409690766e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,35984,403,0.90 [0.73-1.11],0.320174692309947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36156,386,0.94 [0.83-1.07],0.3818017400043391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY2,Protein canopy homolog 2,41880,443,1.10 [0.96-1.25],0.1724743124659941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNPY4,Protein canopy homolog 4,42503,452,1.03 [0.92-1.15],0.6386766889368688
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNST,Consortin,42691,456,1.02 [0.94-1.10],0.6756757382066834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTF,Ciliary neurotrophic factor,35984,403,0.95 [0.70-1.27],0.7075201114953185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,43204,461,0.54 [0.40-0.74],9.890601206183168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN2,Contactin-2,43059,464,1.07 [0.88-1.29],0.4928199046270526
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,42688,457,0.78 [0.60-1.03],0.0771275663007498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,42688,457,1.26 [0.88-1.80],0.211471286242596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,42793,461,0.55 [0.43-0.69],5.37035048393568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,42620,454,1.31 [1.08-1.58],0.0054702038175914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,36175,396,0.97 [0.88-1.08],0.6403159589867276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,37203,406,1.38 [1.13-1.68],0.0013259019329972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,37205,407,1.73 [1.24-2.41],0.0011169174250429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,42852,460,3.73 [2.65-5.23],2.7935405928815062e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,43204,461,1.39 [0.98-1.96],0.0632437168618646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,37041,407,1.26 [1.05-1.51],0.0133175393549364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,36175,396,0.80 [0.70-0.92],0.0014038444569087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL2A1,Collagen alpha-1(II) chain,36223,386,0.93 [0.82-1.05],0.2553862206664639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL3A1,Collagen alpha-1(III) chain,37205,407,1.99 [1.33-2.96],0.0007326819775782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,42691,456,2.13 [1.76-2.58],7.837736709837946e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,36450,400,1.26 [1.03-1.53],0.0261487538188083
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,36382,391,2.00 [1.63-2.47],6.630556590273252e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,43204,461,2.41 [1.97-2.93],3.4688458816621165e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,42620,454,1.80 [1.52-2.12],3.139156599597349e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,36507,400,0.91 [0.72-1.16],0.4463209574817955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,42656,457,3.08 [2.32-4.08],6.101806740852297e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,36223,386,0.94 [0.80-1.11],0.4870465935433927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD9,COMM domain-containing protein 9,37037,409,0.78 [0.60-1.01],0.0622695623757686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMP,Cartilage oligomeric matrix protein,42214,452,1.07 [0.83-1.37],0.6133037096471847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,41427,434,1.12 [1.01-1.25],0.037412416695465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPB2,Coatomer subunit beta',35986,394,0.87 [0.68-1.12],0.2800192283951677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COPE,Coatomer subunit epsilon,41707,446,0.84 [0.69-1.03],0.0972264165967971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36223,386,1.45 [1.19-1.77],0.0002876110898598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,41817,445,1.03 [0.93-1.13],0.5808744877728089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO6,Coronin-6,35984,403,1.07 [0.82-1.39],0.6134561200081542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42503,452,1.25 [1.11-1.41],0.0002181906920009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,37203,406,0.96 [0.71-1.30],0.7866166023030997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,43204,461,1.00 [0.88-1.14],0.9692956567111012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA2,Carboxypeptidase A2,42935,460,0.82 [0.72-0.93],0.0019571942461586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA4,Carboxypeptidase A4,35661,388,1.25 [0.98-1.58],0.0688754125061102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,43204,461,0.98 [0.86-1.12],0.7466642645623657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB2,Carboxypeptidase B2,37174,404,0.76 [0.50-1.18],0.2201067895099429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPE,Carboxypeptidase E,42729,460,0.94 [0.76-1.16],0.5669573576615494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPLX2,Complexin-2,35893,396,0.92 [0.66-1.28],0.6060601328548132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,42868,460,1.75 [1.38-2.21],3.058637527231875e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36116,394,1.31 [0.92-1.87],0.1354588993414006
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,43074,461,1.09 [0.96-1.24],0.1846703672575357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPQ,Carboxypeptidase Q,37135,406,1.18 [0.90-1.55],0.2337696676674261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,35986,394,0.92 [0.71-1.20],0.5354537149760623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,42985,463,1.36 [1.10-1.69],0.0051136727966142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,42814,456,1.16 [1.03-1.31],0.0125880319617158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,37203,406,1.92 [1.37-2.69],0.0001632820439003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR1,Complement receptor type 1,37097,408,1.19 [0.91-1.57],0.2035917504107899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,42847,457,0.73 [0.61-0.88],0.0008573179865185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41668,448,1.00 [0.90-1.11],0.9922065646406766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRADD,Death domain-containing protein CRADD,42293,453,0.98 [0.88-1.10],0.7691596934098363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,35893,396,1.06 [0.89-1.26],0.5399379754349425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,35893,396,1.01 [0.68-1.50],0.97288805631326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,42116,446,1.85 [1.53-2.24],2.621717571161496e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,36382,391,1.95 [1.51-2.52],4.015240401592793e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,42795,460,1.19 [1.01-1.40],0.034129603103392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,41594,447,0.80 [0.72-0.89],3.4783060415532815e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,42656,457,1.80 [1.34-2.43],0.0001145615221818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,41880,443,1.05 [0.91-1.21],0.5007029847391398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,42864,461,3.88 [2.69-5.58],3.3058121478553374e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,42367,453,1.22 [0.98-1.53],0.081534589315107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,43059,464,0.69 [0.60-0.79],1.2953575452946752e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,36905,405,0.71 [0.50-1.01],0.054601064524082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRKL,Crk-like protein,42722,459,0.98 [0.91-1.07],0.6744917767104518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRLF1,Cytokine receptor-like factor 1,42864,461,1.26 [0.91-1.75],0.1602947181695124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRNN,Cornulin,41453,450,1.14 [1.00-1.29],0.0513053229812007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAC1,Cartilage acidic protein 1,43204,461,0.56 [0.43-0.72],1.311417938289386e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,42367,453,1.04 [0.88-1.22],0.6596998411242256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRTAP,Cartilage-associated protein,36175,396,0.87 [0.69-1.11],0.2665466709541585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRX,Cone-rod homeobox protein,41880,443,0.96 [0.88-1.05],0.4098787864775612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB1,Beta-crystallin B1,37203,406,1.06 [0.91-1.22],0.4483903572798196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYBB2,Beta-crystallin B2,37122,409,1.19 [1.07-1.33],0.0018366155739524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYGD,Gamma-crystallin D,37122,409,1.02 [0.92-1.12],0.7650311869525446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYM,Ketimine reductase mu-crystallin,35984,403,1.06 [0.93-1.21],0.3644693019128306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,36223,386,0.96 [0.86-1.07],0.4618854873200444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSDE1,Cold shock domain-containing protein E1,35986,394,1.00 [0.91-1.10],0.99008203511092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,42864,461,3.20 [2.44-4.20],4.9791271990839007e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,37239,408,1.68 [1.36-2.09],2.297238014815316e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,35986,394,1.26 [0.98-1.63],0.0715366445561727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42367,453,1.31 [1.15-1.50],6.650818347173194e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,36116,394,1.44 [1.14-1.84],0.0026857580636211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,41875,450,1.16 [0.98-1.38],0.0834377546248075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,36116,394,1.40 [1.04-1.88],0.0262434800205866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,37239,408,1.14 [0.87-1.48],0.3403860239697337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK1D,Casein kinase I isoform delta,36116,394,0.94 [0.80-1.12],0.5034791288927524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,37147,408,1.13 [0.91-1.41],0.2514751831758152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,37205,407,0.99 [0.74-1.32],0.9574169686907316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,35984,403,0.90 [0.72-1.11],0.3154590370112924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,35986,394,1.05 [0.95-1.16],0.3480585450510373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST1,Cystatin-SN,32300,346,0.96 [0.86-1.07],0.4984652604413417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,42777,455,2.12 [1.62-2.76],3.081061626249312e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST5,Cystatin-D,41881,448,1.08 [0.92-1.26],0.334826082940826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,41561,443,0.97 [0.81-1.16],0.7152391454939712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,42723,460,1.16 [1.08-1.25],6.740607933779583e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,42082,454,1.63 [1.36-1.96],1.5256325354436765e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,36436,399,0.83 [0.67-1.02],0.0828283013796436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,36711,403,1.26 [0.86-1.84],0.2275276370226798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTF1,Cardiotrophin-1,41880,443,0.97 [0.88-1.08],0.5948402501193275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,37205,407,2.41 [1.75-3.33],7.615132567336887e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,37205,407,1.23 [0.90-1.69],0.1925984729747751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTNNA1,Catenin alpha-1,35984,403,0.90 [0.65-1.24],0.5132999049456768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRB1,Chymotrypsinogen B,42688,457,0.76 [0.66-0.88],0.0003016757104349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,42655,458,0.73 [0.65-0.83],2.1781210516334174e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,37122,409,0.72 [0.63-0.82],7.813264782051282e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,42710,458,1.28 [1.10-1.49],0.0017547510842402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,42574,458,1.51 [1.25-1.82],1.5002694307403784e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,39873,423,1.86 [1.57-2.20],3.508898598721717e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSE,Cathepsin E,36382,391,1.16 [0.96-1.39],0.127702448045044
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,42814,456,1.21 [0.99-1.49],0.0621734593280259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,41741,442,1.08 [0.96-1.22],0.1797874883528628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,42691,456,2.97 [2.15-4.10],3.607582554515672e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,43147,461,1.70 [1.31-2.21],5.618173436307703e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,33538,355,2.75 [1.80-4.19],2.5135936413382195e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSV,Cathepsin L2,42919,461,0.94 [0.76-1.15],0.5221037571288859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,42705,457,1.90 [1.47-2.46],1.1568942125211782e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,36175,396,1.23 [0.98-1.54],0.0790788352448579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,36838,404,1.07 [0.91-1.25],0.4359834769120877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CX3CL1,Fractalkine,42367,453,1.28 [1.00-1.64],0.0542343444312792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,42620,454,1.86 [1.62-2.14],5.825711688302269e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL1,Growth-regulated alpha protein,42583,460,0.91 [0.82-1.00],0.0474412193684095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL10,C-X-C motif chemokine 10,42864,461,1.27 [1.13-1.42],6.2614734151711e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,43074,461,1.29 [1.17-1.41],1.0772024252329429e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,41875,450,1.56 [1.27-1.92],2.3725538089433305e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,43074,461,1.34 [1.21-1.48],2.2765531812769243e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL14,C-X-C motif chemokine 14,41875,450,1.04 [0.89-1.20],0.6373834863312253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,43130,460,3.02 [2.15-4.24],1.7245214863814263e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,43147,461,2.06 [1.79-2.37],2.0868706099167134e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL3,C-X-C motif chemokine 3,42654,459,0.90 [0.82-0.98],0.0159632825318702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,42549,456,0.91 [0.85-0.98],0.0137349949057344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL6,C-X-C motif chemokine 6,43147,461,0.84 [0.76-0.95],0.0031944975850532
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,42357,461,1.28 [1.16-1.42],2.5445716417827746e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,42864,461,1.43 [1.28-1.60],1.827874010584796e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5A,Cytochrome b5,35893,396,1.05 [0.91-1.21],0.5186738918481725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,36620,400,1.36 [1.16-1.60],0.0001718898619152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",35986,394,1.03 [0.92-1.16],0.5785712705865682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTH3,Cytohesin-3,35893,396,1.03 [0.90-1.19],0.6653241410105223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,37205,407,1.54 [1.06-2.23],0.0219210835119434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,36382,391,0.97 [0.86-1.10],0.6566101770939534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAB2,Disabled homolog 2,43059,464,0.99 [0.92-1.07],0.7875393865691501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAG1,Dystroglycan,42864,461,1.28 [1.08-1.53],0.0055621630755233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAND5,DAN domain family member 5,36116,394,1.00 [0.83-1.21],0.9648969023376586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,36116,394,1.04 [0.87-1.23],0.6920331783598562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42620,454,0.97 [0.90-1.04],0.3297897630227679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",42293,453,0.91 [0.81-1.03],0.1348804751481613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBH,Dopamine beta-hydroxylase,37169,408,0.95 [0.88-1.03],0.2492136001960911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,42486,454,1.09 [0.97-1.21],0.1376085412203267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBN1,Drebrin,36116,394,0.96 [0.78-1.18],0.6928271127490555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBNL,Drebrin-like protein,42864,461,1.00 [0.91-1.10],0.9521568329924398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42814,456,1.98 [1.57-2.49],7.203706378842795e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,36175,396,0.95 [0.62-1.46],0.8103595960494115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,35893,396,0.97 [0.82-1.15],0.7325716635181743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCLRE1C,Protein artemis,35893,396,0.91 [0.65-1.27],0.5882953476159433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCN,Decorin,41880,443,0.97 [0.66-1.42],0.8750410857428713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTD,Deoxycytidylate deaminase,36382,391,0.95 [0.85-1.05],0.2990356790774143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN1,Dynactin subunit 1,43059,464,0.93 [0.81-1.06],0.2534231431421024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN2,Dynactin subunit 2,42503,452,0.87 [0.79-0.96],0.0045625538489877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTN6,Dynactin subunit 6,41707,446,0.99 [0.87-1.11],0.8122795932390873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,42691,456,1.31 [1.01-1.70],0.0385112341046411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D1,DCN1-like protein 1,35984,403,1.03 [0.89-1.17],0.7200059362044038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCUN1D2,DCN1-like protein 2,35893,396,1.08 [0.96-1.22],0.2238431952180235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,42814,456,1.06 [0.91-1.24],0.4202315218387751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,35986,394,1.13 [0.88-1.46],0.3477169871031557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42503,452,1.64 [1.38-1.94],1.3824994066844964e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,42627,456,1.28 [1.09-1.50],0.0032788027557465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDHD2,Phospholipase DDHD2,37147,408,0.97 [0.83-1.12],0.6693693810591381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDI2,Protein DDI1 homolog 2,36382,391,0.97 [0.85-1.11],0.6308768104543092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,43074,461,2.31 [1.72-3.12],3.516198676769619e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDT,D-dopachrome decarboxylase,37205,407,1.10 [0.87-1.38],0.4186947839636927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,37041,407,1.01 [0.83-1.23],0.9253615530932132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,36175,396,0.87 [0.65-1.17],0.3652219758626991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,36116,394,0.74 [0.47-1.18],0.2111850868933121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,36116,394,0.92 [0.75-1.13],0.4373128856472176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,36175,396,1.07 [0.80-1.42],0.6545268426816027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,41668,448,1.03 [0.89-1.19],0.6821131916774823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42620,454,1.11 [1.01-1.21],0.0231002606424737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,41804,445,1.12 [0.97-1.30],0.1252608332351318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,35846,393,1.11 [0.89-1.40],0.3553155909384079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,35984,403,0.94 [0.78-1.13],0.510734819235962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB116,Beta-defensin 116,35984,403,1.04 [0.91-1.20],0.5262863023216169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB118,Beta-defensin 118,35984,403,0.97 [0.82-1.15],0.7490594630269425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,42090,445,1.06 [1.00-1.12],0.0575139711068536
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENND2B,DENN domain-containing protein 2B,35986,394,1.09 [0.89-1.33],0.4081292922821331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DENR,Density-regulated protein,36116,394,0.96 [0.81-1.15],0.6888760342157354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,43147,461,1.06 [0.93-1.20],0.3823019334735666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGCR6,Protein DGCR6,35984,403,1.24 [1.01-1.53],0.0385778213274429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKA,Diacylglycerol kinase alpha,36116,394,1.04 [0.86-1.25],0.7009759275928111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DGKZ,Diacylglycerol kinase zeta,41875,450,0.97 [0.76-1.24],0.813679713975209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHODH,Dihydroorotate dehydrogenase,35986,394,0.90 [0.71-1.14],0.3879224745936453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHPS,Deoxyhypusine synthase,37037,409,0.97 [0.75-1.24],0.7938027925607929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37122,409,1.25 [1.02-1.52],0.0273463644403567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",42550,455,1.01 [0.94-1.10],0.7534308171312106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,36175,396,0.93 [0.72-1.20],0.5684617920819424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,36382,391,1.52 [1.08-2.15],0.0171617570327404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK1,Dickkopf-related protein 1,43074,461,1.03 [0.89-1.18],0.7280311742807741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK3,Dickkopf-related protein 3,43204,461,1.06 [0.80-1.41],0.6627288984639947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKK4,Dickkopf-related protein 4,42296,452,1.22 [1.03-1.45],0.0203681899897838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,42503,452,0.99 [0.89-1.09],0.7868723449270301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLG4,Disks large homolog 4,37122,409,0.93 [0.80-1.07],0.3084882366428794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLGAP5,Disks large-associated protein 5,37147,408,0.96 [0.77-1.19],0.6940605563298777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,43204,461,0.77 [0.67-0.90],0.0006523281361498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,42814,456,2.36 [1.83-3.06],6.293970365764703e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL4,Delta-like protein 4,36223,386,1.03 [0.93-1.14],0.5639126057634609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMD,Dystrophin,36223,386,1.09 [0.90-1.32],0.3918274715149467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,36223,386,0.96 [0.81-1.14],0.6475555639414572
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,35893,396,1.01 [0.82-1.25],0.913214643086593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,43007,460,1.01 [0.91-1.12],0.9109780881090423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,37122,409,1.02 [0.89-1.17],0.7403690361307487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,42503,452,1.01 [0.91-1.11],0.9118003292900267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,37041,407,1.03 [0.88-1.19],0.7308311555841629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,36382,391,0.91 [0.75-1.10],0.311995570133887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,36049,390,0.96 [0.85-1.08],0.489910155629477
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,41880,443,0.94 [0.80-1.10],0.4169871599544401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,37122,409,0.97 [0.75-1.26],0.8370268013648459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,36223,386,1.01 [0.90-1.14],0.8611965100769885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,37041,407,1.04 [0.92-1.19],0.5092410051598264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,42580,458,0.68 [0.49-0.95],0.0227471857757214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNLZ,DNL-type zinc finger protein,35984,403,1.02 [0.90-1.14],0.7851405893542176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM1,Dynamin-1,37041,407,0.96 [0.88-1.04],0.3273146384499571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,37147,408,1.23 [1.04-1.45],0.0143851280782853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,42367,453,1.10 [0.95-1.26],0.1952125080007972
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPEP,Aspartyl aminopeptidase,37122,409,1.02 [0.86-1.21],0.7963663000266292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42791,460,1.21 [1.03-1.43],0.0239784228163237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,36175,396,1.10 [0.85-1.43],0.4606432302535715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,35984,403,1.03 [0.95-1.12],0.4699278418941957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK1,Docking protein 1,37122,409,0.97 [0.90-1.04],0.3507860414536174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,42691,456,1.02 [0.95-1.09],0.6612452251686811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,42293,453,0.90 [0.75-1.08],0.2576128797931259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP2,Dipeptidase 2,42503,452,1.84 [1.39-2.43],2.3673430058688533e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,42620,454,1.58 [1.30-1.92],3.266247919850764e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,41866,446,1.03 [0.76-1.39],0.8454735645296939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,42503,452,0.68 [0.53-0.88],0.0025490255781033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,42350,452,1.49 [1.30-1.70],4.266231547178195e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPT,Dermatopontin,43204,461,0.81 [0.59-1.11],0.1891478686473944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,42928,464,1.32 [1.17-1.49],1.1724752042304829e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRAXIN,Draxin,42367,453,1.23 [1.01-1.50],0.0432722482592125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,42503,452,0.95 [0.82-1.11],0.5272161156440444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,42199,454,1.69 [1.35-2.11],4.02957604279888e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,37147,408,0.88 [0.67-1.16],0.3596010433299575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,42688,457,1.18 [0.86-1.61],0.3017429162516988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG3,Desmoglein-3,42919,462,1.05 [0.83-1.34],0.6730105160238737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG4,Desmoglein-4,42367,448,0.91 [0.76-1.09],0.3027408373928988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,36382,391,0.95 [0.84-1.07],0.3789048580234301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,36963,408,1.59 [1.31-1.93],2.447921962182009e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,36175,396,0.90 [0.75-1.07],0.2337542846904039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,42503,452,2.03 [1.50-2.76],5.052569487361163e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTYMK,Thymidylate kinase,37203,406,1.00 [0.86-1.15],0.9773508501160786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUOX2,Dual oxidase 2,41880,443,0.98 [0.86-1.11],0.735870699872115
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,37037,409,0.92 [0.72-1.17],0.4894047783611038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP29,Dual specificity phosphatase 29,36175,396,0.83 [0.70-0.99],0.0375558836106713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,41707,446,0.97 [0.88-1.08],0.6367498063977284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37041,407,1.07 [0.97-1.17],0.1735193229619296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DXO,Decapping and exoribonuclease protein,37122,409,1.15 [0.93-1.42],0.1910438761933343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37037,409,0.86 [0.68-1.09],0.2226459108849819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,36175,396,0.95 [0.84-1.08],0.4333129174021479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,37037,409,0.90 [0.71-1.12],0.3445262631687369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42367,453,1.02 [0.93-1.12],0.6287570777123979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EBI3_IL27,Interleukin-27,43000,464,1.78 [1.40-2.26],2.6298151612547643e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,41707,446,1.26 [0.99-1.60],0.057342270187125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37203,406,1.28 [1.14-1.43],2.585702296663121e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",36223,386,1.23 [1.11-1.36],6.810827678117726e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,35986,394,1.20 [1.03-1.39],0.0163765771541313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECM1,Extracellular matrix protein 1,36241,397,0.89 [0.68-1.17],0.4155579863695567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,35984,403,0.99 [0.81-1.22],0.936800809806489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,43059,464,2.12 [1.75-2.56],7.492191541903228e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,42620,454,0.76 [0.69-0.84],1.6455357431833985e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,37037,409,0.71 [0.58-0.86],0.0003869182125391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,35986,394,0.94 [0.70-1.27],0.6938051266091765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDF1,Endothelial differentiation-related factor 1,37147,408,1.07 [0.93-1.23],0.3327009296354586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41880,443,1.98 [1.61-2.43],6.75250861498929e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,36223,386,2.79 [2.05-3.79],5.827763903748049e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDNRB,Endothelin receptor type B,36116,394,1.11 [0.90-1.38],0.3328772025865338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,37203,406,1.06 [0.95-1.18],0.2913668242660118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,37041,407,1.43 [1.07-1.91],0.0143849040616762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,36507,400,1.05 [0.80-1.39],0.7236560000564976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42774,456,2.56 [2.01-3.26],3.4437914144536174e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFHD1,EF-hand domain-containing protein D1,37147,408,1.30 [1.01-1.66],0.0407161807978659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,42618,457,1.99 [1.52-2.60],4.977069710904496e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,42294,453,2.02 [1.60-2.54],2.7607522218805393e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNB2,Ephrin-B2,36175,396,1.14 [0.98-1.33],0.0936592344275099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGF,Pro-epidermal growth factor,42586,457,0.99 [0.91-1.07],0.7198140770881752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,41668,448,1.59 [1.29-1.94],9.231266590561111e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,37041,407,1.35 [1.00-1.83],0.0488106323132337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,43204,461,0.16 [0.10-0.27],1.6019631058717557e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,42620,454,1.30 [1.16-1.46],6.354901750901478e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHBP1,EH domain-binding protein 1,37203,406,1.00 [0.88-1.15],0.9413231977733864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EHD3,EH domain-containing protein 3,36223,386,0.94 [0.86-1.02],0.1383171555229136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37122,409,1.00 [0.83-1.20],0.9979383958935996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",36907,407,1.05 [0.96-1.15],0.2894834239695949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,35986,394,1.06 [0.91-1.23],0.4610194879083871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36223,386,1.00 [0.77-1.28],0.9777222806764796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,42367,453,0.94 [0.80-1.09],0.4087194547926078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,36116,394,1.01 [0.90-1.13],0.8405289439642776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42691,456,1.24 [1.10-1.41],0.0007178338930331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,43147,461,1.04 [0.95-1.13],0.4093351606529822
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37147,408,0.97 [0.84-1.13],0.734096673606766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,35986,394,0.93 [0.74-1.19],0.5719011197990225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,41875,450,1.03 [0.78-1.37],0.8251076929035946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,37147,408,0.97 [0.87-1.09],0.6260668338554292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELAVL4,ELAV-like protein 4,35984,403,1.06 [0.94-1.19],0.3421516106733986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,37203,406,1.89 [1.46-2.44],1.3817567672778578e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,42503,452,1.17 [1.02-1.34],0.0234343145598089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOB,Elongin-B,35986,394,1.09 [0.85-1.41],0.4902221562577807
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,41875,450,1.28 [1.08-1.53],0.0048370047083497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,34348,371,0.96 [0.79-1.17],0.6874308397091752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENG,Endoglin,43204,461,1.97 [1.21-3.20],0.0060193908995923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO1,Alpha-enolase,42643,457,1.07 [0.96-1.20],0.2064752665457809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO2,Gamma-enolase,43074,461,0.93 [0.82-1.06],0.2874457751325626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENO3,Beta-enolase,36223,386,0.77 [0.64-0.92],0.0035193747773012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOPH1,Enolase-phosphatase E1,37037,409,0.87 [0.70-1.07],0.1918210743532545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,35986,394,1.20 [0.84-1.70],0.3117299168676701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPEP,Glutamyl aminopeptidase,35986,394,1.15 [0.93-1.42],0.2016436897896931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,43204,461,1.70 [1.25-2.30],0.0006620564912224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42864,461,0.73 [0.62-0.85],0.0001168967277455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36223,386,0.81 [0.61-1.07],0.1308118042628035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41369,441,1.39 [1.25-1.53],1.7028612384573834e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENSA,Alpha-endosulfine,37037,409,1.00 [0.83-1.20],0.9823199044814231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41668,448,1.39 [1.16-1.67],0.0003191541856269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41880,443,1.41 [0.94-2.12],0.0943317761550901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41880,443,2.08 [1.46-2.97],4.854491833351278e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,36223,386,1.20 [1.04-1.40],0.0156773654160722
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EP300,Histone acetyltransferase p300,36116,394,0.84 [0.60-1.16],0.2877212185315606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPB41L5,Band 4.1-like protein 5,36175,396,1.05 [0.92-1.21],0.4668391953229954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPCAM,Epithelial cell adhesion molecule,42654,457,1.11 [1.01-1.22],0.0228953888866957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPGN,Epigen,37037,409,1.15 [0.96-1.39],0.1348698106849842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,42791,460,1.17 [0.91-1.52],0.2184945232185831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA10,Ephrin type-A receptor 10,41707,446,1.11 [0.99-1.25],0.0854688973713479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,41191,443,2.44 [1.97-3.03],4.777435771285327e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,36382,391,1.10 [0.79-1.55],0.5664919213071622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,43204,461,2.48 [1.84-3.33],1.6148426576384044e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB6,Ephrin type-B receptor 6,42293,453,1.16 [0.89-1.51],0.2786202653848081
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,41880,443,1.02 [0.88-1.17],0.8293407532996224
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPN1,Epsin-1,36507,400,0.91 [0.71-1.18],0.4836090641684208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,42620,454,1.23 [1.12-1.36],1.5401071808161167e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,36223,386,1.26 [1.12-1.43],0.0001905048132824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42987,464,1.96 [1.53-2.50],6.609358776097811e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,42814,456,2.08 [1.50-2.88],1.0144053027340958e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,42512,457,1.49 [0.98-2.27],0.0635943061757701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,42814,456,1.14 [0.81-1.61],0.4495840461189277
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBIN,Erbin,42503,452,0.99 [0.91-1.07],0.7746226420139739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERC2,ERC protein 2,36175,396,0.96 [0.83-1.11],0.5879424882676862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,35893,396,0.68 [0.48-0.96],0.0272971897380056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,42293,453,1.01 [0.91-1.12],0.885955492668578
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,36507,400,1.17 [0.89-1.54],0.2708514599843772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERMAP,Erythroid membrane-associated protein,36116,394,0.95 [0.76-1.19],0.6727094981444024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37037,409,1.37 [1.06-1.76],0.0147565935902794
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,36382,391,1.00 [0.91-1.08],0.913142403516052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,42432,449,1.15 [0.83-1.60],0.4105508694535758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,35986,394,0.84 [0.66-1.06],0.1406912243166155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,43204,461,1.33 [1.04-1.71],0.0257324054359498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,42656,457,1.07 [0.84-1.36],0.5683767736872685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESPL1,Separin,35893,396,0.96 [0.79-1.17],0.6796176519614111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESR1,Estrogen receptor,36116,394,0.93 [0.76-1.13],0.4569899379456263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESYT2,Extended synaptotagmin-2,37122,409,1.04 [0.92-1.16],0.5631561033586387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI2B,Protein EVI2B,35893,396,0.80 [0.59-1.07],0.1334742541394808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,36116,394,0.95 [0.85-1.07],0.3901473326974464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EVPL,Envoplakin,36507,400,1.11 [0.82-1.50],0.4947497742649015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXOSC10,Exosome component 10,35986,394,1.11 [0.95-1.30],0.1900634436888737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EXTL1,Exostosin-like 1,35986,394,0.75 [0.59-0.95],0.0182471768148462
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,43074,461,1.61 [1.18-2.20],0.0025831185576023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,37239,408,1.07 [0.74-1.56],0.7106802874796503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11,Coagulation factor XI,36717,401,0.80 [0.58-1.12],0.1950648768722392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,42688,457,1.12 [0.96-1.30],0.1464183196553348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F12,Coagulation factor XII,37249,405,1.00 [0.79-1.27],0.9825761726005144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,37041,402,1.09 [0.75-1.59],0.6539252437589319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2,Prothrombin,37249,405,0.91 [0.47-1.77],0.7908180174864655
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,42795,460,1.09 [0.94-1.26],0.2423236226977342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F3,Tissue factor,42794,461,1.06 [0.77-1.45],0.7217242585945909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,42779,457,1.01 [0.77-1.34],0.9296983434076956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,42779,457,2.39 [1.50-3.80],0.000234470273084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",42656,457,1.39 [1.28-1.50],1.4051442640527313e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",42691,456,1.20 [1.08-1.32],0.0003679244750552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",37203,406,1.40 [1.18-1.65],8.152468803128573e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",43204,461,1.65 [1.42-1.92],3.5358575162242726e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,42929,460,1.20 [1.06-1.36],0.0031335544813844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP6,Gastrotropin,41812,442,1.02 [0.88-1.19],0.7803824601504782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP9,Fatty acid-binding protein 9,42620,454,1.08 [0.93-1.26],0.3196852196313106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FADD,FAS-associated death domain protein,42691,456,0.97 [0.87-1.09],0.6593909868342771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM13A,Protein FAM13A,37041,407,1.01 [0.87-1.17],0.8966386673324273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171A2,Protein FAM171A2,37147,408,1.03 [0.97-1.10],0.2902650143343933
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM171B,Protein FAM171B,37037,409,1.28 [0.91-1.81],0.1529728193207571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,36223,386,0.87 [0.73-1.02],0.0898753305295738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,37203,406,2.33 [1.69-3.20],1.890016529977624e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,42503,452,1.60 [1.25-2.05],0.0001899447575976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,42627,456,1.46 [1.11-1.92],0.0062402496583367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3D,Protein FAM3D,37041,407,1.16 [1.03-1.30],0.0125373210849407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,43204,461,0.81 [0.60-1.09],0.1690848645225032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,36175,396,1.01 [0.88-1.17],0.8517394324200619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,43062,460,1.37 [1.11-1.69],0.0035353642928445
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,43147,461,0.72 [0.58-0.89],0.0030165168739111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBLN2,Fibulin-2,37205,407,2.08 [1.56-2.76],4.386935938048061e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBN2,Fibrillin-2,36175,396,1.02 [0.86-1.22],0.7814373543517601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",42691,456,1.36 [1.22-1.51],1.0670866913628398e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37203,406,1.10 [0.96-1.25],0.1743686352444912
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,42620,454,1.82 [1.53-2.16],1.0795327920882291e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37147,408,1.41 [0.93-2.13],0.1010130554102339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,42688,457,0.91 [0.77-1.08],0.2728746439503871
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42494,452,1.12 [0.96-1.31],0.1536967552334121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41668,448,1.08 [0.93-1.24],0.3105873591861905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42717,456,1.27 [1.07-1.52],0.0075758842203789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,37169,408,1.70 [1.40-2.07],8.355904084324598e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN2,Ficolin-2,42484,455,0.78 [0.64-0.95],0.0116886270802361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,42691,456,0.77 [0.64-0.93],0.0080671621503791
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL2,Fc receptor-like protein 2,42946,459,1.01 [0.85-1.20],0.9267119330119092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL3,Fc receptor-like protein 3,41875,450,0.93 [0.80-1.10],0.4081421411296057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL5,Fc receptor-like protein 5,42688,457,1.18 [1.02-1.36],0.023284877488849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL6,Fc receptor-like protein 6,42620,454,1.10 [0.97-1.24],0.142921473741055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,41668,448,1.41 [1.26-1.57],1.9428603338824794e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",35986,394,1.17 [1.02-1.35],0.0293938089302467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",35986,394,1.29 [1.10-1.52],0.0022636494619293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FEN1,Flap endonuclease 1,41668,448,1.03 [0.91-1.17],0.6712384243494746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,41668,448,0.98 [0.82-1.18],0.8346625549863969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FETUB,Fetuin-B,42779,457,1.14 [0.87-1.48],0.3416816181288947
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,36379,392,1.97 [1.45-2.68],1.4117056131686336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37147,408,0.96 [0.85-1.09],0.566882106026704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF12,Fibroblast growth factor 12,36116,394,1.16 [0.95-1.40],0.144024967655736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF16,Fibroblast growth factor 16,36116,394,0.83 [0.66-1.05],0.1254876489969735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,42864,461,1.19 [1.07-1.32],0.0018392368306548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,42620,454,1.11 [0.98-1.25],0.0905124637939304
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF20,Fibroblast growth factor 20,36116,394,1.06 [0.85-1.32],0.6323966078318901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,43000,464,1.38 [1.30-1.46],3.44153858715396e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,42992,464,1.42 [1.27-1.59],7.281057937494489e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF3,Fibroblast growth factor 3,36116,394,0.81 [0.56-1.16],0.2452424657016229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,41875,450,1.30 [1.01-1.67],0.041107305033941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF6,Fibroblast growth factor 6,36116,394,1.33 [1.09-1.62],0.0041608169015173
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF7,Fibroblast growth factor 7,35893,396,1.05 [0.93-1.18],0.4428511142567617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF9,Fibroblast growth factor 9,35828,395,1.03 [0.80-1.32],0.8361025091103512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,42814,456,0.59 [0.45-0.75],3.218719001022489e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,37205,407,0.80 [0.66-0.97],0.0241062371912712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,37122,409,1.03 [0.80-1.34],0.8121957101517804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,42814,456,3.27 [2.34-4.57],3.504657420176205e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,36382,391,0.80 [0.66-0.97],0.0212729886585808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,37239,408,2.16 [1.89-2.48],4.3294076593719733e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGR,Tyrosine-protein kinase Fgr,41707,446,1.18 [1.04-1.34],0.0097108856924241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FH,"Fumarate hydratase, mitochondrial",35984,403,1.05 [0.93-1.18],0.4374272201741511
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,35986,394,0.83 [0.66-1.03],0.0910860291836797
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,41707,446,1.02 [0.91-1.15],0.7089635109490485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,42650,459,1.11 [1.00-1.24],0.0515394114740084
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37147,408,1.06 [0.96-1.17],0.2393356964730753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42805,457,0.93 [0.86-1.00],0.0468142097903813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42367,453,1.51 [1.24-1.85],6.232229891546473e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42367,453,1.11 [1.01-1.22],0.0232835026987378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41633,446,1.15 [0.97-1.35],0.1018583618033968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBPL,FK506-binding protein-like,37041,407,1.02 [0.86-1.21],0.8077237179381654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,41668,448,0.98 [0.91-1.06],0.6082785610593866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42367,453,1.83 [1.37-2.43],3.681614635422775e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,42427,452,2.05 [1.54-2.74],1.1070934015963991e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,41668,448,0.76 [0.57-1.03],0.0759089081598223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,43147,461,1.62 [1.28-2.06],7.278127566685435e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,42814,456,1.10 [0.85-1.40],0.4718316462182848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMNL1,Formin-like protein 1,41707,446,1.08 [0.95-1.22],0.2384227211565209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FMR1,Synaptic functional regulator FMR1,41668,448,1.03 [0.80-1.32],0.8286576829642346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FN1,Fibronectin,37249,405,1.16 [0.80-1.67],0.4334252680650174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,37122,409,1.17 [0.95-1.44],0.1408184919942613
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37037,409,1.31 [1.00-1.71],0.047552437791358
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,36116,394,0.97 [0.87-1.09],0.6413818504981837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,42635,454,1.71 [1.31-2.24],7.610100525643196e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR2,Folate receptor beta,43074,461,2.03 [1.54-2.67],5.130455956234653e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR3,Folate receptor gamma,42680,452,1.04 [1.00-1.08],0.0722955372054202
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOS,Proto-oncogene c-Fos,35828,395,1.44 [1.11-1.88],0.0067763661637587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOSB,Protein fosB,41707,446,1.06 [0.85-1.31],0.6031390926019176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,36116,394,0.90 [0.71-1.13],0.3576795263498251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,42620,454,1.01 [0.91-1.12],0.8535927793405179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,41668,448,1.03 [0.94-1.13],0.5354846979674701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD4B,FERM domain-containing protein 4B,35986,394,1.01 [0.87-1.17],0.9364989794488634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRMD7,FERM domain-containing protein 7,36175,396,0.98 [0.73-1.32],0.914766024158528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FRZB,Secreted frizzled-related protein 3,42230,453,1.04 [0.75-1.44],0.8364626269252299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSHB,Follitropin subunit beta,36223,386,1.13 [0.94-1.35],0.2038482997066448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,42795,460,1.39 [1.18-1.64],8.936651267163302e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,36223,386,5.23 [3.61-7.58],2.613086233940812e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,42599,458,3.16 [2.54-3.92],2.107499296082732e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,37048,408,1.06 [0.95-1.18],0.3065388556790103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,42934,458,1.10 [0.98-1.22],0.099805108910658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,36382,391,1.39 [1.20-1.61],9.267567989530962e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,42814,456,1.38 [1.08-1.77],0.0106759488285989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,41602,448,1.16 [0.94-1.43],0.1760800239463814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36435,399,1.09 [0.93-1.26],0.2817931019004357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,43074,461,2.07 [1.74-2.46],2.481962654773414e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",42367,453,0.99 [0.85-1.15],0.8879145713344513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXN,"Frataxin, mitochondrial",43059,464,1.14 [1.02-1.28],0.019972723186906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,41875,450,0.99 [0.87-1.13],0.8893551182652821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,42620,456,0.99 [0.91-1.09],0.912099249336228
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,36175,396,1.09 [0.93-1.28],0.2773936248734547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD8,Frizzled-8,35984,403,1.11 [0.88-1.39],0.3875955159848225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,37037,409,1.01 [0.83-1.24],0.9076649340146294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36507,400,0.90 [0.76-1.07],0.2373943351083176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,35984,403,1.08 [0.93-1.25],0.2935077552587261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD1,Glutamate decarboxylase 1,35893,396,1.11 [0.75-1.64],0.5975842650869085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAD2,Glutamate decarboxylase 2,36116,394,1.05 [0.85-1.31],0.622418525818242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36507,400,1.08 [0.89-1.30],0.4493319327410695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36223,386,1.16 [0.97-1.39],0.11242331213867
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,35893,396,0.96 [0.81-1.14],0.6324828777529554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,42864,461,0.91 [0.80-1.03],0.1466212007675866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42503,452,2.51 [1.88-3.34],3.068256134308153e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,43059,464,0.64 [0.46-0.88],0.0058520406259895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41875,450,1.08 [0.88-1.32],0.4511941138775853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37203,406,2.45 [1.79-3.37],2.9615305599626984e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,42503,452,0.97 [0.64-1.47],0.8931510249319048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,35986,394,1.03 [0.78-1.38],0.8133711072963339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,35595,387,1.05 [0.74-1.49],0.787452615700936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,37147,408,0.77 [0.51-1.15],0.2060294735568294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS2,Growth arrest-specific protein 2,36507,400,1.15 [0.96-1.37],0.1239581456170484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,42928,460,2.90 [2.11-4.00],5.565641520743278e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GASK1A,Golgi-associated kinase 1A,35986,394,0.70 [0.55-0.89],0.0036008434173067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,37122,409,1.36 [1.28-1.45],3.69594679444898e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,35893,396,0.80 [0.55-1.17],0.2502038583435385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36223,386,1.05 [0.92-1.19],0.5048947565142012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,36175,396,1.15 [0.97-1.37],0.111003344958547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,37056,408,1.31 [1.14-1.52],0.0002411258310207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP2,Guanylate-binding protein 2,41875,450,1.13 [0.98-1.30],0.0868942094621108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP4,Guanylate-binding protein 4,41707,446,1.13 [0.95-1.34],0.1779440987479355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP6,Guanylate-binding protein 6,35986,394,1.00 [0.79-1.27],0.991261842492283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GC,Vitamin D-binding protein,37249,405,1.27 [0.87-1.86],0.2118772933185955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,37122,409,1.02 [0.93-1.12],0.6652724758917945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,41668,448,0.98 [0.91-1.05],0.4891986771176548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,35508,382,1.56 [1.33-1.82],6.082994704909128e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,35986,394,1.10 [0.89-1.35],0.3930899569454164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42503,452,1.39 [1.09-1.77],0.0080836917201144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,43204,461,2.18 [1.94-2.45],8.13709738654299e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,42691,456,1.05 [0.83-1.33],0.6624032720845289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,41707,446,1.37 [1.10-1.70],0.0047218124807032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GET3,ATPase GET3,37203,406,1.16 [0.99-1.36],0.0641116378805619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFAP,Glial fibrillary acidic protein,41603,447,1.05 [0.87-1.28],0.5996826425963782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,41668,448,1.26 [1.11-1.44],0.000435284749636
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41668,448,0.97 [0.90-1.04],0.3646890252486608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,43000,464,2.68 [2.06-3.49],2.713167248814661e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA2,GDNF family receptor alpha-2,42503,452,1.61 [1.06-2.42],0.0240081279595629
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA3,GDNF family receptor alpha-3,42233,451,0.98 [0.72-1.34],0.901041266256731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,36019,391,0.79 [0.67-0.93],0.0046340954825133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,41707,446,1.11 [0.98-1.25],0.1034108525295927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,37203,406,0.98 [0.85-1.13],0.7959658782118089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,37132,405,0.98 [0.79-1.20],0.8236079626343652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,41946,448,1.39 [1.10-1.76],0.0052210518853037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,42618,457,1.85 [1.62-2.11],5.949420125716321e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,42367,453,3.31 [2.42-4.53],7.55224219920002e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,42627,456,1.09 [1.04-1.14],0.000411294841997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,41668,448,1.02 [0.97-1.08],0.3817296007970253
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHR,Growth hormone receptor,36382,391,0.48 [0.34-0.67],2.157090827426992e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,41707,446,0.96 [0.81-1.14],0.6420707230608207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,42691,456,1.04 [0.94-1.16],0.4096417866258627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,37147,408,1.06 [0.81-1.40],0.6612970089173459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,37147,408,1.05 [0.92-1.20],0.4516208501018415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP7,GTPase IMAP family member 7,36382,391,0.94 [0.69-1.28],0.7105677321594952
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIMAP8,GTPase IMAP family member 8,35893,396,1.03 [0.85-1.26],0.7336987627322953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,36223,386,1.28 [1.06-1.55],0.0119197377568701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,37122,409,2.11 [1.61-2.77],6.846978771017529e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,37041,407,1.00 [0.90-1.10],0.968641748076143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,36116,394,0.99 [0.79-1.23],0.9238766817704086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,36116,394,0.99 [0.89-1.10],0.8116269443473193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GJA8,Gap junction alpha-8 protein,35893,396,0.96 [0.81-1.15],0.6635704006359424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,40922,436,1.86 [1.37-2.54],8.58467239861348e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,36317,391,1.74 [1.35-2.24],1.874602314477518e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,42367,453,1.32 [1.08-1.61],0.0055791173362616
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLI2,Zinc finger protein GLI2,36116,394,1.11 [0.81-1.53],0.5199589864153489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,41880,443,1.45 [1.25-1.68],8.112950290230305e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,42581,458,1.15 [0.90-1.47],0.2632580211759697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,35984,403,1.05 [0.80-1.38],0.724351883281354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX,Glutaredoxin-1,42430,453,1.07 [0.93-1.24],0.3539780342926091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36382,391,1.10 [0.99-1.23],0.086528532937887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41707,446,0.93 [0.76-1.13],0.452975167999547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,37037,409,1.06 [0.90-1.25],0.4565238406782431
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,36299,397,1.67 [1.39-1.99],1.789639102726712e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMFG,Glia maturation factor gamma,37203,406,0.96 [0.84-1.10],0.5784932559957594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR,GMP reductase 1,43147,461,0.88 [0.74-1.05],0.1471845714166328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GMPR2,GMP reductase 2,36382,391,0.93 [0.80-1.09],0.3659417380906934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNAS,Neuroendocrine secretory protein 55,37147,408,0.99 [0.89-1.10],0.831254956621789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41668,448,1.05 [0.92-1.20],0.4716950363194545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36175,396,1.04 [0.85-1.27],0.7079777808296035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNLY,Granulysin,42688,457,1.18 [1.01-1.39],0.0407102473320459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,36223,386,0.70 [0.50-0.98],0.0357021598532662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,36382,391,0.82 [0.62-1.07],0.1477384968773467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLGA3,Golgin subfamily A member 3,37147,408,1.00 [0.88-1.14],0.9484863696441546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,43074,461,2.22 [1.61-3.08],1.5273387238364649e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42620,454,0.99 [0.91-1.07],0.7672305391130676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,37041,407,0.95 [0.77-1.17],0.6352186685271821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",37205,407,1.46 [1.20-1.77],0.0001272497209102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,42493,453,0.93 [0.72-1.20],0.5801226179253021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,35986,394,0.99 [0.86-1.15],0.9331753627641584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41339,437,0.98 [0.88-1.09],0.7306559740477692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP5,Platelet glycoprotein V,36382,391,0.78 [0.60-1.02],0.0722441695135207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP6,Platelet glycoprotein VI,42620,456,1.00 [0.91-1.10],0.9574642754250252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPA33,Cell surface A33 antigen,42503,452,1.02 [0.96-1.09],0.4615369849426162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC1,Glypican-1,43059,464,0.72 [0.54-0.96],0.0236117139572409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,42367,453,0.64 [0.55-0.75],1.1965684477262275e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,37037,409,1.45 [1.23-1.71],1.025397448513178e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,37041,407,0.99 [0.79-1.25],0.958680501358434
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPI,Glucose-6-phosphate isomerase,37239,408,1.10 [0.90-1.34],0.3331100070978835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37041,407,0.97 [0.85-1.11],0.6740355264707734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,41707,446,1.47 [1.16-1.86],0.0014499067197523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,41538,443,1.30 [0.96-1.75],0.0903371811056756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR101,Probable G-protein coupled receptor 101,35984,403,1.06 [0.91-1.25],0.4403818985881339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR158,Probable G-protein coupled receptor 158,37147,408,1.18 [0.91-1.53],0.2229823526828457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,37041,407,1.38 [1.18-1.60],4.1831556831783285e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,41880,443,1.40 [1.23-1.59],4.99962525537271e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,37037,409,1.49 [1.30-1.71],1.0947267333852058e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRAP2,GRB2-related adapter protein 2,42691,456,0.98 [0.92-1.05],0.5703004802435528
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37203,406,1.10 [0.94-1.29],0.2167085707300989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",37147,408,0.94 [0.74-1.20],0.6087557197373568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",35984,403,0.89 [0.72-1.09],0.2576301338451991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRK5,G protein-coupled receptor kinase 5,41880,443,0.98 [0.82-1.17],0.8207276413135538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,42474,454,2.12 [1.57-2.88],1.2579933807014468e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,36223,386,1.03 [0.86-1.24],0.7591380254813023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",42503,452,1.68 [1.49-1.88],7.593666321628609e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRSF1,G-rich sequence factor 1,35699,394,0.99 [0.88-1.13],0.9327151944841338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSAP,Gamma-secretase-activating protein,41668,448,1.00 [0.90-1.11],0.9949819473166726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,37109,408,0.40 [0.27-0.59],3.7675983932814713e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSR,"Glutathione reductase, mitochondrial",37025,407,1.50 [0.99-2.28],0.0546200058115838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,42632,455,1.03 [0.93-1.14],0.5354938235975406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,41668,448,1.03 [0.92-1.16],0.5777027620691402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,35986,394,1.09 [0.95-1.24],0.2085063007774646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTP1,Glutathione S-transferase P,41439,440,1.00 [0.87-1.14],0.9493343089716176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,37122,409,0.97 [0.93-1.01],0.0905588294935472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36507,400,1.03 [0.90-1.19],0.6334312781420265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GTPBP2,GTP-binding protein 2,36175,396,0.93 [0.82-1.05],0.2621650418518201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,42473,456,1.42 [1.12-1.79],0.0036851793876068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,36507,400,1.03 [0.92-1.17],0.5762749085208172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUK1,Guanylate kinase,35986,394,1.05 [0.83-1.32],0.6824008757183502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,42866,459,1.53 [1.34-1.75],3.7238175471570606e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",41880,443,1.04 [0.95-1.15],0.3716246753626869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMA,Granzyme A,43147,461,1.21 [0.95-1.53],0.1199084933751255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMB,Granzyme B,42620,454,0.95 [0.84-1.09],0.4818916366543788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GZMH,Granzyme H,41880,443,1.10 [0.99-1.22],0.0686561138193851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",H2AP,Huntingtin-interacting protein M,35893,396,0.95 [0.76-1.19],0.6521690440243292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",35986,394,1.00 [0.86-1.16],0.9887321733557768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42938,461,1.02 [0.91-1.15],0.7453442228824197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,43059,464,1.12 [1.05-1.20],0.0004538466201301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",42688,457,1.02 [0.91-1.14],0.6888350208084251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,42997,461,1.79 [1.60-1.99],1.0051316580128796e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,42688,457,2.21 [1.78-2.74],6.336382379136367e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,42938,461,0.85 [0.76-0.96],0.0071956748207571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,43059,464,0.93 [0.81-1.08],0.337664513010246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBZ,Hemoglobin subunit zeta,37203,406,0.98 [0.89-1.07],0.6666451575841018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCG22,Protein PBMUCL2,35986,394,0.98 [0.82-1.18],0.8606976592872106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,43147,461,1.07 [0.91-1.25],0.4182351397239787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC8,Histone deacetylase 8,36116,394,0.96 [0.79-1.15],0.6449999470221515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDAC9,Histone deacetylase 9,35984,403,0.96 [0.82-1.13],0.6169397314354579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,37041,407,0.86 [0.69-1.08],0.2038435718944976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGF,Hepatoma-derived growth factor,42998,463,1.08 [0.98-1.18],0.1107576531840739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,37122,409,1.01 [0.87-1.18],0.8778177504851715
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,41880,443,0.96 [0.81-1.14],0.6681121363035984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,36382,391,2.64 [1.88-3.71],1.8303574123155483e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPACAM2,HEPACAM family member 2,37122,409,0.84 [0.67-1.05],0.1252323630043533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,37203,406,1.85 [1.26-2.70],0.0015394960943761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,42620,454,1.06 [0.95-1.18],0.3167863302538876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,43147,461,2.73 [2.24-3.33],2.6618391653638923e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGFAC,Hepatocyte growth factor activator,36896,404,0.75 [0.54-1.04],0.0827835042681037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41668,448,1.06 [0.95-1.19],0.2995628585092124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,37122,409,1.06 [0.93-1.21],0.3766501973352406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,36116,394,0.93 [0.79-1.09],0.3759460078855114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1,Huntingtin-interacting protein 1,35986,394,0.96 [0.72-1.30],0.8028787469677566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,37051,408,1.47 [1.25-1.73],3.3523273486664847e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,37147,408,1.31 [1.07-1.61],0.0098818407185669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HK2,Hexokinase-2,41880,443,1.12 [0.81-1.55],0.4861907492926142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",37147,408,1.40 [1.03-1.90],0.0292492339818556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",42500,449,1.49 [1.18-1.87],0.0006549861862138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",42620,454,2.13 [1.64-2.78],1.8567225592408933e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMBS,Porphobilinogen deaminase,43059,464,1.15 [0.93-1.41],0.1934215847701567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMCN2,Hemicentin-2,36321,390,1.07 [0.90-1.28],0.4476557720208285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36223,386,1.26 [1.03-1.53],0.0232910780689291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",35986,394,1.17 [0.94-1.47],0.1644815826031389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMMR,Hyaluronan mediated motility receptor,35820,395,1.08 [0.87-1.33],0.4910772877578583
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX1,Heme oxygenase 1,42208,453,1.19 [1.01-1.41],0.0360494232020964
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,41707,446,1.40 [1.20-1.64],2.608680632278097e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,36175,396,1.05 [0.93-1.20],0.424572276787878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,42166,453,1.42 [1.20-1.69],5.810574635627854e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41739,441,1.07 [0.96-1.20],0.2399509227051514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37147,408,1.21 [1.01-1.46],0.040861673603574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPCAL1,Hippocalcin-like protein 1,43147,461,0.99 [0.89-1.12],0.9224070026124116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,41668,448,0.48 [0.38-0.60],5.26414576660897e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,36717,404,1.12 [1.01-1.24],0.0340977264850332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRAS,GTPase Hras,36436,400,1.00 [0.90-1.11],0.9614804069003676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36223,386,0.86 [0.64-1.15],0.3058453709147176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HRG,Histidine-rich glycoprotein,37041,402,0.98 [0.73-1.32],0.905775667215053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,36223,386,0.98 [0.88-1.10],0.779940684026471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42503,452,1.25 [1.00-1.57],0.0498937170026342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,43059,464,0.87 [0.68-1.11],0.2617944355273103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36116,394,0.85 [0.64-1.14],0.2741050709088179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSBP1,Heat shock factor-binding protein 1,36223,386,0.92 [0.83-1.03],0.1449054357376294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42620,454,1.66 [1.35-2.04],1.4458605036398957e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37122,409,1.14 [0.97-1.33],0.1007933929508877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,35986,394,0.90 [0.72-1.12],0.331825007212059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36223,386,1.23 [1.00-1.51],0.0452270743801052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSP90B1,Endoplasmin,41507,441,0.94 [0.81-1.09],0.3872209590154573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,42791,460,1.09 [0.97-1.23],0.1350265731109271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,37037,409,1.14 [0.86-1.50],0.3557219783728713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB1,Heat shock protein beta-1,42018,448,1.07 [0.94-1.22],0.3104947818018192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,43059,464,1.25 [1.02-1.54],0.0349495327923388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42349,451,2.47 [1.90-3.21],1.2024874689423808e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,35984,403,1.08 [0.96-1.22],0.1964548973437667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,35984,403,0.98 [0.77-1.25],0.8624606568086206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",42814,456,1.23 [1.08-1.41],0.0022867205261062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,42438,454,3.07 [2.22-4.25],1.3503425461486826e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,43204,461,1.14 [0.79-1.64],0.4953264174811214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICA1,Islet cell autoantigen 1,41875,450,0.98 [0.88-1.10],0.7695581414638941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,42493,454,3.36 [2.65-4.28],4.518220231428581e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM2,Intercellular adhesion molecule 2,43204,461,1.40 [1.08-1.83],0.0124818563643726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,43204,461,1.80 [1.33-2.43],0.0001255662258288
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM4,Intercellular adhesion molecule 4,42620,454,0.97 [0.83-1.14],0.7203459872482598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,42691,456,2.16 [1.79-2.59],2.8214245453361073e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICOSLG,ICOS ligand,42503,452,0.64 [0.41-1.00],0.0484153373748392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,36507,400,1.02 [0.81-1.29],0.8455578613571184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,41707,446,1.08 [0.90-1.30],0.3990755662224163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",36223,386,1.12 [0.96-1.30],0.1414549966023549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,43147,461,0.46 [0.19-1.11],0.0846251999447403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,43059,464,1.53 [1.27-1.84],6.619273109763709e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36136,397,2.58 [2.11-3.15],2.3792224630801846e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36507,400,1.03 [0.85-1.26],0.7447741398355436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36507,400,1.11 [0.87-1.42],0.4002082492588721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,37041,407,1.35 [0.94-1.95],0.106021622029458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,41875,450,1.10 [1.02-1.18],0.0153253623677089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR1,Interferon gamma receptor 1,42864,461,1.73 [1.20-2.50],0.003439368734787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,42367,453,1.38 [1.18-1.61],4.2303039761381136e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,41707,446,1.20 [1.01-1.42],0.0411800705969677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL2,Interferon lambda-2,35984,403,1.10 [0.95-1.28],0.1918440430135284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,42620,454,1.20 [0.96-1.49],0.1156868424120236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNW1,Interferon omega-1,35986,394,1.06 [0.81-1.39],0.6796785516935143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,36175,396,0.96 [0.75-1.23],0.7595105534430506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,37147,408,0.99 [0.84-1.17],0.9319294190665516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,35984,403,1.01 [0.84-1.23],0.8825631109957386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37205,407,0.82 [0.58-1.18],0.286638838803924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,42503,452,1.61 [1.15-2.24],0.0052994661393909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,35986,394,0.83 [0.64-1.08],0.1595529284136218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,42688,457,2.25 [1.60-3.18],3.877804343055148e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,43133,461,1.29 [1.20-1.38],6.201518132780834e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,43134,461,1.64 [1.43-1.88],1.024308806678609e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,42847,457,0.40 [0.32-0.51],1.1377160076644944e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,42136,451,1.92 [1.64-2.25],8.233723564600213e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,42498,455,0.94 [0.71-1.23],0.6398955923476151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,43204,461,2.50 [2.05-3.05],1.415545821302592e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,42691,456,3.00 [2.43-3.70],1.5372772837691299e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFL4,Insulin growth factor-like family member 4,36116,394,0.98 [0.85-1.12],0.7697452868521233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,35986,394,1.00 [0.83-1.20],0.9659381156181212
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,37189,404,2.15 [1.72-2.69],1.5748278816578776e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLON5,IgLON family member 5,35893,396,0.95 [0.84-1.07],0.3832527141451132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,36223,386,0.79 [0.60-1.04],0.0990194792819649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,42503,452,1.82 [1.54-2.15],2.0254575563220214e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,42691,456,1.76 [1.37-2.28],1.3627928534843104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,37203,406,1.30 [1.17-1.45],1.2811519224395963e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,42620,454,0.96 [0.87-1.05],0.3604698851563568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKZF2,Zinc finger protein Helios,41668,448,1.04 [0.94-1.15],0.4240847449589344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10,Interleukin-10,41875,450,1.07 [0.97-1.19],0.1933755306686702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,41875,450,1.10 [0.95-1.26],0.2051511796242168
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,42864,461,2.73 [2.16-3.44],3.9036644617640206e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL11,Interleukin-11,41875,450,1.06 [0.93-1.21],0.4028197437442351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12A_IL12B,Interleukin-12,42503,452,1.12 [1.01-1.25],0.0402167341283194
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,43147,461,1.12 [0.97-1.30],0.1234232048557921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,41875,450,1.29 [1.02-1.62],0.0324104267644808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,36116,394,1.13 [0.89-1.43],0.3126862587661063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13,Interleukin-13,41875,450,0.93 [0.76-1.14],0.4873522426073657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,42162,446,1.00 [0.69-1.45],0.9953325856415296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,35984,403,1.11 [0.78-1.58],0.5605778999315747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,42620,454,2.51 [1.99-3.16],1.0955782425569746e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,41875,450,1.51 [1.18-1.93],0.0010947013819175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,43147,461,1.13 [0.94-1.37],0.1953550167851497
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17A,Interleukin-17A,41805,449,1.34 [1.14-1.58],0.000362977370507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,41875,450,1.37 [1.23-1.52],1.4072614365025962e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17D,Interleukin-17D,41875,450,1.14 [0.90-1.44],0.2873537496875018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17F,Interleukin-17F,41875,450,1.08 [0.97-1.20],0.1821412745308397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RA,Interleukin-17 receptor A,42688,457,1.20 [0.99-1.46],0.0588095115602105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,42089,450,0.83 [0.71-0.97],0.0202291057362433
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,42511,455,1.76 [1.49-2.09],8.709729896924465e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,42847,457,2.63 [2.07-3.34],1.9740971556292483e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,43147,461,1.88 [1.48-2.38],1.7841888963508937e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,42092,453,1.00 [0.95-1.05],0.927021045437754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,41625,448,1.57 [1.42-1.73],1.525346793466958e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1A,Interleukin-1 alpha,41875,450,1.02 [0.88-1.19],0.7466680994370782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,41672,447,1.27 [1.11-1.44],0.0003817647474939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,42618,457,2.41 [1.72-3.38],3.567360876386568e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,42588,457,1.48 [0.97-2.27],0.0723547569411742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,42688,457,0.55 [0.45-0.68],2.7594427389749392e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,43062,460,2.14 [1.79-2.55],3.494671156462024e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,41875,450,0.42 [0.34-0.52],1.275043033699317e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,42575,459,1.54 [1.36-1.75],1.5994445352928168e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2,Interleukin-2,41875,450,1.17 [0.88-1.55],0.2817758654879809
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,41875,450,1.00 [0.84-1.20],0.9902026399745444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,41875,450,0.92 [0.75-1.14],0.4640504600394328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,36116,394,0.96 [0.76-1.22],0.7442515300691352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,36116,394,1.03 [0.86-1.24],0.7219471360784773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,37037,409,1.67 [1.49-1.88],1.1398057584056925e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,41875,450,1.11 [0.92-1.35],0.2841628523870911
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL24,Interleukin-24,41875,450,1.03 [0.85-1.24],0.7733417995077772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL25,Interleukin-25,35769,395,1.17 [0.87-1.56],0.2995977107528255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,42368,452,2.35 [1.96-2.83],8.917439751810782e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,41875,450,0.88 [0.68-1.12],0.2955606844136524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,37037,409,1.30 [1.03-1.64],0.0248419159142123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,35893,396,1.12 [0.94-1.34],0.206094990232417
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31,Interleukin-31,36116,394,1.09 [0.91-1.29],0.3442860769262934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,35973,391,1.05 [0.81-1.37],0.6908394614323141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,42620,454,1.64 [1.39-1.94],4.7868805786077595e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL33,Interleukin-33,41875,450,1.05 [0.84-1.32],0.6439326228585607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,41639,442,1.28 [1.00-1.64],0.0546661776931295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36A,Interleukin-36 alpha,36116,394,1.23 [1.06-1.43],0.0064589901531786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL36G,Interleukin-36 gamma,35977,394,1.24 [1.09-1.41],0.0007754609788845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,41875,450,1.27 [0.97-1.67],0.082784826291937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4,Interleukin-4,41875,450,1.02 [0.92-1.12],0.7028995329421391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,42620,454,2.24 [1.85-2.71],1.2014218168075786e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5,Interleukin-5,41875,450,0.98 [0.92-1.04],0.5308316498624193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,42620,454,1.11 [0.96-1.28],0.1668381964103052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,42503,452,1.53 [1.42-1.66],2.781348666034201e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,42425,454,1.20 [0.94-1.54],0.1450531095616755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,42691,456,3.46 [2.18-5.50],1.345562523970599e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7,Interleukin-7,42620,454,0.96 [0.84-1.10],0.5562209721901941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,42688,457,0.80 [0.69-0.93],0.0041680059463197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL9,Interleukin-9,36507,400,1.06 [0.89-1.26],0.4877535838223736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41639,444,1.06 [0.91-1.23],0.4670198069528125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,37037,409,1.58 [1.32-1.89],4.334583659346072e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPA1,Inositol monophosphatase 1,42367,453,0.94 [0.81-1.08],0.3729595594900944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPACT,Protein IMPACT,37122,409,1.03 [0.86-1.23],0.782010879067196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,35984,403,1.10 [0.79-1.51],0.5800397445998662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,41633,446,0.94 [0.77-1.14],0.5297496570379561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,36382,391,1.71 [1.44-2.03],8.078224848180206e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,42688,457,1.19 [0.96-1.48],0.1182178089700111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,42503,452,1.00 [0.85-1.17],0.981383771147907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36223,386,1.08 [0.91-1.28],0.4053671862858181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37147,408,0.91 [0.71-1.17],0.4660319087834963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42503,452,1.00 [0.92-1.10],0.9278623067375384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,37122,409,0.68 [0.61-0.76],1.0223776890384347e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL4,Early placenta insulin-like peptide,37037,409,1.04 [0.86-1.26],0.6683121335604766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,37041,407,1.18 [1.07-1.30],0.0005947196388963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,36116,394,3.39 [1.97-5.82],1.0081945329475356e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,42294,453,1.07 [0.97-1.18],0.1827908064613382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,42503,452,1.18 [1.02-1.38],0.0309374727225755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41880,443,1.03 [0.93-1.13],0.6072300819128705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,41875,450,1.01 [0.89-1.15],0.8440861798596164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,42620,454,0.99 [0.91-1.07],0.7543245691156278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41118,439,1.07 [0.85-1.34],0.5626997064522352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,42620,454,1.41 [1.14-1.75],0.0016409037610211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM2,Isthmin-2,37205,407,1.03 [0.83-1.29],0.7818892344858052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IST1,IST1 homolog,36771,405,1.00 [0.91-1.11],0.952839587322778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,42620,454,0.60 [0.47-0.76],3.531590824616193e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,36382,391,0.59 [0.44-0.79],0.0003908036803159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,42688,457,2.83 [2.06-3.89],1.6265522794862575e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA6,Integrin alpha-6,42620,454,0.89 [0.75-1.05],0.173513409256067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAL,Integrin alpha-L,36116,394,1.37 [1.07-1.74],0.0108569533851513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,42688,457,0.68 [0.52-0.89],0.0048861743533295
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,43059,464,0.33 [0.20-0.53],3.695088177900462e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAX,Integrin alpha-X,36507,400,1.18 [0.99-1.40],0.0655382306507991
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,42635,455,1.28 [0.86-1.88],0.2193508273273612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,41668,448,1.12 [0.91-1.38],0.2928233133533398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,41880,443,1.05 [0.97-1.13],0.2530280102900989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,42414,456,0.72 [0.53-0.97],0.0321908728258566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB5,Integrin beta-5,42814,456,1.09 [0.88-1.35],0.4241620014219243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB6,Integrin beta-6,41875,450,0.90 [0.67-1.20],0.4643758192927291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB7,Integrin beta-7,43059,464,1.31 [1.10-1.56],0.0020039659504924
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,37205,407,2.04 [1.66-2.52],2.4295589420678668e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37249,405,0.86 [0.50-1.48],0.5788715183231512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42847,457,2.22 [1.77-2.78],3.0517873113592068e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37249,405,1.54 [1.10-2.14],0.0113859864050245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37037,409,1.19 [0.97-1.47],0.0988966634367052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITM2A,Integral membrane protein 2A,42620,454,1.03 [0.90-1.19],0.6375494632569659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,35986,394,1.10 [0.95-1.28],0.2094606711326707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36223,386,1.00 [0.86-1.15],0.9558101722473432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",35984,403,1.04 [0.83-1.30],0.7210318605655079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41707,446,1.17 [0.98-1.38],0.0767513361946126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,35893,396,1.02 [0.83-1.25],0.8690351653937756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM2,Junctional adhesion molecule B,43074,461,1.15 [0.84-1.57],0.3909274910157765
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,36382,391,1.13 [0.94-1.37],0.1965214601346073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,41875,450,1.36 [1.18-1.56],1.496748297802024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,35893,396,0.82 [0.67-1.00],0.0485940128223067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,37041,407,1.01 [0.90-1.13],0.9065419203901306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JUN,Transcription factor AP-1,41875,450,1.15 [0.97-1.35],0.1000861419472531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42503,452,0.82 [0.69-0.99],0.0378466649954025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZN,Kazrin,37041,407,1.00 [0.91-1.10],0.961079051167558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,35984,403,0.98 [0.81-1.19],0.8426263575035475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,36175,396,0.99 [0.86-1.15],0.923105732844656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCNIP4,Kv channel-interacting protein 4,41707,446,0.87 [0.71-1.06],0.1585026567502545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,36427,404,1.22 [1.00-1.49],0.0543487421522201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDM3A,Lysine-specific demethylase 3A,36116,394,0.99 [0.88-1.13],0.9358591505365896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,42814,456,0.89 [0.64-1.24],0.4824347925226534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KEL,Kell blood group glycoprotein,41707,446,1.09 [0.86-1.38],0.4875119252593392
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHDC3L,KH domain-containing protein 3,35893,396,0.92 [0.79-1.08],0.3197653326271844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,36223,386,1.08 [0.92-1.27],0.3251826482303965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,37122,409,1.00 [0.73-1.37],0.97971621924706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,36507,400,1.09 [0.94-1.26],0.2481133827480943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,36507,400,1.06 [0.75-1.50],0.737807358255908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,37037,409,1.06 [0.89-1.26],0.512060089909844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF1C,Kinesin-like protein KIF1C,35986,394,1.42 [1.15-1.77],0.0012905372066275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF20B,Kinesin-like protein KIF20B,35984,403,1.02 [0.89-1.17],0.7520541946087549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIF22,Kinesin-like protein KIF22,35986,394,1.03 [0.95-1.12],0.4211992529207752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIFBP,KIF-binding protein,42503,452,1.00 [0.90-1.11],0.9351857904877888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37037,409,1.13 [1.02-1.27],0.0250633862968328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41668,448,1.13 [1.01-1.26],0.0389711725312105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37041,407,1.02 [0.96-1.08],0.5014594933906427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41668,448,1.01 [0.94-1.08],0.7757228715431881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,35893,396,1.08 [0.98-1.21],0.1335923591590189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,35984,403,1.02 [0.86-1.21],0.798569981853334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,41707,446,0.96 [0.77-1.20],0.7477920759278449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,42779,457,0.55 [0.41-0.72],2.853699878740421e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,42691,456,0.48 [0.39-0.59],7.17006272441678e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLB,Beta-klotho,41707,446,0.94 [0.84-1.05],0.2773600052322111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,35984,403,1.31 [1.04-1.65],0.0206858153174908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLHL41,Kelch-like protein 41,37147,408,0.93 [0.76-1.14],0.5004787470895927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK1,Kallikrein-1,42266,449,1.05 [0.98-1.12],0.1567409670631604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,42687,454,1.71 [1.42-2.07],2.4636381291161893e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,42414,453,1.90 [1.54-2.34],1.6444154243157115e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK12,Kallikrein-12,41668,448,1.02 [0.95-1.08],0.6159787925715152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,41744,437,1.23 [1.02-1.49],0.0305551166071507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,43059,464,1.41 [1.18-1.67],0.0001012891234456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK15,Kallikrein-15,36968,408,1.13 [0.94-1.36],0.1960528033136319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK3,Prostate-specific antigen,37205,407,0.81 [0.73-0.90],0.000100532218248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,43059,464,1.39 [1.24-1.56],2.995791335272127e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK6,Kallikrein-6,42745,456,0.88 [0.67-1.16],0.3804209821176105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK7,Kallikrein-7,35447,386,0.99 [0.76-1.28],0.9205229784602909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK8,Kallikrein-8,41259,438,1.59 [1.26-2.01],9.268895747974118e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLKB1,Plasma kallikrein,36496,399,0.56 [0.38-0.83],0.0037741548890671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,43147,461,0.93 [0.75-1.16],0.518735608781337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,35984,403,1.06 [0.91-1.24],0.4557286634253154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,43147,461,1.16 [0.98-1.39],0.090367401493549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,36116,394,1.24 [1.01-1.52],0.0444736846044197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,37122,409,1.14 [0.92-1.41],0.2455568583429798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",40375,427,0.78 [0.56-1.09],0.1517063725432759
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",35986,394,0.99 [0.76-1.29],0.9316442147841106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",42503,452,1.25 [1.14-1.37],3.3706413385748057e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",42550,453,1.29 [1.16-1.45],8.446785380972396e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",41707,446,0.93 [0.78-1.11],0.4223311570354966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",35986,394,1.11 [0.86-1.43],0.4153656616409263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",35984,403,1.19 [1.07-1.33],0.0011907142092538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,42617,455,1.10 [0.95-1.27],0.2187635146198959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,43147,461,1.38 [1.16-1.64],0.0003244437724056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L1CAM,Neural cell adhesion molecule L1,42814,456,1.19 [0.89-1.59],0.2394781761512845
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37203,406,1.12 [1.00-1.25],0.0434214613607091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACRT,Extracellular glycoprotein lacritin,36972,408,1.03 [0.84-1.27],0.7541860000784042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LACTB2,Endoribonuclease LACTB2,42691,456,1.05 [0.92-1.19],0.503958035009326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,42503,452,0.92 [0.75-1.13],0.4332966203900109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42656,457,1.86 [1.57-2.21],1.1019467307766866e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42367,453,1.04 [0.96-1.14],0.3097138560098901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA1,Laminin subunit alpha-1,35986,394,1.09 [0.92-1.30],0.3171474996113548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,42864,461,1.59 [1.25-2.01],0.0001245858909123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMB1,Laminin subunit beta-1,36223,386,0.91 [0.65-1.25],0.546905299389817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,36145,397,1.54 [1.21-1.96],0.0003718269314348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,41383,445,1.63 [1.05-2.53],0.0293537575865351
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,43075,460,1.82 [1.58-2.10],7.114700564780712e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,37037,409,0.88 [0.68-1.12],0.2925662575540234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAP3,Cytosol aminopeptidase,41875,450,1.17 [0.98-1.39],0.0781743344795579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LARP1,La-related protein 1,37037,409,1.02 [0.88-1.20],0.7649426042806159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT,Linker for activation of T-cells family member 1,43147,461,1.00 [0.89-1.12],0.9663702246015908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,42503,452,1.01 [0.94-1.08],0.7310608143424037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,36116,394,0.99 [0.88-1.12],0.9007458497875171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,42293,453,2.10 [1.69-2.60],1.4387833575812828e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,42847,457,1.47 [1.28-1.68],5.729813169070545e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,43074,461,1.19 [1.07-1.33],0.0019209244779274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,37239,408,0.44 [0.31-0.64],1.6351248833825256e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN15,Lipocalin-15,37147,408,1.14 [0.99-1.31],0.0740786810950279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,41375,440,1.49 [1.23-1.81],4.272079427335049e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCP1,Plastin-2,37205,407,1.12 [0.92-1.37],0.2489667151927436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,42794,456,0.77 [0.66-0.91],0.002014088625635
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,37147,408,0.97 [0.88-1.08],0.6125271082432584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,37203,406,1.19 [1.03-1.37],0.0149087649974406
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEFTY2,Left-right determination factor 2,43000,464,0.91 [0.77-1.06],0.2202636746911965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,35153,376,1.33 [1.17-1.53],2.900586486384814e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,35984,403,1.04 [0.91-1.19],0.5412820637658697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,37147,408,1.48 [1.16-1.89],0.0014860300002313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEP,Leptin,42691,456,1.11 [0.98-1.26],0.0992273890908544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEPR,Leptin receptor,42691,456,1.73 [1.37-2.18],3.1893756818279862e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,37147,408,1.30 [1.10-1.54],0.0025007833386574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,42691,456,1.32 [1.05-1.67],0.0183939824647023
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,42796,459,1.80 [1.38-2.35],1.7576787591233963e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,37249,405,2.15 [1.66-2.80],9.199779569677813e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,42656,457,1.96 [1.71-2.24],2.27183523363622e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,42563,459,1.35 [1.12-1.62],0.0013247128260983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,43074,461,1.02 [0.89-1.17],0.8093490861400241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,42654,459,2.67 [2.11-3.39],3.3925997296655543e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,42864,461,2.36 [1.90-2.94],1.5710583851887735e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHB,Lutropin subunit beta,41668,448,1.03 [0.93-1.14],0.5790604715690331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42716,460,1.13 [0.98-1.29],0.0969760370799362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,41707,446,1.23 [1.05-1.43],0.0106608686971301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIFR,Leukemia inhibitory factor receptor,42620,454,2.26 [1.67-3.05],1.072069171419448e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42688,457,1.66 [1.30-2.12],5.0214123660074114e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37205,407,1.01 [0.94-1.08],0.829291146725293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,35986,394,1.10 [0.91-1.33],0.3434966588895995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42627,456,2.30 [1.78-2.97],1.4833135253149115e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37203,406,1.21 [1.06-1.38],0.0057847310128232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,43204,461,1.64 [1.21-2.23],0.0015404817064394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42992,460,1.50 [1.16-1.92],0.0017767830954512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41875,450,1.44 [1.19-1.74],0.0001629401984158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,43204,461,1.00 [0.89-1.13],0.9835730326321608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,36223,386,1.18 [1.01-1.38],0.0343717297699973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB1,Lamin-B1,36970,406,1.12 [0.96-1.30],0.1458270438957954
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,37122,409,1.80 [1.32-2.46],0.0002018536493483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,37147,408,1.51 [1.20-1.90],0.0003844188752921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD2,Leiomodin-2,35984,403,1.05 [0.89-1.23],0.5438673959242747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",36223,386,1.15 [1.03-1.28],0.0158230725747713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPA,Apolipoprotein(a),36367,397,1.03 [0.97-1.09],0.332989462322368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,42503,452,1.20 [1.03-1.41],0.0223578107255163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPL,Lipoprotein lipase,42691,456,1.16 [0.97-1.38],0.1061491589089984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPO,Lactoperoxidase,41286,445,1.31 [1.14-1.51],0.0001177301025211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPP,Lipoma-preferred partner,35986,394,0.93 [0.80-1.08],0.3213435383754855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,35986,394,1.15 [1.00-1.33],0.0462616674868261
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36175,396,0.90 [0.72-1.14],0.3951914910670556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,37249,405,3.29 [2.36-4.58],2.1730308623898866e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42938,461,1.33 [1.06-1.68],0.015387861071788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,35988,394,1.12 [0.78-1.61],0.5271528041661053
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,42503,452,1.67 [1.24-2.26],0.000750628077508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,42691,456,1.38 [1.10-1.73],0.0054325419678545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,36175,396,0.99 [0.75-1.31],0.9440760022268369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP2BP,LRP2-binding protein,36175,396,1.04 [0.92-1.18],0.5035674618690829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,43074,461,1.16 [1.02-1.33],0.0267233271094568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,42503,452,1.92 [1.60-2.30],1.55098462361646e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,37041,407,1.07 [0.85-1.34],0.5824331454424094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,36175,396,0.95 [0.77-1.19],0.6741137687627496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,37203,406,1.06 [0.87-1.29],0.5381049758401721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37037,409,1.13 [0.93-1.37],0.2368303587951586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,41875,450,0.45 [0.37-0.56],1.1577470125366753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36175,396,1.13 [0.89-1.43],0.3122787246437274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37147,408,0.69 [0.47-1.02],0.0654537604577986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,41668,448,0.99 [0.85-1.16],0.932916896104054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,36507,400,0.90 [0.78-1.03],0.1322078087674132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,42620,454,1.27 [1.03-1.56],0.0239629109233114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA,Lymphotoxin-alpha,42620,454,1.07 [0.86-1.32],0.5461178202075478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,43059,464,1.16 [1.03-1.32],0.0191723402493378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTB,Lymphotoxin-beta,37037,409,0.72 [0.52-1.01],0.055257077083832
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,43204,461,2.46 [1.96-3.09],7.231085666138904e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,41668,448,1.42 [1.24-1.62],2.3180837532931518e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,42442,455,2.60 [2.01-3.37],3.82913076554197e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTO1,Protein LTO1 homolog,41875,450,0.93 [0.74-1.16],0.5058851020836066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LUZP2,Leucine zipper protein 2,37037,409,1.12 [0.90-1.39],0.3175988448150678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LXN,Latexin,42165,450,0.92 [0.80-1.05],0.1943494207878773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,42436,457,1.44 [1.18-1.77],0.0003530737037768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY75,Lymphocyte antigen 75,42620,454,1.06 [0.85-1.32],0.6043845687504397
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,42197,445,1.75 [1.33-2.30],6.22554370836908e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,42367,453,2.39 [1.97-2.91],2.892285074441517e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,41668,448,0.96 [0.81-1.14],0.6247394003555897
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYN,Tyrosine-protein kinase Lyn,42503,452,1.02 [0.92-1.13],0.7386879911383573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,41707,446,1.14 [1.01-1.28],0.037431332060105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,42486,453,1.34 [1.05-1.71],0.019051909656983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,41668,448,1.30 [1.12-1.52],0.0007862357190603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,35984,403,1.00 [0.91-1.10],0.9794525869630928
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36175,396,1.05 [0.96-1.16],0.2881174607019899
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37249,405,2.81 [1.71-4.62],4.4535067641280895e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYZL2,Lysozyme-like protein 2,35893,396,0.52 [0.38-0.72],7.612155456429878e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,36382,391,0.88 [0.77-1.02],0.091046864429858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,36223,386,1.29 [1.03-1.62],0.0297832937046531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42219,452,1.26 [1.10-1.46],0.0012409294105983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,41668,448,0.98 [0.78-1.23],0.8705173263910873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAG,Myelin-associated glycoprotein,36175,396,0.94 [0.76-1.16],0.5471227750590342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGEA3,Melanoma-associated antigen 3,36507,400,0.98 [0.86-1.10],0.6939886379808208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAGED1,Melanoma-associated antigen D1,41668,448,1.07 [0.89-1.28],0.4549245036178335
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC2,MAM domain-containing protein 2,37203,406,1.69 [1.31-2.20],6.831900278483198e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,37037,409,1.15 [0.98-1.35],0.0803318331414286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36223,386,1.34 [0.91-1.96],0.1419556079359157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,37203,406,1.16 [0.99-1.38],0.0742994417303112
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",35893,396,1.18 [0.97-1.44],0.0890967082023568
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,42864,461,1.02 [0.95-1.09],0.6408905357660517
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC1,MANSC domain-containing protein 1,42814,456,1.72 [1.28-2.31],0.0002858321322821
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,35986,394,1.10 [0.95-1.27],0.2010748442980144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,35984,403,0.98 [0.71-1.35],0.904571182778074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,35986,394,1.05 [0.91-1.22],0.5147513501164116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2,Microtubule-associated protein 2,37122,409,1.23 [1.01-1.50],0.0411294659977455
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37041,407,0.98 [0.84-1.14],0.7852470460944376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42620,454,0.96 [0.88-1.04],0.3365382821500412
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41668,448,0.95 [0.86-1.04],0.234613272939464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42293,453,0.99 [0.91-1.07],0.784349916277129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,35893,396,1.14 [0.92-1.42],0.2255706130915415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,42620,454,0.92 [0.76-1.13],0.4379884574554409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,36507,400,0.93 [0.81-1.06],0.2726051229176774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,35893,396,0.98 [0.90-1.06],0.6051571776657931
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPT,Microtubule-associated protein tau,41707,446,1.10 [0.92-1.31],0.2967986618608476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,42691,456,1.96 [1.42-2.71],4.93691755124584e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",36317,391,0.96 [0.86-1.09],0.539583631607287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,42293,453,0.73 [0.51-1.05],0.0900477051347874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,42726,459,2.87 [2.19-3.76],2.3692026091339515e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,42294,453,1.34 [1.04-1.74],0.0257056636224402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,41668,448,1.06 [0.96-1.17],0.2375495207733891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAX,Protein max,41707,446,1.02 [0.94-1.11],0.5585072420793276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MB,Myoglobin,43204,461,0.90 [0.76-1.05],0.1851970074952361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MBL2,Mannose-binding protein C,36722,400,1.11 [1.02-1.22],0.0204407921734461
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,42847,457,1.06 [0.82-1.37],0.643111408834422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37147,408,0.92 [0.72-1.16],0.4742088836728197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,36116,394,1.12 [1.00-1.25],0.0436271245847953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,42499,455,1.28 [1.06-1.54],0.0118852672060614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,37041,407,0.71 [0.47-1.08],0.1073124752862207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42367,453,1.00 [0.88-1.13],0.967525188412787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",37032,408,0.98 [0.77-1.25],0.8759462208830731
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,42691,453,1.58 [1.38-1.81],5.542120477248543e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDM1,Nuclear protein MDM1,36175,396,0.96 [0.69-1.33],0.8022731925484279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36223,386,1.14 [1.02-1.27],0.0180271438080296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,41668,448,0.99 [0.88-1.11],0.8892774490684643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,35986,394,0.79 [0.62-1.01],0.0615925064029074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,42656,457,1.24 [1.00-1.54],0.0519368146071078
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,35986,394,0.97 [0.70-1.33],0.8462798691811
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,43062,460,1.45 [0.97-2.17],0.0688538459064349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MELTF,Melanotransferrin,37203,406,1.17 [0.84-1.61],0.3548242762468421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MENT,Protein MENT,36382,391,0.53 [0.35-0.81],0.0030186550105895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,37041,407,1.00 [0.88-1.14],0.9821731158625612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,42691,456,0.76 [0.71-0.81],2.3877591886019832e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,42656,457,0.55 [0.40-0.75],0.0001354697272575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MERTK,Tyrosine-protein kinase Mer,43147,461,1.89 [1.38-2.59],7.890979858252946e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MESD,LRP chaperone MESD,42688,457,1.03 [0.96-1.10],0.4811960135322484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,42794,453,0.61 [0.40-0.93],0.0218720010089121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1,Methionine aminopeptidase 1,41707,446,1.00 [0.74-1.35],0.9825788559347066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42620,454,1.14 [1.03-1.26],0.0125912047581817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",METAP2,Methionine aminopeptidase 2,43000,464,1.07 [0.92-1.24],0.3906200928022623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,41880,443,0.92 [0.75-1.11],0.3852881919995383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,36175,396,1.00 [0.86-1.17],0.9789328136838696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,36382,391,1.67 [1.24-2.24],0.0006246827322207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFAP5,Microfibrillar-associated protein 5,43204,461,0.96 [0.78-1.18],0.6766474772402367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,42688,457,1.43 [1.19-1.71],0.0001121624851643
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGLL,Monoglyceride lipase,42795,460,0.96 [0.87-1.06],0.408740017474686
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,42620,454,0.96 [0.90-1.03],0.2817764618169803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIA,Melanoma-derived growth regulatory protein,42814,456,0.85 [0.67-1.07],0.1592761192053945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICALL2,MICAL-like protein 2,36175,396,1.03 [0.89-1.18],0.7291723943840652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42620,454,1.15 [1.07-1.24],9.189053375901804e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MIF,Macrophage migration inhibitory factor,42619,456,1.04 [0.91-1.18],0.5814017738237376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MILR1,Allergin-1,41875,450,1.48 [1.26-1.73],1.0174467705628068e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37037,409,1.01 [0.92-1.10],0.9124171280398746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MINK1,Misshapen-like kinase 1,37122,409,1.00 [0.90-1.12],0.9564892478549448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MITD1,MIT domain-containing protein 1,42367,453,1.00 [0.91-1.09],0.9778790408301448
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MKI67,Proliferation marker protein Ki-67,36116,394,1.04 [0.81-1.33],0.7518548211701503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLLT1,Protein ENL,35893,396,1.10 [0.96-1.27],0.1661593445541265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,42620,454,1.07 [0.98-1.18],0.1459159324624601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,42503,452,1.29 [1.16-1.42],1.1977805484161066e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,41125,434,1.24 [1.12-1.38],3.267079455304626e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,42586,457,1.41 [1.23-1.61],4.652923824529447e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,42736,459,2.04 [1.78-2.34],2.3853959477017342e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP13,Collagenase 3,41707,446,1.33 [1.01-1.75],0.0395249412525017
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP15,Matrix metalloproteinase-15,37203,406,1.01 [0.83-1.22],0.9599622565043712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,42688,457,1.22 [1.03-1.44],0.021937583351796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,41814,442,2.22 [1.85-2.67],2.560645713353568e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,43004,460,1.47 [1.33-1.64],5.003541459254109e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,42619,457,1.58 [1.38-1.82],7.944852371259829e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",35986,394,1.09 [0.89-1.34],0.4155418804560131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MN1,Transcriptional activator MN1,36175,396,0.87 [0.71-1.05],0.1513444205435148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,36507,400,0.90 [0.71-1.15],0.3969498266068817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,42632,455,1.11 [1.03-1.20],0.0083559660115095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,36382,391,1.06 [0.91-1.23],0.4424914406208172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,43059,464,0.78 [0.60-0.99],0.0444109322456058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,37122,409,1.09 [0.77-1.55],0.6283343954776757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,36507,400,1.03 [0.81-1.32],0.784496493592819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,35893,396,1.05 [0.79-1.38],0.7387994492245866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MORN4,MORN repeat-containing protein 4,35893,396,0.90 [0.78-1.03],0.1355234815614163
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,41880,443,1.00 [0.89-1.12],0.9676002187114427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPI,Mannose-6-phosphate isomerase,42503,452,0.99 [0.90-1.10],0.9071774751353382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42795,460,1.01 [0.91-1.14],0.7992370766259965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,42688,457,1.38 [1.17-1.62],0.0001320526663266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,36965,408,1.02 [0.81-1.27],0.884301449381669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,37239,408,4.67 [3.47-6.29],2.735212728621167e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,36175,396,0.90 [0.77-1.04],0.1448470815866402
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",35986,394,1.08 [0.83-1.39],0.5650560148635779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",37147,408,0.86 [0.63-1.18],0.363329828510353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",41707,446,1.43 [1.08-1.91],0.0136328606370469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",35820,395,1.24 [0.88-1.75],0.2187486938558561
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37147,408,1.16 [1.03-1.32],0.0158504698086661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",36116,394,1.07 [0.75-1.53],0.7029805054467839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,42435,452,1.57 [1.40-1.77],9.010610647493965e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLNL,Mesothelin-like protein,36175,396,1.14 [0.88-1.46],0.3225211804023813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,42582,456,1.16 [1.03-1.31],0.0149056922194767
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,43074,461,2.19 [1.85-2.60],1.746396798244108e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,42814,456,1.00 [0.89-1.13],0.9995666788858856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,36684,402,1.15 [0.97-1.37],0.1060187260046292
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,41880,443,0.58 [0.50-0.68],2.565555846579503e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,36116,394,1.03 [0.93-1.15],0.5302992391220092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37122,409,1.51 [1.10-2.07],0.010347113259805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36507,400,1.01 [0.93-1.10],0.8039333330583625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",37041,407,1.10 [0.99-1.23],0.0806099971084123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTPN,Myotrophin,41880,443,0.83 [0.62-1.11],0.2064034932105155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTR,Methionine synthase,35986,394,0.89 [0.75-1.05],0.1609860395945654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS1,Protein MTSS 1,37041,407,0.98 [0.90-1.07],0.6502972732175294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,37037,409,1.06 [0.96-1.16],0.2836038099232166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,36507,400,1.38 [1.19-1.60],2.113128159871312e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,41707,446,1.28 [1.10-1.50],0.0015141631689501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC16,Mucin-16,42503,452,1.00 [0.96-1.05],0.8873613301114796
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC2,Mucin-2,37205,407,1.00 [0.90-1.11],0.982662530095634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUCL3,Mucin-like protein 3,35893,396,0.95 [0.75-1.21],0.6926593631287161
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,41875,450,1.36 [1.23-1.50],8.19662102971885e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,36382,391,0.87 [0.62-1.20],0.3895073740914647
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",37203,406,1.01 [0.89-1.16],0.8612543004154705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",36223,386,0.97 [0.86-1.09],0.6163718174309509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37147,408,1.07 [0.93-1.24],0.3302618601479951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYDGF,Myeloid-derived growth factor,37203,406,1.07 [0.97-1.18],0.1914891250739079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,35986,394,0.99 [0.79-1.24],0.9123293966591588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH7B,Myosin-7B,35893,396,1.27 [1.03-1.56],0.0230952765489005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH9,Myosin-9,37205,407,1.02 [0.94-1.12],0.5919172978925036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",35986,394,0.91 [0.70-1.19],0.4936135883256323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,36223,386,0.89 [0.78-1.02],0.0990964998313246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL4,Myosin light chain 4,36223,386,1.08 [0.90-1.29],0.406630448317932
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL6B,Myosin light chain 6B,36175,396,1.07 [0.96-1.19],0.2285734901710531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36175,396,1.09 [0.91-1.30],0.3577948575052966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO6,Unconventional myosin-VI,37147,408,0.97 [0.74-1.28],0.8544284807892443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYO9B,Unconventional myosin-IXb,41875,450,1.01 [0.88-1.15],0.9003154712089233
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOC,Myocilin,42688,457,1.04 [0.87-1.26],0.6481306842536365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM1,Myomesin-1,35984,403,1.00 [0.81-1.23],0.9816515270368398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM2,Myomesin-2,35986,394,0.91 [0.75-1.11],0.3626825738139033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYOM3,Myomesin-3,36382,391,0.93 [0.84-1.03],0.1751319814010908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,42795,460,1.91 [1.65-2.21],5.09595585790429e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,41668,448,0.96 [0.80-1.14],0.6033001307514232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA10,N-alpha-acetyltransferase 10,35986,394,1.11 [0.91-1.35],0.3175016793369749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAA80,N-alpha-acetyltransferase 80,36175,396,0.96 [0.88-1.04],0.323460867956709
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,42157,448,0.91 [0.78-1.05],0.1808415145076422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,37037,409,1.06 [0.89-1.26],0.5310046687906922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NADK,NAD kinase,42691,456,1.17 [1.03-1.34],0.0198786221068196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,36046,393,0.94 [0.77-1.15],0.5659770238031505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,36156,386,0.91 [0.77-1.09],0.3159232508669781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36382,391,2.23 [1.42-3.50],0.0004912351840666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,41668,448,1.23 [1.08-1.41],0.0023121006619707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,36967,406,0.98 [0.76-1.25],0.8491463152583802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,37122,409,0.76 [0.55-1.04],0.0892726966215242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",37147,408,0.91 [0.74-1.13],0.4021186647240834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,42814,456,2.11 [1.57-2.85],8.627999320802045e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,41875,450,1.06 [0.92-1.23],0.4147175206785108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,42847,457,0.70 [0.53-0.92],0.0111725738502496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,42688,457,1.14 [0.83-1.56],0.418381630925521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,43074,461,0.62 [0.49-0.76],1.2131640754277058e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCF2,Neutrophil cytosol factor 2,42551,453,1.19 [1.09-1.30],0.00014088990929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCK2,Cytoplasmic protein NCK2,42864,461,0.98 [0.91-1.07],0.707667035950868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCLN,Nicalin,41875,450,1.03 [0.86-1.22],0.7660856984266396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,42558,454,1.10 [0.88-1.37],0.4226484243980264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37041,407,1.88 [1.46-2.41],9.107475106083224e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCS1,Neuronal calcium sensor 1,43059,464,1.49 [1.11-1.98],0.0070776985467473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDRG1,Protein NDRG1,41707,446,1.11 [0.99-1.24],0.0777232514635088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37037,409,1.02 [0.87-1.19],0.7874865853365803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36054,392,1.06 [0.80-1.41],0.6867403394408325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37041,407,0.95 [0.85-1.07],0.4129461639740478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41668,448,1.11 [1.00-1.22],0.0445986328828107
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEB,Nebulin,35986,394,1.19 [0.93-1.51],0.1626171134940419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,35986,394,1.06 [0.91-1.22],0.4605028795508855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN1,Nectin-1,36116,394,1.01 [0.73-1.40],0.9373055713800088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,42627,456,2.37 [1.85-3.02],5.2449826210456906e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,42814,456,1.79 [1.43-2.24],2.8006777189855214e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36116,394,0.98 [0.79-1.22],0.8698625451734232
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEDD9,Enhancer of filamentation 1,36116,394,0.97 [0.72-1.31],0.8538161457331073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,41577,444,1.59 [1.34-1.89],7.723875966130458e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,36507,400,0.88 [0.75-1.03],0.112740511839622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,42814,456,0.74 [0.60-0.90],0.003057574481744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,42864,461,1.24 [0.93-1.64],0.1411136451009318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NENF,Neudesin,37037,409,1.03 [0.94-1.12],0.5637846190153633
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEO1,Neogenin,37147,408,0.92 [0.59-1.45],0.7303808186968026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEXN,Nexilin,37239,408,1.01 [0.88-1.17],0.8804541880553873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,43147,461,2.22 [1.70-2.90],6.066969942871307e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,36116,394,1.09 [0.97-1.22],0.1524657311735453
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42620,454,0.93 [0.85-1.02],0.1253525105570243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41875,450,1.53 [1.36-1.73],2.9273359176235e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,36223,386,0.95 [0.83-1.09],0.4816150918416831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFIC,Nuclear factor 1 C-type,37147,408,1.25 [1.05-1.48],0.0109270995538836
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,35986,394,1.06 [0.93-1.22],0.3782293835596437
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,36507,400,1.14 [0.98-1.32],0.0811019216498102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,41668,448,1.04 [0.88-1.25],0.633328689298787
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37041,407,1.10 [1.00-1.21],0.0491232818096148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFX1,Transcriptional repressor NF-X1,35986,394,0.91 [0.78-1.07],0.2538219009939065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,35986,394,1.08 [0.85-1.38],0.524380616823982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGF,Beta-nerve growth factor,42367,453,1.99 [1.02-3.89],0.0441127303873116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,37203,406,1.13 [0.84-1.53],0.4133420173423779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NGRN,Neugrin,37122,409,1.37 [0.89-2.11],0.1543627476203145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,35523,385,2.78 [2.02-3.81],2.4130247225705916e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,42706,456,1.38 [1.11-1.72],0.0039195940469356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,42688,457,1.09 [0.97-1.22],0.1392942804021941
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NINJ1,Ninjurin-1,41668,448,1.17 [1.01-1.35],0.0327611303806148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT1,Deaminated glutathione amidase,36223,386,0.71 [0.57-0.88],0.0021316789530174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NIT2,Omega-amidase NIT2,37066,403,1.02 [0.90-1.17],0.7444240291202111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN1,Neuroligin-1,36175,396,0.99 [0.85-1.15],0.8644867721329619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NLGN2,Neuroligin-2,35984,403,1.13 [0.92-1.39],0.2330559146881239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME1,Nucleoside diphosphate kinase A,36116,394,1.00 [0.62-1.61],0.998200563894259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,42726,459,2.14 [1.60-2.85],2.284896596384381e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMI,N-myc-interactor,36897,407,1.14 [1.00-1.31],0.051706323208332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42367,453,1.07 [0.95-1.19],0.2562243532260729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,35893,396,1.03 [0.81-1.31],0.8227716873160673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37147,408,1.08 [0.93-1.25],0.2927661682736674
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,42688,457,1.31 [0.92-1.87],0.1304861503288823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOP56,Nucleolar protein 56,35986,394,0.99 [0.89-1.09],0.7849734448910184
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",41707,446,1.12 [0.96-1.30],0.1596448204020428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS2,"Nitric oxide synthase, inducible",35986,394,1.20 [0.95-1.51],0.1264451522883575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",41707,446,1.45 [1.27-1.65],4.102977027225333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,43204,461,0.85 [0.50-1.43],0.5370873231092936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,37205,407,1.25 [0.82-1.92],0.2980294115175235
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,43204,461,1.38 [1.09-1.74],0.0070705765806395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,36579,400,2.42 [1.96-3.00],5.141291103028676e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,42691,456,1.89 [1.53-2.35],5.946690018952541e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS1,Nephrin,36116,394,1.18 [0.89-1.56],0.2478633401029576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,36116,394,0.94 [0.85-1.04],0.2408257040495057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,37203,406,1.44 [1.18-1.77],0.0003514833188427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,41880,443,1.17 [1.09-1.25],6.274390778232796e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPC,C-type natriuretic peptide,42620,454,1.15 [0.98-1.35],0.0905566761571971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,35986,394,0.98 [0.74-1.28],0.8668654587539665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTN,Neuroplastin,41668,448,1.02 [0.92-1.13],0.7336291358411848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,42688,457,1.60 [1.33-1.93],6.824277515492614e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX2,Neuronal pentraxin-2,37205,407,1.89 [1.42-2.51],1.287523931891464e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,42691,456,0.63 [0.48-0.81],0.0004634356649694
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,43059,464,0.85 [0.75-0.96],0.0103293788252783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,42691,456,0.94 [0.70-1.26],0.6860388077417456
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRGN,Neurogranin,37239,408,0.99 [0.89-1.11],0.9046578433566514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRN1,Neuritin,37147,408,1.25 [1.00-1.57],0.0467676742138664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP1,Neuropilin-1,42920,457,2.18 [1.62-2.93],2.877088103468441e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRP2,Neuropilin-2,42688,457,1.40 [1.05-1.86],0.0218051881132148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRTN,Neurturin,41875,450,1.08 [0.92-1.28],0.3507971656529492
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRXN3,Neurexin-3,36175,396,0.89 [0.65-1.22],0.4741089790351487
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NSFL1C,NSFL1 cofactor p47,43074,461,1.03 [0.90-1.17],0.695788785129701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37203,406,0.98 [0.86-1.12],0.7847497683249252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,37122,409,2.20 [1.78-2.71],2.8897648847334e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,42557,452,0.90 [0.81-0.99],0.0332441773489852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,42814,456,1.41 [1.23-1.63],2.0692123257397776e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,42620,454,1.11 [0.87-1.40],0.4011161805736761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF4,Neurotrophin-4,41668,448,1.01 [0.82-1.26],0.90073960944565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,42691,456,0.67 [0.48-0.93],0.0165794383884429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,43074,461,0.50 [0.34-0.73],0.0003916821396584
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,42691,456,1.31 [1.23-1.41],1.3772029226339932e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUB1,NEDD8 ultimate buster 1,42620,454,0.97 [0.88-1.08],0.5770611688601659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37037,409,1.05 [0.94-1.17],0.3684848201002965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,42993,463,1.31 [1.05-1.63],0.0157961160595332
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDC,Nuclear migration protein nudC,43147,461,1.04 [0.91-1.19],0.5578122369904803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36223,386,1.13 [0.75-1.70],0.5586862166208634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,35986,394,1.04 [0.86-1.26],0.7070153619305237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,36973,406,1.11 [1.00-1.24],0.0579937557576573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42503,452,0.84 [0.71-0.98],0.0296873655396848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,42688,457,1.21 [1.03-1.43],0.0227983730082545
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUMB,Protein numb homolog,36116,394,0.97 [0.86-1.09],0.5843598690745866
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,35986,394,1.06 [0.77-1.46],0.7358801743853753
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPE4,NXPE family member 4,35986,394,1.03 [0.75-1.41],0.8466046949958858
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH1,Neurexophilin-1,41707,446,0.91 [0.72-1.14],0.4013205826984325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,36116,394,0.94 [0.68-1.30],0.7148257026413334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OBP2B,Odorant-binding protein 2b,42226,453,0.87 [0.76-1.01],0.0597543913817802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,37147,408,2.49 [2.10-2.95],7.048036423848574e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,41639,442,0.72 [0.61-0.87],0.0003917368798356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,36507,400,1.06 [0.92-1.23],0.420026232260116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGA,Protein O-GlcNAcase,37041,407,1.03 [0.89-1.18],0.7154571935591774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGFR,Opioid growth factor receptor,42503,452,0.92 [0.70-1.19],0.5122569086604645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,42688,457,1.45 [1.20-1.75],0.0001397122004264
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36507,400,0.84 [0.69-1.01],0.0647987284807156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLFM4,Olfactomedin-4,35037,379,1.15 [1.06-1.25],0.0011778816335222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,42273,451,1.37 [1.21-1.54],4.266344135676354e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,42864,461,0.87 [0.72-1.05],0.1427753450578973
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,42503,452,0.72 [0.64-0.82],3.782518458200386e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMP,Olfactory marker protein,35984,403,1.04 [0.84-1.28],0.7355911561483489
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPHN1,Oligophrenin-1,37122,409,1.02 [0.93-1.11],0.7442124366719673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPLAH,5-oxoprolinase,36223,386,1.05 [0.91-1.22],0.5078820867035365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OPTC,Opticin,42503,452,1.10 [0.91-1.32],0.3328481699032575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,37115,405,2.39 [1.52-3.78],0.0001805871320921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,37122,409,1.14 [0.91-1.43],0.2543774209146195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,42726,459,2.62 [2.04-3.36],3.858794331657282e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,42412,450,1.49 [1.33-1.67],1.0201436233219376e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,42920,457,4.77 [3.23-7.04],4.249035924429053e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSTN,Osteocrin,36175,396,0.99 [0.79-1.25],0.9496880728773732
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTOA,Otoancorin,35984,403,1.08 [0.91-1.29],0.3898027619763197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,37041,407,0.99 [0.83-1.17],0.8890921667628244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OTUD7B,OTU domain-containing protein 7B,37147,408,1.11 [0.95-1.30],0.1730926332436463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36223,386,1.11 [0.97-1.27],0.1457873231866679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,43074,461,1.09 [1.03-1.16],0.0020624611799909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,42479,450,1.39 [1.12-1.73],0.0025188108617442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,35986,394,0.95 [0.81-1.12],0.5658056401076381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI2,Protein-arginine deiminase type-2,41875,450,1.01 [0.87-1.18],0.8479252553642317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PADI4,Protein-arginine deiminase type-4,41639,442,1.02 [0.91-1.14],0.7510303558330549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAEP,Glycodelin,42367,453,0.99 [0.93-1.06],0.8340475179561855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37147,408,1.00 [0.91-1.09],0.9534845008647876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36507,400,0.95 [0.77-1.18],0.6566718754484873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41880,443,1.17 [1.01-1.35],0.0324755260509665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,36223,386,0.78 [0.61-0.99],0.0433372988201786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,35828,395,0.87 [0.71-1.08],0.2035953862437219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,41707,446,1.02 [0.88-1.17],0.8202167879069325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALLD,Palladin,36116,394,1.04 [0.80-1.34],0.7904731941045129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM,Paralemmin-1,36836,405,1.22 [0.90-1.66],0.1935151213772464
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,37122,409,2.40 [1.97-2.92],1.6198507878685354e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM3,Paralemmin-3,35986,394,1.03 [0.89-1.19],0.6948835782367052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,42998,461,1.19 [0.88-1.62],0.2561663450498579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAMR1,Inactive serine protease PAMR1,42688,457,0.79 [0.58-1.07],0.1279815402548875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAPPA,Pappalysin-1,41875,450,1.04 [0.86-1.24],0.712954571620622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARD3,Partitioning defective 3 homolog,36507,400,1.01 [0.89-1.16],0.8627908146852544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARK7,Parkinson disease protein 7,42688,457,1.05 [0.89-1.24],0.5746467708425469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,42620,454,1.12 [0.99-1.28],0.0748780623267653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,36382,391,1.10 [0.89-1.36],0.3795425931854496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,35893,396,1.01 [0.73-1.40],0.9438061272125208
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,41707,446,0.96 [0.81-1.13],0.6158914459635592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37041,407,0.75 [0.53-1.06],0.1080757283936881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCARE,Photoreceptor cilium actin regulator,35984,403,1.00 [0.89-1.12],0.9920411081589948
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36311,391,1.27 [1.05-1.54],0.0134724057885894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBP2,Poly(rC)-binding protein 2,37147,408,1.00 [0.88-1.15],0.9554817161272344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH1,Protocadherin-1,43012,459,1.09 [0.73-1.63],0.6652630620845362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH12,Protocadherin-12,37147,408,1.78 [1.26-2.53],0.001204969148691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,42691,456,1.17 [0.93-1.46],0.1714456976742742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH7,Protocadherin-7,37041,407,0.78 [0.57-1.07],0.1191896177891093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,37041,407,0.71 [0.54-0.94],0.0154601366111525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDHB15,Protocadherin beta-15,37037,409,1.43 [1.14-1.81],0.0024109085342454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCNA,Proliferating cell nuclear antigen,35893,396,1.11 [0.97-1.26],0.1243035805729919
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,37037,409,1.05 [0.85-1.30],0.6346993286288942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,43204,461,1.56 [1.27-1.92],2.5827829534805025e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,37041,407,1.10 [0.97-1.25],0.1509790967636894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,37203,406,0.99 [0.90-1.10],0.8660191549854187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1,Programmed cell death protein 1,42988,461,1.27 [1.05-1.53],0.0148549369335051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,42503,452,1.56 [1.20-2.02],0.0008831977854239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,43074,461,1.18 [1.02-1.36],0.0237726667070326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD6,Programmed cell death protein 6,42691,456,1.10 [0.97-1.25],0.1480815753500109
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCL2,Phosducin-like protein 2,35893,396,1.00 [0.82-1.22],0.962832154162334
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",35893,396,1.03 [0.85-1.25],0.7516460393333741
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",35986,394,1.08 [0.92-1.26],0.3447427944240968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36382,391,0.94 [0.85-1.03],0.1929573445853938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,43204,461,1.05 [0.93-1.18],0.4176903269301427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,42864,461,1.08 [0.98-1.19],0.1424986322134087
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFC,Platelet-derived growth factor C,41668,448,1.31 [0.98-1.77],0.0725796648227024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,42691,456,1.56 [1.17-2.08],0.0021714270910442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,43204,461,0.89 [0.70-1.13],0.3382512489917449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA2,Protein disulfide-isomerase A2,35893,396,1.03 [0.80-1.34],0.7942925649056024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,36382,391,1.30 [0.90-1.89],0.1634495189849222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA4,Protein disulfide-isomerase A4,37205,407,1.09 [0.93-1.28],0.2824261346086566
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA5,Protein disulfide-isomerase A5,35893,396,1.01 [0.85-1.19],0.9435616302996604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,37147,408,0.99 [0.92-1.08],0.8963811329762201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,42864,461,0.99 [0.93-1.06],0.8336879252882864
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41668,448,1.08 [0.91-1.28],0.3544777984037788
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,36175,396,1.04 [0.85-1.26],0.726070722163215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,35893,396,1.13 [0.97-1.31],0.1075224609840612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,35986,394,1.23 [1.05-1.43],0.0097120914364012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36116,394,1.65 [1.38-1.97],4.5210667031485264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,43204,461,1.04 [0.72-1.52],0.8184513797366333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,42688,457,1.11 [0.96-1.29],0.1678349311972906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,42688,457,1.35 [1.02-1.78],0.0347442230739921
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,36223,386,1.16 [0.83-1.62],0.3903612430433136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,36382,391,1.35 [1.01-1.80],0.0453879268295441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PEPD,Xaa-Pro dipeptidase,37239,408,1.22 [0.85-1.75],0.2896538486825547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PER3,Period circadian protein homolog 3,36116,394,1.08 [0.99-1.17],0.0743803610959206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,36962,403,1.02 [0.92-1.13],0.6610138622579245
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN2,Prefoldin subunit 2,41707,446,0.99 [0.84-1.17],0.9225588061017052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN4,Prefoldin subunit 4,35893,396,0.92 [0.75-1.13],0.4347708099013241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFDN6,Prefoldin subunit 6,36175,396,1.02 [0.87-1.19],0.7906530955176139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42432,449,1.02 [0.91-1.14],0.7407094346871841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,37239,408,1.52 [1.33-1.74],5.216113102195913e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37203,406,1.07 [0.90-1.29],0.4410825759209237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,43147,461,2.10 [1.67-2.65],3.4087437527073687e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,42992,460,1.38 [1.15-1.65],0.0005370644409696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,36771,401,1.03 [0.74-1.44],0.8595933803330007
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,35986,394,1.14 [0.98-1.33],0.0802777604248015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGM2,Phosphoglucomutase-2,36175,396,1.00 [0.84-1.19],0.9947537513461914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGR,Progesterone receptor,36116,394,0.93 [0.82-1.05],0.248274072342071
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,37147,408,1.03 [0.94-1.12],0.5596775404090557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,37041,407,1.34 [1.12-1.59],0.0013631803644806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,35893,396,0.93 [0.83-1.05],0.2311322232805798
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42367,453,1.25 [0.92-1.69],0.152107249865215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36382,391,1.07 [0.85-1.35],0.5445310371338465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI16,Peptidase inhibitor 16,37239,408,0.98 [0.66-1.46],0.9311958391944466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,42117,453,1.61 [1.42-1.84],6.83687477645068e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37147,408,0.99 [0.88-1.13],0.937684479811638
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,42136,452,3.71 [3.08-4.48],6.46548764695714e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42620,454,1.16 [1.01-1.33],0.0307875149542376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42688,457,1.74 [1.33-2.29],6.934241424046134e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36116,394,1.08 [0.91-1.28],0.4039186868542155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,42688,457,2.08 [1.70-2.55],8.076221511762945e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,42691,456,1.56 [1.33-1.82],3.653962826105664e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36382,391,1.04 [0.90-1.21],0.5569983235483889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PITHD1,PITH domain-containing protein 1,35828,395,0.99 [0.86-1.12],0.8264485276204854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD1,Polycystin-1,37203,406,2.33 [1.63-3.32],3.0999937283463624e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,35986,394,1.18 [1.00-1.38],0.0461125901227504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKLR,Pyruvate kinase PKLR,42722,459,1.15 [1.01-1.31],0.0288070038980463
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKN3,Serine/threonine-protein kinase N3,36507,400,1.04 [0.92-1.19],0.5183116206011773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,42367,453,1.18 [1.02-1.37],0.0257064820180324
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,42814,456,4.54 [3.44-5.98],5.4119119466672e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,43134,461,0.55 [0.46-0.66],4.4676141609838735e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",42583,457,1.39 [1.23-1.57],1.859293760846132e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,42864,461,1.01 [0.91-1.11],0.9176992453407667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,42688,457,0.53 [0.41-0.68],5.469688408221102e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,43062,460,1.70 [1.44-2.00],1.4678356358215708e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,42688,457,1.98 [1.60-2.45],2.927852991655616e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,42375,455,5.43 [4.27-6.92],4.3138552265762425e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",37122,409,0.89 [0.75-1.05],0.1586304037873174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36116,394,1.16 [0.95-1.43],0.1510125702273344
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37122,409,1.02 [0.92-1.12],0.7400146854221746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,37122,409,1.03 [0.89-1.19],0.6897836869862135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,36299,394,1.85 [1.19-2.87],0.0060680672169315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN1,Perilipin-1,41707,446,1.24 [0.98-1.57],0.068310279344737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,42691,456,1.12 [0.92-1.36],0.2438731873654764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,42691,456,1.05 [0.92-1.19],0.4547314439209441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLSCR3,Phospholipid scramblase 3,37059,409,1.15 [0.97-1.36],0.1011607423167291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,43060,461,1.16 [0.93-1.45],0.1830646059953673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,41668,448,0.68 [0.50-0.93],0.0147191198678946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,37122,409,1.52 [1.10-2.10],0.0119949943292619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNA4,Plexin-A4,42620,454,1.01 [0.91-1.13],0.8099978838234763
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,42993,460,2.45 [1.77-3.38],5.397115394142991e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB3,Plexin-B3,42550,454,0.87 [0.72-1.04],0.1286896935258951
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42491,454,1.01 [0.96-1.05],0.8025341920436956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMCH,Pro-MCH,35986,394,0.93 [0.81-1.07],0.3032061134664263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMM2,Phosphomannomutase 2,35986,394,1.05 [0.89-1.24],0.5740944588702519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMS1,PMS1 protein homolog 1,36175,396,1.29 [1.07-1.55],0.0064752545579263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PMVK,Phosphomevalonate kinase,41635,446,1.01 [0.93-1.10],0.7571168423537178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,37239,408,0.76 [0.65-0.88],0.0001718930164221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,37122,409,0.88 [0.79-0.99],0.0398658410030048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,42656,457,0.99 [0.96-1.02],0.4994037085663801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,36223,386,0.97 [0.81-1.16],0.7598154875292835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,35984,403,0.91 [0.71-1.16],0.4392727800453573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41875,450,1.05 [0.98-1.13],0.1816261310467817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,42503,452,1.14 [0.65-2.00],0.6565577585293514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,42814,456,0.82 [0.61-1.11],0.2028840972589272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POF1B,Protein POF1B,36116,394,1.46 [1.20-1.79],0.000188996615472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,36116,394,0.77 [0.53-1.12],0.171863721124855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42503,452,1.50 [1.24-1.81],2.14240337524154e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,36223,386,0.77 [0.67-0.88],0.0001703935231309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,37239,408,0.73 [0.53-1.02],0.0691584670489961
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,41880,443,1.71 [1.34-2.18],1.637385452674924e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,42864,461,0.70 [0.56-0.88],0.002557873854265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POSTN,Periostin,37205,407,1.25 [0.97-1.62],0.0873298922522036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,36958,403,0.97 [0.87-1.09],0.6504035526611338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,43074,461,1.15 [0.96-1.37],0.1368293664963293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,42705,457,1.03 [0.94-1.12],0.5654969850042895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,36507,400,1.08 [0.93-1.24],0.3210920878950096
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37205,407,1.17 [1.01-1.35],0.0359132640401409
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,36116,394,1.57 [1.19-2.06],0.0013798838817429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1A,Protein phosphatase 1A,41668,448,0.84 [0.62-1.14],0.264884467378095
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1B,Protein phosphatase 1B,36116,394,0.93 [0.78-1.13],0.4787293552573696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPM1F,Protein phosphatase 1F,37203,406,0.94 [0.78-1.13],0.51300454156105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPME1,Protein phosphatase methylesterase 1,42503,452,1.07 [0.93-1.24],0.3394847827881589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37037,409,0.91 [0.80-1.02],0.1090432852211611
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42814,456,1.04 [0.95-1.14],0.3429405632691574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36507,400,0.99 [0.86-1.15],0.9383698390585534
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37147,408,1.01 [0.88-1.14],0.938972782939376
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37147,408,1.56 [1.26-1.94],5.43480295032625e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,42691,456,1.00 [0.90-1.11],0.9581403469383438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R9B,Neurabin-2,43147,461,1.01 [0.92-1.10],0.8961436197658361
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37041,407,1.00 [0.92-1.09],0.9862544944320032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP3R1,Calcineurin subunit B type 1,42367,453,1.08 [0.88-1.32],0.4865127925374322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,36175,396,1.11 [0.99-1.25],0.0741774026486853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,42619,453,0.91 [0.84-0.99],0.0357732889975701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PQBP1,Polyglutamine-binding protein 1,41668,448,1.01 [0.87-1.18],0.8776034841074276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,35893,396,0.97 [0.65-1.44],0.8767542590618218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,37205,407,2.20 [1.70-2.83],1.27626929427423e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRC1,Protein regulator of cytokinesis 1,37037,409,1.13 [0.92-1.37],0.2472473307706466
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,42938,460,1.72 [1.33-2.20],2.52795456996686e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX1,Peroxiredoxin-1,41495,443,0.98 [0.89-1.08],0.6483190246686441
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX2,Peroxiredoxin-2,36616,404,0.95 [0.81-1.11],0.5182378062931792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41875,450,1.21 [1.08-1.36],0.0010181385390024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",43147,461,0.97 [0.85-1.10],0.6409362565087592
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRDX6,Peroxiredoxin-6,43059,464,0.83 [0.72-0.95],0.008554309752127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,41875,450,1.40 [1.07-1.84],0.015115410093364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRELP,Prolargin,42656,457,1.13 [0.77-1.66],0.523897930479988
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,37205,407,1.46 [1.22-1.75],3.8550939240082704e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG3,Proteoglycan 3,37205,407,1.32 [1.09-1.61],0.004789160113851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41875,450,0.98 [0.84-1.16],0.8501586912876923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36175,396,1.02 [0.73-1.42],0.9218257034539316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42691,456,1.03 [0.93-1.14],0.6056897485146352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37053,409,1.02 [0.90-1.16],0.7176576298627597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKCQ,Protein kinase C theta type,41875,450,1.09 [0.90-1.33],0.3745235087196459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,35986,394,0.82 [0.63-1.06],0.1333034098867595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,36382,391,1.00 [0.92-1.09],0.971150048513679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41668,448,0.99 [0.86-1.12],0.8358796479090927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,43074,461,1.10 [0.98-1.23],0.0952362893279539
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRND,Prion-like protein doppel,37122,409,1.56 [1.31-1.85],4.2573175455468905e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROC,Vitamin K-dependent protein C,42779,457,0.66 [0.48-0.91],0.0110317947089882
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROCR,Endothelial protein C receptor,35986,394,1.01 [0.77-1.32],0.9518980609133552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROK1,Prokineticin-1,42620,454,0.91 [0.78-1.06],0.2194256490157222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PROS1,Vitamin K-dependent protein S,37249,405,0.92 [0.62-1.35],0.6677725060784814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR4,Proline-rich protein 4,36120,390,1.07 [0.93-1.23],0.3611544300789471
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRR5,Proline-rich protein 5,36116,394,0.92 [0.73-1.15],0.4533216231766148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,36223,386,1.21 [0.94-1.56],0.1371209219529985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,42847,457,1.18 [1.02-1.36],0.0227684451077614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,36116,394,2.03 [1.68-2.46],2.315471240380652e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,42550,455,0.96 [0.77-1.18],0.6726155874457378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS53,Serine protease 53,37122,409,1.42 [1.11-1.82],0.0052515012913395
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,42505,459,2.66 [2.23-3.18],4.0578778191075376e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41707,446,0.95 [0.88-1.03],0.2106736662318205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTG,Protogenin,43059,464,2.30 [1.70-3.12],7.475692175905443e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,41584,444,1.22 [1.05-1.43],0.011743664224068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,36507,400,1.59 [1.21-2.09],0.0009803871121575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,36854,402,2.52 [1.95-3.25],1.1457237731203018e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,37041,407,1.09 [0.90-1.32],0.3948591847167469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSCA,Prostate stem cell antigen,37041,407,1.02 [0.99-1.06],0.2085229590519012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,42367,453,1.20 [1.10-1.31],2.679233063071728e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,42620,454,1.06 [0.94-1.21],0.3371675747351802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMA1,Proteasome subunit alpha type-1,41668,448,1.15 [0.96-1.37],0.1345255601245379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,35893,396,1.00 [0.71-1.42],0.9904176536595234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,37147,408,0.91 [0.74-1.12],0.3674258793275156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,36175,396,0.96 [0.79-1.17],0.6946183615500976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,42503,452,1.05 [0.90-1.22],0.5370817592445944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME1,Proteasome activator complex subunit 1,42302,453,1.11 [0.88-1.40],0.3923566819154047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,42174,451,1.20 [0.94-1.52],0.1351150538596387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG3,Proteasome assembly chaperone 3,42620,454,1.12 [0.95-1.33],0.1727672292561805
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSMG4,Proteasome assembly chaperone 4,36116,394,1.04 [0.87-1.24],0.6424392889988503
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSPN,Persephin,42620,454,1.06 [0.96-1.17],0.2242905418762851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,41668,448,1.18 [1.02-1.35],0.0247897789599668
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,35060,377,0.97 [0.88-1.07],0.562822010026895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41707,446,1.14 [0.85-1.52],0.3732662599443923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,42352,453,1.42 [1.10-1.84],0.0069695602992171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,35835,388,1.12 [0.93-1.35],0.2174420305322671
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,37203,406,1.17 [1.05-1.31],0.0061790616993399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH,Parathyroid hormone,36175,396,1.08 [0.96-1.21],0.2172365860051143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42620,454,1.25 [1.02-1.52],0.0277451458659231
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,41707,446,1.75 [1.41-2.16],2.754893968717997e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,41880,443,1.74 [1.48-2.03],8.50351153021842e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,36116,394,1.21 [1.01-1.45],0.0351134220497652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42367,453,1.07 [0.96-1.20],0.1958237923081014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42795,460,0.99 [0.90-1.09],0.8454082335560179
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36053,394,1.09 [0.85-1.41],0.4878747173957535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,37203,406,1.75 [1.29-2.39],0.0003734707309839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,37205,407,1.68 [1.12-2.51],0.0113734452122398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,43204,461,0.73 [0.54-0.98],0.0359406138987518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,37041,407,1.01 [0.83-1.23],0.9258299705805826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37041,407,1.89 [1.31-2.72],0.0006043011712137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,42554,452,1.10 [0.77-1.55],0.6088300133629331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42222,452,1.03 [0.80-1.33],0.8283772779584119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,37122,409,0.74 [0.57-0.96],0.0227990774844923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,43204,461,0.59 [0.42-0.82],0.0020144739450574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37203,406,1.75 [1.30-2.36],0.0002279653609145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36382,391,0.84 [0.71-1.00],0.051886437547132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,41518,441,1.25 [1.08-1.44],0.0024375759686165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTTG1,Securin,36507,400,0.95 [0.75-1.21],0.684396500405293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,42620,454,1.60 [1.32-1.95],2.3526805285051934e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVALB,Parvalbumin alpha,42868,459,0.94 [0.88-1.01],0.1102776668585773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,43074,461,2.27 [1.88-2.74],1.5869097621197254e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXDNL,Peroxidasin-like protein,37037,409,1.08 [0.93-1.26],0.3336030784947863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PXN,Paxillin,41707,446,1.22 [1.04-1.42],0.0130656032169966
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYDC1,Pyrin domain-containing protein 1,36223,386,0.98 [0.77-1.26],0.892683979886399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,35986,394,1.11 [1.01-1.22],0.0378678824281962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PZP,Pregnancy zone protein,37249,405,1.00 [0.80-1.25],0.999471486460632
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QDPR,Dihydropteridine reductase,42489,454,1.16 [0.95-1.42],0.1361456794394556
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,42728,459,1.69 [1.24-2.31],0.0008464834987207
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,36501,400,1.37 [1.15-1.64],0.0004135283852272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB10,Ras-related protein Rab-10,37203,406,1.09 [0.91-1.30],0.3679635966231073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,37203,406,0.98 [0.89-1.07],0.6532179527919122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB27B,Ras-related protein Rab-27B,37203,406,1.01 [0.90-1.14],0.8290948797378612
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB2B,Ras-related protein Rab-2B,37037,409,0.98 [0.84-1.15],0.8186827190931381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB33A,Ras-related protein Rab-33A,35986,394,0.95 [0.81-1.10],0.4927647185179785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB37,Ras-related protein Rab-37,41875,450,1.05 [0.94-1.16],0.3892286554539174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB39B,Ras-related protein Rab-39B,35986,394,0.98 [0.88-1.10],0.7862100445768132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,35984,403,0.83 [0.67-1.01],0.0643836677846286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB44,Ras-related protein Rab-44,37037,409,1.13 [0.94-1.35],0.2030860671953255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,42620,454,0.63 [0.52-0.76],1.4634886982594385e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6B,Ras-related protein Rab-6B,41707,446,1.21 [1.02-1.43],0.0305995447425574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,36382,391,0.96 [0.84-1.10],0.5422315212203803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,41668,448,1.21 [1.06-1.39],0.0058194612591014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,41875,450,1.10 [0.96-1.27],0.1776875534001303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,36175,396,0.96 [0.82-1.12],0.6240030825116609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,41668,448,1.06 [0.87-1.28],0.5721967862005328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,36507,400,1.08 [0.90-1.28],0.4086266498832974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALB,Ras-related protein Ral-B,36116,394,1.30 [0.93-1.83],0.1285927645341055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RALY,RNA-binding protein Raly,37037,409,1.17 [0.98-1.40],0.0884640793963479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,36223,386,0.92 [0.76-1.12],0.4158617324980564
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,35984,403,0.93 [0.67-1.27],0.6422532447312624
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,41668,448,1.02 [0.84-1.23],0.8455053516135457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAP1A,Ras-related protein Rap-1A,36116,394,0.94 [0.80-1.10],0.414179190541236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,36507,400,0.92 [0.76-1.12],0.412082005586543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,41668,448,1.07 [0.83-1.39],0.5986869218507259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,42920,457,1.44 [1.24-1.68],3.3457552625398767e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASA1,Ras GTPase-activating protein 1,41707,446,1.16 [0.89-1.50],0.2675299126133685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,35893,396,0.89 [0.70-1.12],0.316875593734506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,41668,448,1.20 [1.06-1.36],0.003795624392185
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,37147,408,1.92 [1.60-2.29],1.243234875622276e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBKS,Ribokinase,41689,444,1.26 [1.06-1.49],0.0072994115019119
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM17,Splicing factor 45,37147,408,0.96 [0.84-1.09],0.5166870488140627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM19,Probable RNA-binding protein 19,35986,394,0.87 [0.69-1.09],0.234809031300309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBM25,RNA-binding protein 25,35893,396,0.93 [0.74-1.17],0.521181092874373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP1,Retinol-binding protein 1,36175,396,1.00 [0.86-1.17],0.9921540892605956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,42503,452,1.34 [1.21-1.49],4.6440908478876194e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,42503,452,1.36 [1.18-1.56],1.5978855694259057e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,37041,407,1.30 [1.14-1.49],0.0001192743792802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,36116,394,0.96 [0.81-1.14],0.6229244673204699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,36223,386,1.01 [0.91-1.11],0.8995859449535323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCC1,Regulator of chromosome condensation,37037,409,1.16 [0.97-1.38],0.1032057605503746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RCOR1,REST corepressor 1,41880,443,1.13 [0.95-1.35],0.1621912683799886
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36223,386,1.42 [0.88-2.30],0.1509590487597148
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REEP4,Receptor expression-enhancing protein 4,37147,408,1.07 [0.91-1.25],0.4151518168869971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,42431,455,1.43 [1.23-1.66],4.580311524789843e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,43204,461,1.26 [1.10-1.44],0.0009318467821905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,43204,461,1.34 [1.19-1.52],2.0442797524079725e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,37037,409,0.80 [0.62-1.04],0.1020320824175981
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,42726,459,1.36 [1.15-1.59],0.0002192728606209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELB,Transcription factor RelB,36116,394,1.35 [1.15-1.59],0.0003120553534553
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,42688,457,1.72 [1.31-2.26],7.990492692783864e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,42691,456,1.52 [1.39-1.67],2.8061451560844845e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,36116,394,1.14 [0.89-1.46],0.3130913894053756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REST,RE1-silencing transcription factor,35893,396,1.05 [0.78-1.40],0.7520600750072399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42503,452,0.69 [0.55-0.86],0.0010465364602467
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,42577,453,1.27 [1.05-1.52],0.0114541688404301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",35986,394,0.93 [0.74-1.16],0.5099392692429567
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,37037,409,1.08 [0.70-1.66],0.7388490589904058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGCC,Regulator of cell cycle RGCC,37147,408,0.97 [0.85-1.11],0.6565095799281313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36507,400,1.02 [0.87-1.20],0.7948379275649872
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,43074,461,0.62 [0.48-0.81],0.0005433693563913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMB,RGM domain family member B,43074,461,1.00 [0.73-1.37],0.9904197246958604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS10,Regulator of G-protein signaling 10,37147,408,0.97 [0.83-1.14],0.7429049839963252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGS8,Regulator of G-protein signaling 8,41875,450,0.97 [0.85-1.12],0.6803999559211946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,42120,451,1.01 [0.93-1.08],0.8701207293372892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,36116,394,1.03 [0.84-1.27],0.7569745343332563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36382,391,1.21 [1.00-1.45],0.0496847184486274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILP,Rab-interacting lysosomal protein,42938,461,1.08 [0.94-1.24],0.3012322114469929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RILPL2,RILP-like protein 2,37203,406,0.99 [0.90-1.10],0.9136533105525504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,35986,394,1.01 [0.86-1.17],0.9375005118529364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN1,Prorelaxin H1,37147,408,1.01 [0.87-1.18],0.8505948828687984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RLN2,Prorelaxin H2,36321,390,0.91 [0.80-1.04],0.1577068360238371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,37239,408,2.51 [1.86-3.40],2.606268503926692e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,36223,386,1.29 [1.06-1.56],0.0105403600929597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE3,Eosinophil cationic protein,42491,454,1.02 [0.94-1.09],0.6868424745669429
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,36035,392,2.29 [1.69-3.10],9.538430128904353e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,36980,407,2.15 [1.77-2.61],1.1414129470692634e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,37147,408,0.77 [0.61-0.97],0.027884776337703
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,43005,460,2.75 [2.09-3.62],6.571115162279281e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,36223,386,2.63 [1.99-3.47],8.014749762481955e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,36116,394,0.85 [0.65-1.12],0.2527628495436481
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,36116,394,0.81 [0.59-1.11],0.1820466656018519
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,36507,400,0.95 [0.81-1.12],0.5403130070402025
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,41668,448,1.05 [0.92-1.19],0.4996617487991651
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,36507,400,1.11 [0.94-1.30],0.2125585146680203
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,36223,386,0.91 [0.79-1.05],0.1882540413762879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO1,Roundabout homolog 1,42726,459,2.10 [1.51-2.91],8.706743862223689e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO2,Roundabout homolog 2,43074,461,1.25 [0.87-1.79],0.2317438094873436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROBO4,Roundabout homolog 4,36223,386,0.90 [0.51-1.60],0.7257577298644384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42691,456,1.05 [0.80-1.36],0.7420267955773312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RP2,Protein XRP2,42503,452,1.26 [1.04-1.53],0.0197463066670725
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPA2,Replication protein A 32 kDa subunit,36116,394,0.99 [0.70-1.39],0.94543832355894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,36507,400,0.97 [0.83-1.12],0.6585603620277399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,36175,396,0.94 [0.73-1.22],0.6596201031255122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPL14,60S ribosomal protein L14,36223,386,1.19 [0.94-1.52],0.1558313780276196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RPS10,40S ribosomal protein S10,35986,394,0.95 [0.73-1.23],0.685121914860293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRAS,Ras-related protein R-Ras,36175,396,1.02 [0.95-1.10],0.5424254588649969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,41668,448,1.35 [1.18-1.55],1.8191123707897176e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41668,448,0.95 [0.84-1.09],0.4783222119332855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRP15,RRP15-like protein,35984,403,1.10 [0.99-1.22],0.0645161527740475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,42367,453,1.66 [1.32-2.08],1.4930410034569996e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,43059,464,1.55 [1.17-2.05],0.0020460072362242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTBDN,Retbindin,42503,452,1.01 [0.77-1.34],0.924526379697727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTKN2,Rhotekin-2,35986,394,1.20 [1.02-1.42],0.0312724858222996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37147,408,1.04 [0.94-1.16],0.4366494797162554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RTN4R,Reticulon-4 receptor,43059,464,0.69 [0.54-0.88],0.0032501692029669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RUVBL1,RuvB-like 1,41668,448,1.02 [0.94-1.11],0.6213582627493424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RWDD1,RWD domain-containing protein 1,43074,461,1.00 [0.87-1.15],0.9840297502143336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RYR1,Ryanodine receptor 1,35986,394,1.04 [0.77-1.41],0.7833809316844601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,42355,451,1.35 [1.17-1.56],4.66055496337333e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,42085,444,1.23 [1.10-1.38],0.0003704169227648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A13,Protein S100-A13,36116,394,0.98 [0.74-1.31],0.9008239629841842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A14,Protein S100-A14,37147,408,1.20 [1.00-1.44],0.047584291839777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A16,Protein S100-A16,41639,442,1.24 [1.09-1.41],0.0013310379572176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A3,Protein S100-A3,37037,409,1.06 [0.86-1.32],0.567809960128771
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A4,Protein S100-A4,42814,456,0.91 [0.78-1.05],0.2047287463941186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100G,Protein S100-G,37147,408,1.33 [1.11-1.60],0.0023405445417562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100P,Protein S100-P,41880,443,1.15 [0.99-1.33],0.0592318815907314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAA4,Serum amyloid A-4 protein,37249,405,0.97 [0.70-1.36],0.870217470341019
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAFB2,Scaffold attachment factor B2,37147,408,1.19 [0.85-1.67],0.3021379927054582
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAG,S-arrestin,35984,403,0.93 [0.77-1.14],0.497754063765162
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,42620,454,1.01 [0.90-1.14],0.8677554543131234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,36507,400,0.98 [0.85-1.13],0.7799080692441739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SARG,Specifically androgen-regulated gene protein,37061,406,0.97 [0.88-1.06],0.4577217523078383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,35986,394,1.24 [1.00-1.54],0.0546596914345889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT1,Diamine acetyltransferase 1,35986,394,0.89 [0.71-1.12],0.33522017455325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,36507,400,1.02 [0.88-1.17],0.8061490415274614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SATB1,DNA-binding protein SATB1,37147,408,0.94 [0.66-1.33],0.7209349918990284
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SBSN,Suprabasin,37136,407,1.58 [1.20-2.07],0.0010540580098942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,42503,452,1.09 [0.99-1.21],0.0936179451533908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARA5,Scavenger receptor class A member 5,43074,461,1.26 [0.96-1.67],0.0968915075897276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB1,Scavenger receptor class B member 1,41707,446,1.04 [0.89-1.22],0.6411982965012373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,41564,442,1.86 [1.47-2.36],2.187495359799831e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,43204,461,1.33 [1.09-1.61],0.0041424092055238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,43074,461,2.33 [1.76-3.10],3.873434472544707e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,42872,460,1.16 [0.90-1.50],0.2420207341766799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG3,Secretogranin-3,42726,459,1.18 [0.91-1.52],0.2061603126315806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,42724,459,0.60 [0.53-0.69],3.1626289497809077e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB2A2,Mammaglobin-A,35986,394,1.22 [0.92-1.63],0.1676378415116557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,36382,391,2.11 [1.46-3.04],6.23800975353715e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,42795,460,1.20 [1.10-1.31],2.7942977912243168e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGN,Secretagogin,41875,450,1.01 [0.83-1.23],0.9140258699103024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCIN,Adseverin,35984,403,0.92 [0.79-1.06],0.2270038159825818
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,42938,461,1.59 [1.36-1.86],1.0063594150277698e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,35984,403,0.94 [0.75-1.17],0.5816629307315877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN2B,Sodium channel subunit beta-2,36175,396,1.29 [0.92-1.80],0.1353921871389922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,36175,396,1.03 [0.78-1.36],0.8524752790820137
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN3B,Sodium channel subunit beta-3,35984,403,0.88 [0.69-1.11],0.266477556075903
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,36223,386,0.99 [0.79-1.25],0.9571325881680396
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCP2,Non-specific lipid-transfer protein,41668,448,1.18 [1.07-1.31],0.0016218399978367
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,36083,386,1.37 [1.13-1.66],0.0011360532742615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRG1,Scrapie-responsive protein 1,37203,406,1.41 [1.02-1.96],0.0371073218195743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRIB,Protein scribble homolog,36223,386,1.10 [0.99-1.22],0.0676419318473554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCRN1,Secernin-1,42620,454,0.99 [0.85-1.16],0.9240358014516664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,36175,396,0.61 [0.49-0.76],1.07520102275967e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC1,Syndecan-1,42691,456,1.41 [1.17-1.70],0.0003563830200364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDC4,Syndecan-4,42691,456,0.74 [0.62-0.88],0.0006093712832828
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,37037,409,0.99 [0.91-1.08],0.7893648083362491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDHB,Succinate dehydrogenase,37041,407,1.29 [1.13-1.46],0.0001343294206989
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SDK2,Protein sidekick-2,36382,391,1.06 [0.81-1.39],0.6618200444934312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEC31A,Protein transport protein Sec31A,36223,386,0.96 [0.84-1.09],0.5244888553161894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,36223,386,1.58 [1.26-1.98],7.76422352901261e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,43204,461,1.51 [1.27-1.79],2.7123707440617265e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,37249,405,0.26 [0.17-0.40],1.0797759956307199e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,37249,405,0.82 [0.54-1.26],0.3672999489046389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,42847,457,1.10 [0.95-1.27],0.2184916981796116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,42620,454,1.47 [1.09-1.97],0.0105105174484352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,42691,456,1.45 [1.06-1.99],0.0189630901730658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3G,Semaphorin-3G,36382,391,0.98 [0.78-1.23],0.8900822001183427
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4C,Semaphorin-4C,42503,452,1.08 [0.79-1.46],0.6380628491984958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA4D,Semaphorin-4D,43074,461,1.09 [0.82-1.44],0.5647634827207645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA6C,Semaphorin-6C,36116,394,1.19 [0.80-1.77],0.3885298027411283
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA7A,Semaphorin-7A,43062,460,1.17 [0.88-1.57],0.2855600743240922
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,37147,408,1.26 [1.12-1.42],0.0001635044625333
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN7,Septin-7,36507,400,1.06 [0.89-1.26],0.5321961289801342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,37054,407,2.16 [1.71-2.74],1.6703810990726704e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN9,Septin-9,42503,452,0.94 [0.69-1.27],0.6667954572868702
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,36554,400,6.67 [2.63-16.91],6.345093537404742e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,43204,461,1.94 [1.58-2.40],3.8744631468970916e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA12,Serpin A12,41451,444,0.92 [0.85-1.00],0.0619275627343276
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,37119,404,3.91 [2.36-6.48],1.218107319659175e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA4,Kallistatin,36583,398,0.41 [0.27-0.62],1.6322344616997215e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA5,Plasma serine protease inhibitor,36714,401,0.62 [0.44-0.87],0.0051126670377642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,37249,405,2.69 [1.55-4.68],0.0004626973588827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA7,Thyroxine-binding globulin,37249,405,1.50 [0.90-2.51],0.1237199574420533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,42305,448,1.19 [1.07-1.34],0.0020351059013819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,42550,456,0.99 [0.90-1.09],0.867159838175092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB5,Serpin B5,41880,443,0.96 [0.80-1.15],0.6690627620798499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB6,Serpin B6,42937,461,1.02 [0.88-1.18],0.8069923350013679
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,43147,461,1.23 [1.09-1.38],0.0007273646536365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB9,Serpin B9,42367,453,0.99 [0.75-1.30],0.93693288411209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINC1,Antithrombin-III,37174,404,0.34 [0.18-0.64],0.0009926451293048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,37174,404,1.82 [1.29-2.55],0.0005643435607055
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,43204,461,1.16 [1.02-1.32],0.0220365792139974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,37203,406,1.08 [0.93-1.25],0.3032970010310595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,36683,401,1.55 [1.07-2.24],0.0213579731848653
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,36552,400,0.36 [0.17-0.74],0.0058861103725318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,37174,404,3.14 [1.88-5.24],1.1667482019290949e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,36507,400,1.07 [0.99-1.15],0.0906049559978449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI1,Neuroserpin,36317,391,1.16 [0.84-1.60],0.3566899171507385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINI2,Serpin I2,37041,407,0.84 [0.70-0.99],0.0411320011945704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41707,446,1.02 [0.89-1.17],0.8070420336444362
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,42223,451,1.18 [0.90-1.55],0.2255988106192064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6,Seizure protein 6 homolog,36175,396,1.29 [0.95-1.75],0.1049775720460273
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,42814,456,0.84 [0.62-1.13],0.2506136287602318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L2,Seizure 6-like protein 2,42503,452,2.21 [1.64-2.99],2.6615527449853575e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SF3B4,Splicing factor 3B subunit 4,42503,452,1.02 [0.91-1.14],0.7738639674670122
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,42223,452,1.57 [1.32-1.86],2.355415076548388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,36382,391,0.76 [0.60-0.97],0.026878975292562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,41668,448,1.28 [1.12-1.45],0.0001965699224533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,41668,448,1.44 [1.26-1.65],1.1190623747641444e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,42691,456,1.15 [1.02-1.30],0.0278643198778067
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,36596,402,1.25 [1.06-1.48],0.0090402654922204
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,41668,448,1.00 [0.91-1.09],0.9782652342168372
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,42620,454,1.02 [0.88-1.17],0.8280280690383077
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,35984,403,0.96 [0.81-1.14],0.6633694843988573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3BP1,SH3 domain-binding protein 1,37041,407,0.90 [0.73-1.12],0.3481860072695748
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GL3,Endophilin-A3,36299,397,0.98 [0.87-1.11],0.7467043556241388
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH3GLB2,Endophilin-B2,37122,409,1.15 [1.00-1.33],0.0570834890384286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHBG,Sex hormone-binding globulin,37239,408,1.71 [1.39-2.10],2.4975991931714465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHC1,SHC-transforming protein 1,35893,396,1.00 [0.92-1.09],0.9553033771755438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHD,SH2 domain-containing adapter protein D,35915,393,0.96 [0.85-1.09],0.5547333261622608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHH,Sonic hedgehog protein,36116,394,0.84 [0.66-1.09],0.1937890518117639
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,37205,407,2.71 [2.11-3.48],4.405148085170502e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",42795,460,1.05 [0.95-1.16],0.3470120929868141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHPK,Sedoheptulokinase,36507,400,1.04 [0.81-1.34],0.7537064977713824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,42740,454,1.52 [1.27-1.82],3.5930136654634368e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,42864,461,2.20 [1.83-2.63],1.8516541148236518e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,42620,454,1.96 [1.57-2.44],2.794098455983896e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,41707,446,1.04 [0.94-1.16],0.4354808376897959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,42688,457,1.07 [0.99-1.16],0.0947135828315398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,43059,464,1.08 [0.84-1.38],0.5347926934010642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,42691,456,2.30 [1.72-3.08],2.4776586207436256e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,36223,386,1.36 [1.10-1.68],0.0046589130197328
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,42997,461,1.81 [1.37-2.39],2.783947382051825e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,36223,386,1.14 [0.85-1.51],0.3834181758673693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42780,459,1.24 [1.06-1.45],0.0070446412936603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,42583,456,1.53 [1.28-1.83],2.5093575309048e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,36116,394,0.95 [0.83-1.09],0.4669774328970124
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,42503,452,1.03 [0.93-1.14],0.5744159697296853
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41707,446,0.97 [0.82-1.14],0.7121111275098315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,41875,450,1.18 [1.02-1.37],0.0296124805309782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,42293,453,1.01 [0.90-1.13],0.9254771306039452
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,42864,461,1.01 [0.93-1.09],0.8600178010151736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKIV2L,Helicase SKI2W,35986,394,0.98 [0.76-1.25],0.8436242319949877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLA2,Src-like-adapter 2,37147,408,0.96 [0.88-1.06],0.4159580875168356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,41875,450,1.38 [1.19-1.60],1.5345900592390518e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,41668,448,1.45 [1.17-1.80],0.000665013620825
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,42620,454,1.50 [1.32-1.72],1.7698372907709279e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,41668,448,1.72 [1.46-2.03],1.1067420074413252e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC12A2,Solute carrier family 12 member 2,35986,394,1.44 [1.03-2.02],0.033127583261111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC13A1,Solute carrier family 13 member 1,37037,409,0.92 [0.77-1.11],0.3958292163276707
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC16A1,Monocarboxylate transporter 1,41707,446,1.33 [1.18-1.51],5.393558556763612e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC1A4,Neutral amino acid transporter A,36175,396,1.00 [0.81-1.22],0.9632653258142754
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,41707,446,1.10 [0.98-1.24],0.1204475280848348
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,35893,396,1.16 [1.00-1.35],0.053975985856338
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,35893,396,0.73 [0.57-0.93],0.0095528767470831
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,41707,446,1.29 [1.02-1.63],0.0346305388014303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,42620,454,0.98 [0.84-1.16],0.8464319183892041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC44A4,Choline transporter-like protein 4,36175,396,0.96 [0.82-1.13],0.6425212471677558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,37205,407,0.86 [0.70-1.05],0.1415362666282775
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC51B,Organic solute transporter subunit beta,35986,394,1.03 [0.89-1.18],0.7067423893757341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36382,391,1.01 [0.89-1.13],0.9159037673712178
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37041,407,1.12 [0.93-1.35],0.2332609543157219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",35893,396,0.99 [0.83-1.18],0.930234709197102
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLIT2,Slit homolog 2 protein,41707,446,1.31 [1.13-1.53],0.000416071113075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,36116,394,0.61 [0.45-0.83],0.0014642482716849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,43059,464,0.70 [0.57-0.86],0.0006544325658061
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,41880,443,0.74 [0.57-0.95],0.0204253353075562
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,36507,400,0.84 [0.72-0.99],0.0336342520605743
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,37041,407,1.05 [0.93-1.18],0.4228293965184329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,36935,405,1.19 [0.94-1.52],0.1525951317285813
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,41668,448,0.95 [0.86-1.06],0.3703394007428195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,37037,409,1.02 [0.88-1.17],0.8198158369969327
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,37037,409,0.91 [0.75-1.11],0.366281068199031
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,42503,452,1.45 [0.93-2.24],0.1012395127794565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,41707,446,1.13 [1.00-1.27],0.0447380112281428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,35893,396,0.99 [0.82-1.19],0.8980726073128041
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,37041,407,1.15 [1.00-1.31],0.0519989124550085
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,43059,464,1.47 [1.15-1.89],0.0022230558364685
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,42864,461,1.88 [1.53-2.30],9.751138875004808e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,42871,459,1.72 [1.48-1.99],1.9350909440466346e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,36116,394,0.99 [0.81-1.20],0.9004960422598315
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42791,460,1.14 [1.01-1.30],0.0375840044730266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37037,409,1.12 [1.00-1.25],0.059541685840306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMS,Spermine synthase,35984,403,0.98 [0.83-1.16],0.8438476720292238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,37047,408,1.12 [1.01-1.24],0.0261994375000939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP23,Synaptosomal-associated protein 23,42691,456,0.99 [0.90-1.10],0.900365443916079
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP25,Synaptosomal-associated protein 25,35984,403,1.08 [0.89-1.32],0.4380209999614018
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAP29,Synaptosomal-associated protein 29,42814,456,1.04 [0.94-1.14],0.4572308442065298
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNAPIN,SNARE-associated protein Snapin,37147,408,0.92 [0.77-1.09],0.3215517175576243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCA,Alpha-synuclein,36382,391,0.95 [0.87-1.04],0.2861786615620524
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNCG,Gamma-synuclein,42367,453,1.13 [0.99-1.28],0.0639583941162499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36223,386,1.50 [1.13-1.98],0.005060073886251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',37122,409,1.22 [1.03-1.45],0.0221853595468246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNU13,NHP2-like protein 1,35986,394,0.92 [0.78-1.09],0.319555482587727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX15,Sorting nexin-15,36382,391,0.99 [0.83-1.19],0.9311025113529262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX18,Sorting nexin-18,37041,407,1.04 [0.83-1.30],0.755706902451773
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX2,Sorting nexin-2,37037,409,1.06 [0.94-1.19],0.3576877112841879
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX5,Sorting nexin-5,36223,386,0.88 [0.62-1.24],0.4592020082136152
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNX9,Sorting nexin-9,42691,456,1.05 [0.92-1.19],0.4763145095370585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],41824,445,1.12 [0.94-1.34],0.2078427336297729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",42688,457,1.93 [1.60-2.32],6.633080692370189e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD3,Extracellular superoxide dismutase,37239,408,1.04 [0.89-1.21],0.6251042972952066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,37147,408,1.40 [1.16-1.68],0.0003858269695035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,41668,448,1.56 [1.24-1.96],0.000170110778365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORD,Sorbitol dehydrogenase,42871,459,1.01 [0.89-1.14],0.902222256771493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,42627,456,1.19 [0.96-1.49],0.113359477698405
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOST,Sclerostin,42627,456,0.68 [0.55-0.85],0.0005729760778587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36175,396,1.07 [0.89-1.30],0.4673577006551945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX2,Transcription factor SOX-2,37073,407,0.85 [0.56-1.31],0.4649048225223779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOX9,Transcription factor SOX-9,36175,396,1.03 [0.71-1.50],0.8721219449627136
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37147,408,1.00 [0.70-1.42],0.99926340893769
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPAG1,Sperm-associated antigen 1,37147,408,0.92 [0.77-1.09],0.3305806866020936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,42814,456,1.06 [0.94-1.20],0.3375116569146846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARCL1,SPARC-like protein 1,42706,453,0.98 [0.72-1.34],0.904434668903316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,36382,391,1.00 [0.88-1.14],0.979020178564614
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPESP1,Sperm equatorial segment protein 1,37203,406,1.37 [1.01-1.85],0.0401214126864088
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,42688,457,1.70 [1.44-2.01],4.6177630309669454e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,36382,391,1.10 [0.85-1.44],0.4591460916159027
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,42620,454,1.24 [1.09-1.40],0.0008508742391321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,42688,457,0.98 [0.77-1.26],0.90409991188244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,43059,464,1.14 [0.97-1.34],0.1061741527145271
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,35986,394,0.87 [0.65-1.16],0.3520612404318485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,42549,456,2.70 [2.13-3.42],2.7815067858193113e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,42864,461,1.40 [1.14-1.72],0.0015121171087573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,37041,407,0.91 [0.86-0.97],0.0027048660460549
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,42367,453,0.87 [0.63-1.21],0.415549562158414
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,42726,459,2.53 [2.04-3.15],5.316557100234399e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,42485,454,2.73 [2.20-3.40],1.5471435143305297e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,43134,461,1.55 [1.30-1.84],7.957955817051035e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36116,394,1.05 [0.83-1.33],0.6887541577022394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRING1,SREBP regulating gene protein,35893,396,0.97 [0.80-1.17],0.7523494989908575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR1B,Cornifin-B,36507,400,0.94 [0.83-1.07],0.3618769893135272
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRR3,Small proline-rich protein 3,37122,409,1.11 [0.96-1.28],0.1585068860802151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,41875,450,1.04 [0.94-1.14],0.4566706462745971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",35984,403,0.96 [0.69-1.33],0.7846579249386092
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,37122,409,1.12 [0.88-1.43],0.3648768268418451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,42743,454,0.96 [0.89-1.03],0.218243419681533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,42503,452,1.19 [1.04-1.36],0.0128405742317785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,42620,454,1.00 [0.90-1.11],0.9705084144728644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,37203,406,1.68 [1.28-2.20],0.0001940214282317
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSB,Lupus La protein,41707,446,1.10 [0.95-1.27],0.1938265291436182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36116,394,1.02 [0.78-1.35],0.8627062186979072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42627,456,0.69 [0.64-0.75],7.566516637792895e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42847,457,1.20 [0.99-1.47],0.0627212480930188
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,35893,396,0.72 [0.50-1.05],0.0864743775497287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,37041,407,1.14 [0.95-1.37],0.1585104418716967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST13,Hsc70-interacting protein,36382,391,0.90 [0.75-1.08],0.254915010025957
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42503,452,1.34 [1.11-1.61],0.0019234400624274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",43204,461,2.30 [1.80-2.94],3.083099098439918e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36116,394,0.92 [0.72-1.16],0.4784585317390045
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,37205,407,1.73 [1.24-2.42],0.0012941992275326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAM,Signal transducing adapter molecule 1,37037,409,1.05 [0.81-1.35],0.7049329483054552
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAMBP,STAM-binding protein,42293,453,0.99 [0.87-1.14],0.9329578831100364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT2,Signal transducer and activator of transcription 2,36116,394,1.04 [0.91-1.18],0.5933398052795205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,42503,452,0.96 [0.90-1.02],0.2094681892791311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,35893,396,1.00 [0.85-1.17],0.9656596139250752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,43074,461,1.36 [1.14-1.63],0.0007249537406255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC2,Stanniocalcin-2,42636,455,1.06 [0.76-1.48],0.7183089892019046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STEAP4,Metalloreductase STEAP4,35984,403,1.02 [0.89-1.17],0.7336157914318289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,42619,456,1.05 [0.92-1.19],0.5054838301120141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK11,Serine/threonine-protein kinase STK11,41880,443,1.01 [0.90-1.14],0.8404123583079484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK24,Serine/threonine-protein kinase 24,41707,446,0.94 [0.82-1.09],0.4043992524479645
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STK4,Serine/threonine-protein kinase 4,42691,456,0.99 [0.89-1.09],0.7776491166416843
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",35893,396,1.02 [0.91-1.14],0.7578838753740739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX16,Syntaxin-16,41668,448,0.93 [0.79-1.10],0.3954760815316374
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX1B,Syntaxin-1B,36175,396,0.94 [0.73-1.20],0.5974498941195695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX3,Syntaxin-3,37122,409,1.03 [0.79-1.34],0.8419327975773766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX4,Syntaxin-4,42503,452,1.13 [0.99-1.28],0.0663507320674699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,36116,394,0.89 [0.68-1.15],0.3682277166828058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX6,Syntaxin-6,41668,448,1.05 [0.92-1.20],0.4761977937820713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX7,Syntaxin-7,36116,394,0.99 [0.80-1.22],0.8971499367289894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,42620,454,1.24 [1.05-1.46],0.0110303544505508
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP1,Syntaxin-binding protein 1,37147,408,1.03 [0.90-1.17],0.6774170443447352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STXBP3,Syntaxin-binding protein 3,41668,448,1.09 [0.90-1.33],0.3820811331368772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,37041,407,0.93 [0.73-1.19],0.5774663931082491
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUGT1,Protein SGT1 homolog,41668,448,1.01 [0.90-1.13],0.8703063060269132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT1A1,Sulfotransferase 1A1,43074,461,0.99 [0.92-1.06],0.7313696092988339
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,42620,454,1.48 [1.33-1.66],2.439792004479109e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF1,Formylglycine-generating enzyme,36116,394,1.12 [0.98-1.29],0.0998528131874946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,43074,461,1.06 [0.90-1.25],0.4747223637138035
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",37147,408,1.17 [1.01-1.36],0.0352475173031449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD1,Sushi domain-containing protein 1,41880,443,0.95 [0.79-1.13],0.550355955047036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,42688,457,2.16 [1.71-2.73],9.37587972998459e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD4,Sushi domain-containing protein 4,37037,409,1.01 [0.79-1.28],0.9580711736816764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,36191,389,0.75 [0.56-1.00],0.0489098180978111
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,36175,396,1.08 [0.93-1.27],0.3088911559143483
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SWAP70,Switch-associated protein 70,37041,407,1.39 [1.09-1.77],0.0078769996058242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYAP1,Synapse-associated protein 1,36382,391,0.94 [0.79-1.12],0.4864544061622446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,35984,403,0.98 [0.83-1.17],0.8545174599396665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYT1,Synaptotagmin-1,37122,409,1.20 [0.95-1.52],0.1237370935448817
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SYTL4,Synaptotagmin-like protein 4,37203,406,1.04 [0.91-1.18],0.6008221859999364
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36507,400,0.96 [0.88-1.06],0.4628666263484446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,42503,452,0.93 [0.86-1.00],0.0417867492717757
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,37842,411,1.92 [1.46-2.53],2.937038463200224e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TADA3,Transcriptional adapter 3,37037,409,1.04 [0.81-1.32],0.7796135522765225
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,42503,452,1.61 [1.30-2.00],1.6492469705848334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAGLN3,Transgelin-3,35893,396,0.91 [0.77-1.08],0.292807313934849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TALDO1,Transaldolase,37065,406,1.15 [0.93-1.43],0.1829696029970386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,41875,450,1.04 [0.92-1.18],0.4962951376381823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAP1,Antigen peptide transporter 1,36507,400,0.92 [0.77-1.10],0.3651106545274747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,41707,446,1.03 [0.92-1.15],0.6379168491183669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36175,396,1.09 [0.96-1.23],0.1759861742892627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37037,409,1.16 [0.89-1.51],0.2677647804443969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,37122,409,1.09 [0.94-1.27],0.2687579300314877
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D17,TBC1 domain family member 17,41707,446,1.06 [0.87-1.28],0.5681086194308014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D23,TBC1 domain family member 23,42503,452,0.96 [0.88-1.06],0.4677365512854936
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBC1D5,TBC1 domain family member 5,42620,454,1.03 [0.93-1.15],0.5718198354243704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCA,Tubulin-specific chaperone A,36382,391,0.98 [0.87-1.10],0.7264989092133223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCB,Tubulin-folding cofactor B,42367,453,1.01 [0.93-1.10],0.7727381270399737
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBCC,Tubulin-specific chaperone C,42367,453,1.01 [0.91-1.12],0.8823996438051281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,41668,448,0.94 [0.85-1.05],0.2661290881712835
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TBR1,T-box brain protein 1,36175,396,0.94 [0.77-1.16],0.5720495410386892
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,42304,453,0.97 [0.89-1.06],0.5390773571337255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,41880,443,0.99 [0.89-1.11],0.9007130120080622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN1,Transcobalamin-1,36497,402,1.87 [1.49-2.35],5.4272750690741424e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,43134,461,2.03 [1.59-2.59],1.0091172328901897e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,37203,406,1.48 [1.14-1.92],0.0029358620415454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCP11,T-complex protein 11 homolog,36507,400,1.14 [0.99-1.32],0.0776658977583318
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,37203,406,2.34 [1.72-3.20],8.437593960897438e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,41707,446,1.05 [0.99-1.12],0.0828556097514131
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",36175,396,1.39 [1.14-1.69],0.0013488258772692
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,37037,409,1.02 [0.88-1.17],0.8129361247427719
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TDRKH,Tudor and KH domain-containing protein,41707,446,1.06 [0.96-1.18],0.2572089397107001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEF,Thyrotroph embryonic factor,35986,394,0.97 [0.76-1.24],0.8005282419359403
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEK,Angiopoietin-1 receptor,42814,456,1.55 [1.06-2.27],0.0243031487901654
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TERF1,Telomeric repeat-binding factor 1,36116,394,0.97 [0.68-1.39],0.8884910447582839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TET2,Methylcytosine dioxygenase TET2,36436,400,0.99 [0.90-1.10],0.8944812022033684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX101,Testis-expressed protein 101,36175,396,0.73 [0.61-0.88],0.0010540323809399
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TEX33,Testis-expressed protein 33,36507,400,1.03 [0.82-1.29],0.8188735570209573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TF,Serotransferrin,37249,405,1.28 [0.81-2.02],0.2934989778940421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,35984,403,1.01 [0.85-1.20],0.9220103807645098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,42478,454,1.45 [1.33-1.59],1.1427718879370673e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,42795,460,2.15 [1.92-2.42],1.0817979394458222e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,42640,452,1.70 [1.48-1.96],1.2082708699727897e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,42565,455,1.28 [1.00-1.64],0.0535566776330287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,42683,454,1.60 [1.41-1.83],1.874403618548552e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFRC,Transferrin receptor protein 1,42849,454,1.17 [0.94-1.44],0.1565288754555074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TG,Thyroglobulin,37037,409,0.88 [0.79-0.97],0.0092162139369214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,42620,454,1.86 [1.60-2.17],7.276196836874887e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,43075,460,1.79 [1.46-2.19],2.248903149950731e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,37037,409,1.19 [1.00-1.43],0.0559702408766496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,42425,454,1.57 [1.15-2.15],0.0042890568562904
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR1,TGF-beta receptor type-1,36116,394,1.52 [1.02-2.28],0.041587583889221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,42814,456,2.04 [1.65-2.53],6.43580068062889e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,43204,461,1.71 [1.30-2.25],0.0001116056301983
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,42623,456,1.09 [0.97-1.22],0.1343929164974373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,37239,408,1.70 [1.19-2.44],0.0037923084617142
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,35828,395,0.90 [0.79-1.02],0.1064534551575713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBD,Thrombomodulin,42691,456,1.40 [1.05-1.87],0.023696308199308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,42688,457,2.50 [2.11-2.96],3.3935447892262024e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS4,Thrombospondin-4,42706,456,1.42 [1.19-1.70],0.000131124562971
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,42492,455,1.35 [1.05-1.74],0.0186259240380586
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,41880,443,0.98 [0.79-1.22],0.8647826915536926
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,35986,394,1.10 [1.01-1.19],0.0233464919639274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,35829,387,1.06 [0.79-1.43],0.6948664600746863
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THTPA,Thiamine-triphosphatase,36969,408,0.95 [0.85-1.06],0.378352499704325
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THY1,Thy-1 membrane glycoprotein,43074,461,1.64 [1.24-2.17],0.0005620713381744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,41412,435,1.02 [0.95-1.09],0.6596202382902607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,43204,461,1.47 [1.17-1.86],0.0010242444053699
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41633,446,1.34 [1.13-1.60],0.0008619820316784
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36507,400,1.13 [0.87-1.48],0.3518338786856558
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42847,457,1.44 [1.20-1.74],0.0001274774290783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37203,406,1.04 [0.82-1.32],0.752632130110955
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37122,409,1.01 [0.90-1.13],0.917109828726569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,42213,449,2.78 [2.18-3.53],6.537405769688508e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,37203,406,1.44 [1.10-1.89],0.0074527655938252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,42864,461,1.10 [1.03-1.17],0.0023453653166628
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,42688,457,2.50 [2.10-2.97],9.518957992496336e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,42552,456,1.49 [1.03-2.17],0.0346171661776419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,42814,456,0.95 [0.86-1.06],0.3871130690074472
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJP3,Tight junction protein ZO-3,35984,403,1.14 [0.91-1.43],0.2595497316784488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TK1,"Thymidine kinase, cytosolic",36507,400,1.18 [0.96-1.45],0.1102578815807301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR1,Toll-like receptor 1,36116,394,1.40 [0.97-2.04],0.0739035167106992
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR2,Toll-like receptor 2,36507,400,1.38 [0.90-2.12],0.1414731858833739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR3,Toll-like receptor 3,43147,461,1.06 [0.93-1.22],0.3752526900316681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TLR4,Toll-like receptor 4,36116,394,1.72 [1.23-2.39],0.0013786310839625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36175,396,1.08 [0.89-1.30],0.4537846083406447
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,36507,400,1.01 [0.84-1.21],0.9298728863470982
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,35986,394,1.00 [0.81-1.24],0.995467169957666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,35986,394,1.09 [0.92-1.30],0.3151381139872781
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMED8,Protein TMED8,37041,407,1.02 [0.92-1.12],0.7589988952231846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM106A,Transmembrane protein 106A,37037,409,0.96 [0.84-1.10],0.5636806542337855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM132A,Transmembrane protein 132A,36223,386,1.22 [1.04-1.43],0.0132549250274171
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMEM25,Transmembrane protein 25,37147,408,1.12 [0.92-1.36],0.2556367725112254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMOD4,Tropomodulin-4,35893,396,1.00 [0.77-1.29],0.9944701279446012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,35984,403,0.95 [0.82-1.09],0.451834266708356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,37054,407,1.80 [1.43-2.26],5.399599683376131e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,42503,452,0.98 [0.89-1.08],0.676317939196422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS5,Transmembrane protease serine 5,42163,451,1.01 [0.80-1.27],0.926382687953734
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,42688,457,1.12 [1.00-1.25],0.053238180326123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,42847,457,1.76 [1.49-2.08],3.560790624633739e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,41825,443,1.44 [1.21-1.72],5.640894253205384e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37041,407,1.28 [1.08-1.53],0.0054761049294619
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41875,450,0.95 [0.74-1.21],0.6537305349930174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36382,391,0.89 [0.76-1.04],0.1525149813219599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42367,453,2.69 [2.21-3.28],7.023985541202161e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42367,453,1.61 [1.44-1.79],6.974892249562915e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42783,459,1.35 [1.14-1.61],0.0006707531920565
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,43147,461,1.66 [1.36-2.02],3.937196316216933e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42656,457,3.42 [2.67-4.37],1.5443601826417322e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42814,456,2.19 [1.79-2.68],4.3382180578598114e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42726,459,1.33 [1.07-1.65],0.0092688711683958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41875,450,0.80 [0.65-0.98],0.0346487269856143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42726,459,2.05 [1.60-2.63],1.2239685057257728e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36382,391,1.28 [1.01-1.62],0.0440358488322238
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,43059,464,1.31 [1.02-1.67],0.0336364155055282
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42688,457,2.63 [2.08-3.33],1.1545439134928725e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42688,457,1.80 [1.55-2.08],5.391438154653717e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,43074,461,2.08 [1.56-2.77],5.14147514091735e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,43075,460,1.79 [1.46-2.19],1.661779308532275e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42367,453,1.75 [1.55-1.98],6.480972456335695e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,43074,461,1.33 [1.12-1.59],0.0012915618638369
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42367,453,1.54 [1.30-1.83],7.160917232002817e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,43147,461,0.62 [0.45-0.84],0.002359035158239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,42620,454,0.75 [0.65-0.86],2.66471751733151e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,43147,461,0.47 [0.35-0.63],3.7220838055249473e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,42864,461,2.49 [1.86-3.35],1.3262030705899722e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,43130,460,2.66 [2.11-3.34],7.602757233008382e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,42367,453,1.25 [1.09-1.45],0.0018361407375634
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,37205,407,1.55 [1.21-1.98],0.0005069708605363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,37122,409,1.04 [0.93-1.16],0.5164124728519999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNN,Tenascin-N,37205,407,0.81 [0.64-1.02],0.0718989271656329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNNI3,"Troponin I, cardiac muscle",41880,443,1.08 [0.97-1.20],0.1609291448790949
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNPO1,Transportin-1,36507,400,1.13 [0.85-1.51],0.3923722783695929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,42367,453,0.61 [0.50-0.74],1.0598176179581589e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNXB,Tenascin-X,42688,457,1.45 [1.05-2.00],0.0239961051325575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37203,406,1.13 [1.00-1.28],0.0507419801579804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,37041,407,1.03 [0.94-1.12],0.5655669700007755
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",35893,396,0.97 [0.78-1.20],0.7678639495738542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,36116,394,1.04 [0.92-1.18],0.5497989724645285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,36223,386,1.02 [0.85-1.23],0.8350678272238942
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53,Cellular tumor antigen p53,41668,448,0.93 [0.76-1.15],0.4994627432244336
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,36116,394,1.06 [0.94-1.20],0.3103649707657587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,35606,386,1.19 [0.99-1.43],0.0673440148330082
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,41880,443,1.19 [0.93-1.53],0.1711022455683609
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP73,Tumor protein p73,36175,396,0.89 [0.66-1.19],0.4319706190560705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPBGL,Trophoblast glycoprotein-like,36175,396,1.01 [0.79-1.30],0.9112588990353386
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPD52L2,Tumor protein D54,36382,391,0.96 [0.87-1.05],0.3469966043645182
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,37203,406,1.23 [0.89-1.71],0.2127584777810321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPM3,Tropomyosin alpha-3 chain,35986,394,0.97 [0.77-1.22],0.7801558804787778
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPMT,Thiopurine S-methyltransferase,41668,448,1.03 [0.91-1.16],0.6180097790981378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,42378,455,1.80 [1.56-2.07],8.49928966093245e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,36507,400,1.04 [0.92-1.18],0.5286656573696678
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,41707,446,0.94 [0.75-1.19],0.6248647653773509
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPR,Nucleoprotein TPR,35986,394,1.17 [0.99-1.39],0.0637698396690419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,35893,396,0.95 [0.81-1.13],0.5822239237208626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSAB1,Tryptase alpha/beta-1,43078,460,0.87 [0.74-1.02],0.0928260816971009
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSD1,Tryptase delta,37147,408,0.96 [0.73-1.26],0.7763251296520206
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPSG1,Tryptase gamma,36116,394,1.01 [0.68-1.48],0.9796122943196768
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,41875,450,0.82 [0.70-0.96],0.0165910475156599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF2,TNF receptor-associated factor 2,42620,454,0.89 [0.78-1.00],0.0589162175781451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",36116,394,0.85 [0.64-1.12],0.2450163070934806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,35986,394,0.87 [0.69-1.09],0.226776646175482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36507,400,1.08 [0.97-1.21],0.1766748857188761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREH,Trehalase,37205,407,0.87 [0.76-0.98],0.0279215287360868
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,42656,457,1.78 [1.54-2.05],6.673491660190546e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML1,Trem-like transcript 1 protein,37239,408,0.96 [0.80-1.16],0.6889336362160234
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREML2,Trem-like transcript 2 protein,42688,457,0.74 [0.57-0.94],0.0153378386550908
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,43059,464,1.20 [1.05-1.37],0.0071200198174297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,42620,454,0.91 [0.81-1.01],0.0842966908828134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,36436,399,0.98 [0.84-1.14],0.749438611846097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37041,407,1.02 [0.93-1.11],0.7355418150569248
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM26,Tripartite motif-containing protein 26,35893,396,1.00 [0.84-1.19],0.9602044185170764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,36175,396,1.00 [0.87-1.14],0.9945689634821704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM5,Tripartite motif-containing protein 5,42620,454,0.97 [0.88-1.07],0.5722489081148521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,37037,409,1.01 [0.90-1.13],0.8977097052175103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,35986,394,1.00 [0.81-1.23],0.9909698094368792
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC1,Hamartin,36116,394,0.93 [0.79-1.09],0.3509313183086501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSC22D1,TSC22 domain family protein 1,37147,408,1.10 [0.95-1.27],0.2063996029590642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSHB,Thyrotropin subunit beta,42691,456,0.94 [0.84-1.05],0.2882792002726512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSLP,Thymic stromal lymphopoietin,41880,443,1.10 [0.97-1.26],0.1474777448281762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSNAX,Translin-associated protein X,35986,394,0.91 [0.70-1.18],0.4952183303146841
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN1,Tetraspanin-1,41880,443,0.76 [0.64-0.91],0.0023930891676976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN15,Tetraspanin-15,35986,394,0.97 [0.79-1.20],0.781106602307236
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,35984,403,0.93 [0.82-1.05],0.2211158625148683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,37041,407,1.30 [1.18-1.43],1.2939215333846388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,36116,394,1.06 [0.82-1.36],0.6725792251199244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TST,Thiosulfate sulfurtransferase,41629,446,1.07 [0.95-1.20],0.2520463051985262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTF2,Transcription termination factor 2,36175,396,0.98 [0.80-1.21],0.8532634562775501
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTN,Titin,35986,394,1.02 [0.87-1.19],0.8319809611017048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TTR,Transthyretin,36846,401,0.37 [0.26-0.52],2.1269082004160632e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TUBB3,Tubulin beta-3 chain,35984,403,1.31 [0.93-1.84],0.1218549168072132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TWF2,Twinfilin-2,37205,407,1.02 [0.91-1.15],0.7025698695371134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXK,Tyrosine-protein kinase TXK,36507,400,0.90 [0.77-1.04],0.1614212828694373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,42367,453,1.03 [0.94-1.14],0.510876360033824
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXN,Thioredoxin,36638,400,1.08 [0.87-1.35],0.4842066584044799
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,42814,456,2.47 [1.86-3.27],3.492219575831205e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,43074,461,1.21 [1.07-1.36],0.00183159239522
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,37122,409,1.07 [0.89-1.28],0.4814281695476269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNL1,Thioredoxin-like protein 1,35913,402,0.98 [0.87-1.10],0.7194233546128214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42688,457,1.11 [0.92-1.33],0.2698314635732646
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,42413,451,1.17 [1.03-1.33],0.017669928421873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,42691,456,1.63 [1.21-2.20],0.00140494206735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36116,394,1.11 [0.94-1.31],0.200664834439354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,42503,452,1.09 [0.85-1.41],0.4923675840184186
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,37037,409,1.10 [0.77-1.58],0.6086634971308829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37203,406,1.15 [0.98-1.35],0.0836244186266498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36116,394,0.92 [0.76-1.11],0.3808520733601352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBQLN3,Ubiquilin-3,35986,394,1.13 [0.94-1.35],0.1946581532941502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBXN1,UBX domain-containing protein 1,36382,391,0.96 [0.83-1.11],0.5599720619469011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37041,407,0.97 [0.90-1.04],0.406546973821479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,35986,394,1.04 [0.94-1.15],0.449607513962823
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,35986,394,1.11 [0.83-1.49],0.4827989530739034
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,42367,453,1.90 [1.55-2.33],4.410292554439989e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,43066,459,0.72 [0.62-0.83],7.620413727733109e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC5D,Netrin receptor UNC5D,36116,394,0.82 [0.55-1.23],0.3407739881489856
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNC79,Protein unc-79 homolog,35893,396,0.95 [0.79-1.15],0.5980317699123341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UNG,Uracil-DNA glycosylase,37037,409,1.02 [0.76-1.37],0.9064325332583244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,37203,406,1.10 [0.99-1.22],0.0643155445027159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3A,Uroplakin-3a,35984,403,1.11 [0.91-1.36],0.294068697477494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,36433,399,0.98 [0.82-1.18],0.8691596710256114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROD,Uroporphyrinogen decarboxylase,36382,391,0.90 [0.77-1.05],0.1682942943738028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UROS,Uroporphyrinogen-III synthase,36175,396,0.98 [0.84-1.15],0.8395344789093244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USO1,General vesicular transport factor p115,42503,452,1.02 [0.93-1.12],0.6791088708574127
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,37037,409,1.02 [0.89-1.17],0.795348721843379
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,37122,409,1.25 [0.99-1.58],0.0576547418523607
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,35986,394,0.98 [0.87-1.11],0.7571182062288175
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,41880,443,0.97 [0.88-1.06],0.5135121624242682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,41668,448,1.11 [0.94-1.30],0.2162722882617
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,41880,443,1.49 [1.32-1.69],8.578622685489918e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,36116,394,1.08 [0.96-1.20],0.2085109541641749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,42620,454,0.97 [0.88-1.08],0.5878818093180849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASN,Vasorin,41997,449,0.80 [0.58-1.09],0.1623277936165833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,37239,408,0.99 [0.87-1.13],0.896675263138684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42503,452,0.66 [0.43-1.02],0.0641317147602705
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,35984,403,0.96 [0.86-1.06],0.3946870397704229
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAM1,Vascular cell adhesion protein 1,42779,457,2.05 [1.55-2.72],6.203739585011689e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,43074,461,1.69 [1.29-2.21],0.0001316909660974
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,35893,396,1.05 [0.93-1.18],0.4301127947548944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,43007,461,1.41 [1.23-1.62],6.127368158161723e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFB,Vascular endothelial growth factor B,36116,394,2.47 [1.76-3.45],1.478757198471036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,42814,456,0.99 [0.85-1.16],0.9354400276514484
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,43074,461,1.40 [1.12-1.76],0.0036183957646925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VGF,Neurosecretory protein VGF,37147,408,0.82 [0.60-1.13],0.2310476986296313
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIM,Vimentin,41880,443,1.05 [0.97-1.14],0.2330674630842381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,36223,386,1.10 [0.72-1.69],0.6496854646398812
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,37203,406,1.54 [1.19-1.99],0.0009469829678121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,42503,452,1.13 [1.00-1.29],0.0592683749659701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN1,Pantetheinase,37239,408,1.24 [1.07-1.42],0.0034333555040878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,42503,452,1.93 [1.58-2.35],8.358092285624898e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,36507,400,0.92 [0.79-1.07],0.27299575771118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,42503,452,0.90 [0.80-1.00],0.054789581188321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,37037,409,0.95 [0.86-1.06],0.3753385524747978
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,42503,452,0.99 [0.89-1.11],0.8718151025417377
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,37037,409,1.17 [0.91-1.51],0.2128488245353776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,35986,394,1.37 [1.04-1.80],0.0273344977474802
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,37037,409,1.94 [1.70-2.21],7.48788767302935e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,42636,455,1.98 [1.64-2.39],6.07316056243248e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42632,455,1.13 [0.99-1.29],0.0690354019845589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,37122,409,1.30 [1.03-1.65],0.0268301212388548
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,41707,446,1.26 [1.06-1.50],0.0081654544971098
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,36507,400,1.08 [0.85-1.37],0.5256568498910493
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41880,443,1.09 [0.94-1.26],0.241448626461698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,43074,461,1.05 [0.93-1.19],0.4118788392388623
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,41668,448,1.58 [1.22-2.04],0.0005976735442314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36382,391,1.06 [0.90-1.26],0.4909823287806785
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,43000,464,2.11 [1.76-2.52],8.727593619993927e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,35893,396,1.10 [0.99-1.23],0.0874546715193563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,42220,453,1.29 [1.05-1.59],0.0167375847273887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,37147,408,0.93 [0.74-1.18],0.5577574899834153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWF,von Willebrand factor,43204,461,1.26 [1.13-1.42],4.616181770528252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",42688,457,1.51 [1.20-1.89],0.0003801053754557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,41875,450,1.02 [0.89-1.16],0.7757622780445738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,41880,443,0.97 [0.89-1.07],0.5879486510252316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,41707,446,0.98 [0.88-1.09],0.7110341892151959
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASHC3,WASH complex subunit 3,37122,409,1.00 [0.87-1.13],0.9477209963163838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,36116,394,0.98 [0.82-1.17],0.7861702341302432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WDR46,WD repeat-containing protein 46,37037,409,1.03 [0.79-1.34],0.8111031902639099
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,36287,402,1.16 [0.97-1.38],0.0991790973264711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,42985,463,1.33 [1.17-1.51],9.347529186869952e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,40551,426,2.42 [2.06-2.84],1.964728807427069e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42223,451,0.31 [0.25-0.38],2.5221692455703434e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42726,459,1.06 [0.83-1.36],0.6457315668655117
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,43059,464,1.43 [1.13-1.81],0.0027731011358608
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,41875,450,1.69 [1.30-2.20],7.674444616112754e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42367,453,0.94 [0.79-1.11],0.4386045894011421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,43059,464,1.24 [1.08-1.43],0.0026266901518803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XG,Glycoprotein Xg,42997,459,1.09 [0.85-1.39],0.5145085291101046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,36116,394,1.02 [0.85-1.21],0.8551029304346104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,42814,456,1.02 [0.94-1.10],0.7040246432913644
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XRCC4,DNA repair protein XRCC4,41707,446,1.21 [0.96-1.52],0.0998995115205303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,37122,409,2.43 [1.83-3.23],9.62745334688145e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37041,407,1.04 [0.97-1.11],0.3026979796712514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YES1,Tyrosine-protein kinase Yes,42503,452,1.01 [0.94-1.09],0.7318374822339418
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YJU2,Splicing factor YJU2,37037,409,0.99 [0.73-1.33],0.9416709396562198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,35986,394,0.94 [0.80-1.11],0.4814559796468267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YTHDF3,YTH domain-containing family protein 3,41875,450,1.01 [0.91-1.12],0.8778857690388513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YWHAQ,14-3-3 protein theta,36382,391,0.97 [0.84-1.11],0.6403263927483895
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YY1,Transcriptional repressor protein YY1,36116,394,0.76 [0.52-1.09],0.1375599441421538
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBP1,Z-DNA-binding protein 1,36116,394,0.86 [0.66-1.13],0.2889884780369121
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,41668,448,0.94 [0.83-1.07],0.3453670630610197
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,41880,443,1.46 [1.24-1.71],3.8960239672627774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,35986,394,0.98 [0.83-1.16],0.8491502049418205
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,37041,407,0.97 [0.87-1.08],0.5436791908770227
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,37122,409,1.19 [0.92-1.54],0.1806896183786428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF174,Zinc finger protein 174,36116,394,0.89 [0.65-1.21],0.4493406339291032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF75D,Zinc finger protein 75D,36507,400,1.11 [0.96-1.28],0.1625569803015201
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNF830,Zinc finger protein 830,37037,409,0.99 [0.87-1.13],0.870310794128531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,37041,407,1.05 [0.91-1.20],0.5032944918572473
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37037,409,0.91 [0.75-1.10],0.3178793050641927
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,36223,386,1.01 [0.97-1.05],0.761457324965398
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,35893,396,1.01 [0.75-1.37],0.9262279322548476
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZPR1,Zinc finger protein ZPR1,35984,403,1.04 [0.94-1.15],0.429932745841134
